Modular asymmetric synthesis of functionalized azaspirocycles based on the sulfoximine auxiliary by Adrien, Adeline
Modular Asymmetric Synthesis of Functionalized 
Azaspirocycles Based on the Sulfoximine Auxiliary 
Von der Fakultät für Mathematik, Informatik und Naturwissenschaften der Rheinisch-
Westfälischen Technischen Hochschule Aachen zur Erlangung des akademischen Grades 
einer Doktorin der Naturwissenschaften genehmigte Dissertation 
vorgelegt von 
Master of Science 
Adeline Adrien 
aus Lille (Frankreich) 
Berichter: Universitätsprofessor Dr. Ing. Hans-Joachim Gais 
 Universitätsprofessor Dr. rer. nat. Dieter Enders 
Tag der mündlichen Prüfung: 14. März 2008 
Diese Dissertation ist auf den Internetseiten der Hochschulbibliothek online verfügbar. 
The work presented in this thesis was carried out at the Institute of Organic Chemistry of the 
RWTH Aachen University between January 2005 and December 2007 under the supervision 
of PROF. DR. HANS-JOACHIM GAIS. 
First I would like to thank PROF. DR. HANS-JOACHIM GAIS for giving me the opportunity to 
work on this exciting research topic and for the useful discussions. Then I would like to thank 
PROF. DR. DIETER ENDERS for his kind assumption of the co-reference. 
Furthermore I would like to thank the personnel of the Organic Chemistry Institute of the 
RWTH Aachen for their appreciated help during my work, and all the members of the GAIS 
group. I would like to thank my labmates FABIEN LEMASSON, DR. VASILY TSAREV and DR.
PRABAL BANERJEE for the very nice atmosphere during these three years. Special thanks are 
going to CORNELIA VERMEEREN and MAGDALENA GERENCER for carrying out analytical as 
well as preparative HPLC. I sincerely thank VERENA SCHIRRA and BJÖRN SOMMER for the 
preparation of starting materials. 
I would like to thank all people who made my time in Aachen so nice, I will not forget you! 
Last but not least, I would like to thank my family and friends for being always by my side 
and supporting me.  
Parts of this work have already been published in 
A. Adrien, H.-J. Gais, F. Köhler, J. Runsink, G. Raabe 
„Modular Asymmetric Synthesis of Functionlized Azaspirocycles Based on the 
Sulfoximine Auxiliary“ 
Org. Lett. 2007, 9, 2155-2158. 
A Franz, 
A mes parents, 
Table of contents 
A. THEORETICAL PART ..................................................................................................... 1 
1. Introduction to azaspirocycles and aims of the project ................................................................................. 2
1.1 Naturally occurring azaspirocycles .............................................................................................................. 2
1.2 Retrosynthetic analysis of azaspirocyclic core structures............................................................................. 5
1.3 Total syntheses of halichlorine and pinnaic acid.......................................................................................... 6
1.4 Our approach to azaspirocycles.................................................................................................................... 8
2. Construction of the carbocycle having an amino-substituted tertiary C atom.......................................... 10
2.1 The chiral auxiliary .................................................................................................................................... 10
2.1.1 Properties of the chiral auxiliary......................................................................................................... 10
2.1.2 Preparation of chiral auxiliary 15 ....................................................................................................... 11
2.2 Synthesis of oxazinones 29a and 29b ........................................................................................................ 12
2.3 Synthesis of cyclic allylic sulfoximines ..................................................................................................... 12
2.4 Hydroxyalkylation of allylic sulfoximines ................................................................................................. 13
2.4.1 Introduction to hydroxyalkylation of cyclic allylic sulfoximines ....................................................... 13
2.4.2 Application of the hydroxyalkylation reaction to the synthesis of azaspirocycles ............................. 15
2.4.3 Rationalization of the stereoselectivity outcome ................................................................................ 16
2.5 Formation of carbamates from homoallylic alcohols 28a and 28b ............................................................ 19
2.5.1 Results ................................................................................................................................................ 19
2.5.2 Mechanism for the Z/E isomerization................................................................................................. 20
2.6 Aza-MICHAEL addition............................................................................................................................... 22
2.6.1 Results ................................................................................................................................................ 22
2.6.2 Discussion........................................................................................................................................... 22
2.7 Possible structural variations of the carbocycle and the side chain ............................................................ 25
2.7.1 Variations of the carbocycle ............................................................................................................... 26
2.7.2 Hydroxyalkylation with other aldehydes ............................................................................................ 27
3. The Ring-closing metathesis route................................................................................................................. 28
3.1 The plan...................................................................................................................................................... 28
3.2 Synthesis of amino alcohol 49 from sulfoximine 29a ................................................................................ 28
3.3 Iodide substitution ...................................................................................................................................... 29
3.4 Cuprate substitution.................................................................................................................................... 31
3.5 Ring-Closing Metathesis ............................................................................................................................ 33
3.6 Structural variations of the target molecule................................................................................................ 34
4. Cycloalkylation and removal of the sulfoximine group ............................................................................... 36
4.1 The plan...................................................................................................................................................... 36
4.1.1 Target molecule .................................................................................................................................. 36
4.1.2 Dilithiated sulfoximines in the literature ............................................................................................ 36
4.1.3 From dilithiated sulfoximines to the synthesis of the heterocycle ...................................................... 37
Table of contents 
4.2 Cycloalkylation: Similar examples in the literature ................................................................................... 37
4.2.1 With sulfone and carbamate ............................................................................................................... 37
4.2.2 With sulfone and amide ...................................................................................................................... 38
4.2.3 With sulfoxide/sulfone and sulfonamide ............................................................................................ 39
4.3 Cycloalkylation: Results............................................................................................................................. 40
4.4 Cycloalkylation: Discussion....................................................................................................................... 41
4.4.1 Determination of the configuration at the newly formed stereogenic center ...................................... 41
4.4.2 Rationalization of the observed conversions ...................................................................................... 43
4.4.3 Rationalization of the stereoselectivity outcome ................................................................................ 44
4.5 Chloride substitution of the sulfoximine group of the tricycle ................................................................... 47
4.5.1 Results ................................................................................................................................................ 47
4.5.2 Determination of the absolute configuration ...................................................................................... 47
4.5.3 Mechanism of the substitution of secondary sulfoximines................................................................. 48
4.6 Reduction of the sulfoximine moiety ......................................................................................................... 49
5. Functionalization by generation of an N-acyliminium ion .......................................................................... 51
5.1 The plan...................................................................................................................................................... 51
5.2 Importance and reactivity of N-acyliminium ions...................................................................................... 51
5.2.1 Importance of N-acyliminium ions..................................................................................................... 51
5.2.2 Formation and reactivity of N-acyliminium ions................................................................................ 52
5.3 Synthesis of precursors 76 and 78 for the N-acyliminium ion 77 .............................................................. 53
5.3.1 Synthesis of the protected acetal......................................................................................................... 53
5.3.2 Deprotection and cyclization .............................................................................................................. 55
5.4 Applications and structural variations ........................................................................................................ 56
6. Studies toward the synthesis of halichlorine and pinnaic acid.................................................................... 59
6.1 Total and formal syntheses of halichlorine and pinnaic acid in the literature ............................................ 59
6.2 Formal total synthesis including the construction of the stereocenter in α-position to the N-atom of the 
heterocycle ....................................................................................................................................................... 60
6.2.1 The plan.............................................................................................................................................. 60
6.2.2 Stereoselective deprotonation in α-position to the N-atom ................................................................ 63
6.2.3 Addition to N-acyliminium ions ......................................................................................................... 65
6.3 Formal total synthesis avoiding the construction of the stereocenter in α-position to the N-atom of the 
heterocycle ....................................................................................................................................................... 70
6.3.1 The plan.............................................................................................................................................. 70
6.3.2 Results and discussion ........................................................................................................................ 72
6.3.3 Using the double lithiation methodology............................................................................................ 75
6.4 Outlook....................................................................................................................................................... 75
7. Synthesis of protected δ-hydroxy-β-amino acids.......................................................................................... 77
7.1 Introduction to β-amino acids .................................................................................................................... 77
7.1.1 Importance of β-amino acids .............................................................................................................. 77
Table of contents 
7.1.2 Retrosynthesis of β-amino acids......................................................................................................... 78
7.2 Toward a selective protection of δ-hydroxy β-amino acids ....................................................................... 78
7.2.1 Methodology developed by GAIS et al................................................................................................ 78
7.2.2 The plan.............................................................................................................................................. 79
7.3 Results ........................................................................................................................................................ 80
7.3.1 Substitution of the sulfoximine group by a chlorine atom.................................................................. 81
7.3.2 Substitution of the chlorine atom by cyanide ..................................................................................... 81
7.3.3 Cyclization to the lactone ................................................................................................................... 82
7.3.4 Cyclization to the β-lactam................................................................................................................. 82
8. Synthesis of cycloalkenyl oxiranes ................................................................................................................. 83
8.1 Introduction to vinyl oxiranes .................................................................................................................... 83
8.1.1 Vinyl oxiranes as structural element in natural products .................................................................... 83
8.1.2 Vinyl epoxides as interesting starting materials for further transformations ...................................... 83
8.2 Introduction to cycloalkenyl oxiranes ........................................................................................................ 85
8.2.1 Diastereoselective syntheses of cycloalkenyl oxiranes....................................................................... 85
8.2.2 Enantioselective syntheses of cycloalkenyl oxiranes.......................................................................... 86
8.3 REDDY´s synthesis of cycloalkenyl aziridines............................................................................................ 87
8.4 Synthesis of cycloalkenyl oxiranes ............................................................................................................ 88
8.5 Discussion .................................................................................................................................................. 89
8.5.1 Mechanism ......................................................................................................................................... 89
8.5.2 Rationalization of the stereoselectivity outcome ................................................................................ 90
8.6 Conclusion and outlook.............................................................................................................................. 92
9. Conclusion and outlook .................................................................................................................................. 93
B. EXPERIMENTAL PART................................................................................................. 96 
1. General remarks ............................................................................................................................................. 97
2. Construction of the carbocycle having an amino-substituted tertiary C atom........................................ 101
2.1 Synthesis of the cyclic allylic sulfoximines ............................................................................................. 101
2.1.1 (–)-(R)-(S-Cyclopent-1-enylmethyl)-N-methyl-S-phenylsulfoximine (27a) .................................... 101
2.1.1 (–)-(R)-(S-Cyclohexyl-1-enylmethyl)-N-methyl-S-phenylsulfoximine (27b).................................. 102
2.2 Titanium mediated γ-hydroxyalkylation of cyclic allylic sulfoximines with acetaldehyde...................... 102
2.2.1 γ-Hydroxyalkylation of allylic sulfoximine 27a............................................................................... 102
2.2.2 γ-Hydroxyalkylation of allylic sulfoximine 27b............................................................................... 105
2.3 Synthesis of the carbamate from the alcohol............................................................................................ 106
2.3.1 Carbamate from alcohol 28a ............................................................................................................ 106
2.3.2 Carbamate from alcohol 28b ............................................................................................................ 108
2.4 Intramolecular aza-MICHAEL addition...................................................................................................... 110
Table of contents 
2.4.1 (4R,4aS,7aR)-4-Methyl-7a-(((R)-N-
methylphenylsulfonimidoyl)methyl)hexahydrocyclopenta[d][1,3]oxazin-2(1H)-one (29a) ..................... 110
2.4.2 (4R,4aS,8aR)-4-Methyl-8a-(((R)-N-methylphenylsulfonimidoyl)methyl)hexahydro-1H-
benzo[d][1,3]oxazin-2(4H)-one (29b) ....................................................................................................... 112
3. The Ring-closing metathesis route............................................................................................................... 114
3.1 (4R,4aS,7aR)-7a-(Iodomethyl)-4-methylhexahydrocyclopenta[d][1,3]oxazin-2(1H)-one (50)................ 114
3.2 (4R,4aS,7aS)-7a-Allyl-4-methylhexahydrocyclopenta[d][1,3]oxazin-2(1H)-one (60)............................. 115
3.3 (4R,4aS,7aS)-7a-(But-2-enyl)-4-methylhexahydrocyclopenta[d][1,3]oxazin-2(1H)-one (62) ................. 116
3.4 (4R,4aS,7aS)-1-Allyl-7a-(but-2-enyl)-4-methylhexahydrocyclopenta[d][1,3]oxazin-2(1H)-one (52) ..... 117
3.5 (3aS,4R,111S)-4-Methyl-2,3,3a,4,8,11-hexahydrocyclopenta[d]pyrido[1,2-c][1,3]oxazin-6(1H)-one (53)
........................................................................................................................................................................ 119
3.6 (R)-1-((1S,5S)-6-Azaspiro[4.5]dec-8-en-1-yl)ethanol (49) ...................................................................... 120
4. Cycloalkylation and removal of the sulfoximine ........................................................................................ 122
4.1 General procedure for the cycloalkylation (GP1) ..................................................................................... 122
4.2 (3aS,4R,11S,111R)-4-Methyl-11-((R)-N-methylphenylsulfonimidoyl)octahydrocyclopenta[d]pyrido[1,2-
c][1,3]oxazin-6(1H)-one (71) ......................................................................................................................... 122
4.3 (1S,7R,7aS,111R)-7-Methyl-1-((R)-N-methylphenylsulfonimidoyl)octahydrobenzo[d]pyrrolo[1,2-
c][1,3]oxazin-5(1H)-one (72) ......................................................................................................................... 123
4.4 (1R,7R,7aS,111R)-7-Methyl-1-((R)-N-methylphenylsulfonimidoyl)octahydrobenzo[d]pyrrolo[1,2-
c][1,3]oxazin-5(1H)-one (epi-72)................................................................................................................... 125
4.5 (1S,8R,8aS,121R)-8-Methyl-1-((R)-N-methylphenylsulfonimidoyl)octahydro-1H-benzo[d]pyrido[1,2-
c][1,3]oxazin-6(2H)-one (73) ......................................................................................................................... 126
4.6 (3aS,4R,11S,111R)-11-Chloro-4-methyloctahydrocyclopenta[d]pyrido[1,2-c][1,3]oxazin-6(1H)-one (74)
........................................................................................................................................................................ 128
4.7 (3aS,4R,111S)-4-Methyloctahydrocyclopenta[d]pyrido[1,2-c][1,3]oxazin-6(1H)-one (75) ..................... 129
5. N-Acyl iminium ion route............................................................................................................................. 131
5.1 (4R,4aS,7aR)-7a-((R)-3-(1,3-Dioxolan-2-yl)-1-((R)-N-methylphenylsulfonimidoyl)propyl)-4-
methylhexahydrocyclopenta[d][1,3]oxazin-2(1H)-one (80) .......................................................................... 131
5.2 Synthesis of (4R,4aS,7aS)-7a-(3-(1,3-Dioxolan-2-yl)propyl)-4-methylhexahydrocyclopenta[d][1,3]oxazin-
2(1H)-one (79) ............................................................................................................................................... 132
5.3 Synthesis of (3aS,4R,8R,111S)-8-Methoxy-4-methyloctahydrocyclopenta[d]pyrido[1,2-c][1,3]oxazin-
6(1H)-one (76) ............................................................................................................................................... 134
5.4 (3aS,4R,111S)-4-methyl-2,3,3a,4,10,11-hexahydrocyclopenta[d]pyrido[1,2-c][1,3]oxazin-6(1H)-one (78)
........................................................................................................................................................................ 135
6. Efforts toward the formal total synthesis of halichlorine and pinnaic acid ............................................. 137
6.1 1-((1S,5S)-1-((R)-1-hydroxyethyl)-6-azaspiro[4.5]decan-6-yl)-2-methylbutan-1-one (93) ..................... 137
6.2 (3aS,4R,8S,111S)-8-allyl-4-methyloctahydrocyclopenta[d]pyrido[1,2-c][1,3]oxazin-6(1H)-one (87) ..... 139
6.2 (4R,4aS,7aR)-4,7a-dimethylhexahydrocyclopenta[d][1,3]oxazin-2(1H)-one (105) ................................. 140
Table of contents 
7. Synthesis of protected β-amino acids .......................................................................................................... 142
7.1 (4R,4aS,7aR)-7a-(Chloromethyl)-4-methylhexahydrocyclopenta[d][1,3]oxazin-2(1H)-one  (115)......... 142
7.2 2-((4R,4aS,7aS)-4-methyl-2-oxooctahydrocyclopenta[d][1,3]oxazin-7a-yl)acetonitrile (116) ................ 143
7.3 Tert-butyl (1R,4aS,7aS)-1-methyl-3-oxooctahydrocyclopenta[c]pyran-4a-ylcarbamate (118) ................ 144
8. Synthesis of cycloalkenyl oxiranes starting from vinylic sulfoximines ..................................................... 146
8.1 Preparation of the cyclic vinyl sulfoximines ............................................................................................ 146
8.1.1 (+)-(R)-(S-Cyclopentylidenmethyl)-N-methyl-S-phenylsulfoximine (31a) ..................................... 146
8.1.2 (+)-(R)-(S-Cyclohexylidenmethyl)-N-methyl-S-phenylsulfoximine (31b) ...................................... 147
8.2 General procedure for the synthesis of vinyl epoxides (GP2)................................................................... 147
8.3 Preparation of the cyclic alkenyloxiranes................................................................................................. 148
8.3.1 2-Cyclopentenyl-3-phenyloxirane (131a)......................................................................................... 148
8.3.2 2-Cyclohexenyl-3-phenyloxirane (131b) ......................................................................................... 149
8.3.3 2-(4-Bromophenyl)-3-cyclopentenyloxirane (131c)......................................................................... 150
8.3.4 2-(4-Bromophenyl)-3–cyclohexenyloxirane (131d)......................................................................... 151
8.3.5 2-Cyclopentenyl-3-(4–nitrophenyl)oxirane (131e)........................................................................... 152
8.3.6 2-Cyclohexenyl-3-(4-nitrophenyl)oxirane (131f) ............................................................................. 153
9. X-ray crystal structure analyses .................................................................................................................. 155
9.1 Structure of sulfoximine 29a .................................................................................................................... 155
9.2 Structure of sulfoximine 71 ...................................................................................................................... 165
APPENDIX ........................................................................................................................... 176 
List of Abbreviations ........................................................................................................................................ 177
References.......................................................................................................................................................... 180
1A. Theoretical Part 
Theoretical part 
2
1. Introduction to azaspirocycles and aims of the project 
Natural products are built up with structural patterns that inspire synthetic organic chemists.1
The development of new methods and strategies for the construction of these patterns is a 
continuing focus of interest. The strengths and weaknesses of a synthetic approach can be 
evaluated by different criteria including conciseness, efficiency, flexibility, cost as well as 
other factors. Although in practice each method has its own pros and cons, the instructive 
value for each is substantial. 
Most of the natural products are chiral and their biological activities depend essentially on 
receptors, which are themselves chiral. The drama caused by the administration of racemic 
thalidomide (Figure 1) to pregnant women shows the need for methods to prepare 
enantiomerically pure compounds.2
N
O
O
HN
*
O
O
Figure 1. (±)-Thalidomide 
1.1 Naturally occurring azaspirocycles 
Azaspirocycles of type 1 (Figure 2) are found as building blocks in a number of highly 
interesting natural products.1
HN
( )m
( )n
R1
*
R2
Figure 2. Azaspirocycles of type 1
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Inspection of the molecular architecture of the naturally occurring alkaloids histrionicotoxin 
2, lepadiformine 3 and halichlorine 4 (Figure 3), as well as others, reveals a common 
azaspirocyclic 6,6- or 6,5- or 5,6-fused ring system, respectively. Some of these alkaloids 
have important biological activity. 
N
Me
OH
Cl
O
O
H
H
HN
HO
N
OH
n-C6H13
Figure 3. Natural products having a common azaspirocyclic ring system 
In 1971, WITKOP and co-workers reported the isolation and structure of a unique 
azaspirocyclic alkaloid named (–)-histrionicotoxin 2 (Figure 4).3 Since its isolation, further 15 
alkaloids of this family have been identified, varying only in the length and degree of 
saturation present in the two side chains. Histrionicotoxin 2 was isolated from the brightly 
colored “poison arrow” frog of the family Dendrobates histrionicus found in South America. 
Alkaloid 2 and its hydrogenation product, the unnatural perhydrohistrionicotoxin 5, are both 
useful biochemical tools for probing the mechanism of transsynaptic transmission of 
neuromuscular impulses. 
HN
HO
HN
HO
Figure 4. Histrionicotoxin 2 and perhydrohistrionicotoxin 5 
2 3 4 
2 5 
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Cylindricine A 6 and lepadiformine 3 (Figure 5) are marine alkaloids with a common novel 
pyrroloquinoline skeleton.4,5
The cylindricines were isolated from the marine ascidian Clavelina cylindrica by BLACKMAN
and co-workers between 1993 and 1995. Cylindricine A 6, for example, showed some 
biological activity in the brine shrimp assay.  
Lepadiformine 3 was isolated in 1994 by BRIARD and co-workers from Clavelina 
lepadiformis and exhibits moderate cytotoxic activity against various tumor cell lines in vitro, 
as well as high in vitro and in vivo cardiovascular effects.  
N
OH
n-C6H13
N
Cl
n-C6H13
O
Figure 5. Cylindricine A 6 and lepadiformine 3 
In 1996, UEMURA and co-workers isolated a novel marine alkaloid from the sponge 
Halichondria okadai in Japanese waters.6 Halichlorine 4 (Figure 6) was shown to inhibit the 
induced expression of VCAM-1 (vascular cell adhesion molecule-1) at IC50 7 µg.mL-1. 
VCAM-1 regulates the transport of leucocytes, which makes it a potential target for the 
treatment of arteriosclerosis, inflammatory diseases and cancer. Interestingly, closely related 
pinnaic acid 7 displays inhibitory activity against cPLA2 (cytosolic phospholipase A2). 
The unique structure and biological activity of these compounds have promoted a variety of 
synthetic approaches.7 ITOH and co-workers analyzed the biological effects on human cultured 
cells of several compounds having the spirocyclic core subunit, which were prepared in the 
course of total synthetic studies of halichlorine 4. Some of these compounds were 
unexpectedly found to exhibit apoptosis-inducing activity (cellular suicide) as a novel 
biological function. 
6 3 
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N
Me
OH
Cl
O
O
H
H
HN
H
HMe
O
HO
OHCl
HO
Me
Figure 6. Halichlorine 4 and pinnaic acid 7
1.2 Retrosynthetic analysis of azaspirocyclic core structures 
The focus of this chapter is the construction of azaspirocyclic alkaloids of type 1 (Figure 2). 
This system incorporates two rings connected by a spiro ring fusion containing a nitrogen 
atom adjacent to the ring junction. 
The synthesis of such azaspirocycles involves two main synthetic challenges. The first 
problem is the construction of the tertiary carbon atom bearing the nitrogen atom that will 
ultimately become the spirocycle ring junction. This carbon atom is often a stereogenic 
center, which requires a stereochemical control in its formation. The second issue is the 
installation of the rings of the spirocyclic system: the carbocycle and the heterocycle. 
According to DAKE the approaches to azaspirocycles of type 1 can be divided into three 
general groups (Scheme 1).1 The first two strategies require a two-step process in which the 
tertiary carbon atom and the cycles are built up in separate events. The third approach 
combines both, generation of the tertiary carbon atom and one of the ring-closures. 
- a) The carbocycle is already present. Then the tertiary carbon atom is built up and in a 
final step the heterocycle is closed. 
- b) The heterocycle is already present. Then the tertiary carbon atom is built up and in 
a final step the carbocycle is closed. 
- c) One of the cycles is already present, and in one step the tertiary carbon atom is built 
up and the other ring is closed. 
4 
7 
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Scheme 1. Retrosynthetic analysis of azaspirocycles according to DAKE
FG1 = hypothetical functional groups that enable ring closure 
FG2 = hypothetical functional groups that enable formation of the spiro carbon atom 
FG3 = hypothetical functional groups that enable both: ring closure and construction 
of the tertiary carbon atom 
1.3 Total syntheses of halichlorine and pinnaic acid 
The 6-azaspiro[4,5]decane structures of halichlorine 4 and pinnaic acid 7 are even more 
impressive than their bioactivities. They have attracted considerable attention in the synthetic 
chemistry community and have recently been the topic of a specific review and a large 
number of reports describing efforts to synthesize them.6
In 1999, DANISHEFSKY and co-workers published the first asymmetric total synthesis of 
halichlorine and pinnaic acid.8,9 It is so far the only one for halichlorine. In 2007 ZHAO et al. 
and ARIMOTO et al. published independently two new enantioselective total syntheses of 
pinnaic acid 7.10,11 
In 2004, HEATHCOCK and co-workers reported the total synthesis of the racemates of 4 and 
7.12 Later some other groups published formal total syntheses of these marine alkaloids.13,14,15
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To illustrate route a) (Scheme 1) for the construction of azaspirocycles, the key steps of the 
first asymmetric total synthesis reported by DANISHEFSKY and co-workers, focusing on the 
construction of the azaspirocyclic structure, will be described.8,9
The synthesis starts with the known MEYERS lactam 8 (Scheme 2). The crucial tertiary 
stereocenter was introduced using a SAKURAI reaction. After replacement of the 
phenylglycinol moiety with a Boc-protecting group, a selective methylation of 9 from the 
convex face of the bicyclic lactam led to 10. This compound was converted into 11, which 
after hydroboration was submitted to an alkyl-SUZUKI coupling. 
N
H
O
O
Ph
N
H
O
R
N
H
O
Boc
Me
R = CH(Ph)CH2OH
R = Boc
BocHNBocHN
IMeO2C
MeO2C
Me
TBDPSO
Me
TBDPSO
Scheme 2. Construction of the tertiary carbon atom by DANISHEFSKY et al. 
At this stage two functional groups which enable the closure of the heterocycle are present: 
the nucleophilic nitrogen and the MICHAEL acceptor. The unsaturated ester 12 underwent 
intramolecular MICHAEL addition upon deprotection of the amino function with TFA and 
subsequent basification (Scheme 3).  
8 
9 
10 
11 12 
SAKURAI
reaction 
Stereoselective 
methylation 
1) Hydroboration 
2) SUZUKI coupling 
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BocHN
MeO2C
TBDPSO
Me
TBDPSO
Me
HN
MeO2C
H
Scheme 3. Closure of the heterocycle by DANISHEFSKY et al. 
1.4 Our approach to azaspirocycles 
A number of methods have been developed for the construction of azaspirocycles of type 1.1
Although most of these target-molecule orientated methods are imaginative and high yielding, 
there is still an interest in the design of a more general method for the enantioselective 
construction of 1. 
The focus of this thesis was to develop a modular asymmetric synthesis of functionalized 
azaspirocycles of type 1 based on the sulfoximine auxiliary 15.16
The synthetic approach to azaspirocycles described here is based on a two-step strategy in 
which the carbocycle with the tertiary C atom bearing the amino group is constructed 
(Scheme 4). This first part should take advantage of the methods developed in our group for 
the synthesis of β- and γ-amino acids from allylic sulfoximines.17,18 
O
S
MeN CH3
Ph
R1
NHO
O
(  )n
S
O NMe
Ph
Scheme 4. Oxazinone 14: A key intermediate in the synthesis of functionalized 
azaspirocycles 
12 13 
14 
(R)-15
Intramolecular 
MICHAEL addition
Intramolecular  
aza-MICHAEL addition 
γ-Hydroxyalkylation 
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Using oxazinones of type 14, containing the carbocycle, three contiguous stereogenic centers 
and the tertiary carbon atom bearing the nitrogen atom, we developed a modular method for 
the synthesis of azaspirocycle 16 (Figure 7).19
O N
R1
O
α
β
γ
δ
( )n
R
Figure 7. Azaspirocycle 16
The challenging azaspirocyclic core and its promising biological profile make halichlorine 4
an ideal candidate for a synthetic venture. 
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2. Construction of the carbocycle having an amino-
substituted tertiary C atom 
2.1 The chiral auxiliary 
 2.1.1 Properties of the chiral auxiliary 
Sulfoximines are used as highly versatile starting materials and auxiliaries in stereoselective 
synthesis. They are constitutionally and configurationally stable compounds which can be 
manipulated without special care. They show a unique combination of features, including 
chirality, carbanion stabilization, nucleofugacity, basicity, nucleophilicity, and a low redox 
potential (Figure 8).16,20,21
O
S
N
CH3
PhH3C
Acidic
H-atomsNucleophilicN-atom
Chiral
S-atom
Cleavage after
activation
Figure 8. Chiral auxiliary (R)-15
Recent examples where several of these characteristics have been exploited in the GAIS group 
are the asymmetric synthesis of homopropargylic alcohols 17,22 dihydrofurans 18,23 proline 
derivatives 19,24 aziridines 20,25 medium-sized carbocycles 21,26 β-amino acids 22 and γ-
amino acids 23,18,27 as well as others not depicted here (Figure 9).28,29
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Figure 9. Application of 15 in asymmetric syntheses by GAIS and co-workers 
2.1.2 Preparation of chiral auxiliary 15 
Both enantiomers of the N,S-dimethyl-S-phenylsulfoximine 15 are available in 
enantiomerically pure form on preparative scale (Scheme 5).30,31
S CH3
S CH3
O O
S
HN
CH3
O
S
HN
CH3
H2O2
AcOH
NaN3
H2SO4
0.5 eq.
(-) CSA
CH2O
HCOOH
O
S
MeN
CH3
Scheme 5. Preparation of chiral auxiliary (R)-15
First thioanisole 24 is oxidized to the corresponding sulfoxide (±)-25 using hydrogen peroxide 
and acetic acid. Then the imination with sodium azide in presence of sulphuric acid leads to 
racemic S-methyl-S-phenylsulfoximine (±)-26. At this stage the enantiomers are separated. 
An efficient resolution is carried out by the method of half-quantities developed by GAIS and 
17 18 19 20
21
22 23
24 (±)-25 (±)-26 
(R)-26 (R)-15 
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co-workers.32 In order to obtain (R)-26, 0.5 eq. of the (–)-enantiomer of CSA must be 
employed. Sulfoximine (R)-26 can be cleanly N-methylated under ESCHWEILER-CLARK 
conditions to give enantiomerically pure (R)-15 (Scheme 5). 
 
 
2.2 Synthesis of oxazinones 29a and 29b 
 
Allylic sulfoximines 27a and 27b were transformed in three steps into oxazinones 29a and 
29b in 62% and 58% overall yield, respectively (Table 1). This process creates three new 
stereogenic centers within 29a and 29b in a highly diastereoselective fashion. 29a and 29b 
contain the carbocycle of the target azaspirocycle as well as the tertiary C atom bearing the 
amino group. Thus 29a and 29b are key intermediates for the modular synthesis of the 
heterocyclic portion. 
 
Table 1. Synthesis of carbocycles having an amino-substituted tertiary C atom and three 
contiguous stereogenic centers 
S
O NMe
Ph
( )n
Me
HO
S Ph
NMe
O
( )n
Me
O
( )n
NH
O
S
O NMe
Ph
 
n=1 27a 28a: 78%, ≥98% de 29a: 79%, ≥98% de 
n=2 27b 28b: 75%, ≥98% de 29b: 77%, ≥98% de 
 
In the following chapters the steps leading to oxazinone 29 will be detailed. 
 
2.3 Synthesis of cyclic allylic sulfoximines 
 
Allylic sulfoximines play a special role in the chemistry of the sulfoximine family. They can 
be synthesized from 15 using the addition-elimination-isomerization (AEI) route developed 
by GAIS et al. (Scheme 6).33,34 
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O
S
MeN
Ph
CH3
S
TMSO
O NMe
Ph
S
O NMe
Ph
S
O NMe
Ph
(  )n(  )n (  )n
1. n-BuLi
2. cycloalkanone
3. TMSCl n-BuLi NaOMe
Addition Elimination Isomerization
THF
THF THF
Scheme 6. Synthesis of cyclic allylic sulfoximines via the AEI route 
Lithiation of 15 with n-BuLi followed by addition of the cycloalkanone, gave the 
corresponding lithium alkoxide, which was directly converted into silylether 30 using TMSCl. 
Elimination with n-BuLi gave vinyl sulfoximine 31 in high yield. The crude mixture was used 
directly for the isomerization into the corresponding allylic sulfoximine 27 using sodium 
methoxide. This two pot procedure did not require the purification of any intermediate and 
lead to cyclic allylic sulfoximine 27 in high yield. 
Here the five-membered (n=1) and six-membered (n=2) rings were synthesized. Using the 
same procedure seven-membered (n=3) and eight-membered (n=4) rings have also been 
successfully prepared (Scheme 6).34
2.4 Hydroxyalkylation of allylic sulfoximines 
2.4.1 Introduction to hydroxyalkylation of cyclic allylic sulfoximines 
Allylic sulfoximine 27 can be deprotonated at the α-position of the sulfoximine group to give 
α-sulfonimidoyl carbanion 27-Li, the negative charge of which is also stabilized by the double 
bond (Scheme 7). Lithiated allylic sulfoximines can react either at the α- or γ-position leading 
to α- or γ-hydroxyalkylation products 32 or 33, respectively. In the case of γ-hydroxy-
alkylation both Z-33 and E-33 can result. 
Therefore, both regioselectivity and diastereoselectivity have to be effectively controlled. 
15
30 31 27
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Scheme 7. Possible regioisomers and diastereoisomers in the hydroxyalkylation of allylic 
sulfoximines 
The feasibility of a synthesis of Z-33 from 27 was indicated by the results of REGGELIN and 
co-workers (Scheme 7).35,36 They showed that lithium-titanium exchange using ClTi(Oi-Pr)3
of similar lithiated allylic sulfoximines allowed γ-hydroxyalkylation to occur, furnishing 
homoallylic alcohols similar to Z-33 in high regio- and diastereoselectivity. 
Later, such reactions were studied extensively by GAIS and co-workers.37 They developed a 
useful and broad methodology for the hydroxyalkylation of allylic sulfoximines (Scheme 8). 
For example, on one hand lithiation of 27b followed by lithium-titanium exchange with 
ClTi(Oi-Pr)3 gives the corresponding bis(2-alkenyl)diisopropyloxytitanium(IV) complexes, 
27
32 Z-33 E-33 
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which react exclusively at the γ-position to furnish 34 in high diastereoselectivity. On the 
other hand the use of ClTi(NEt2)3 yields the corresponding mono(2-
alkenyl)tris(diethylamino)-titanium(IV) complexes, which react with aldehydes exclusively at 
the α-position to give alcohol 35 in high diastereoselectivity. Direct reaction of 27b-Li with 
aldehydes results in a α-hydroxyalkylation with low diastereoselectivities.
Ph
OH
S Ph
O
MeN
S
MeN O
Ph
S
MeN O
Ph
HO
Ph
1. n-BuLi
2. ClTi(Oi-Pr)3
3. PhCHO
1. n-BuLi
2. ClTi(NEt2)3
3. PhCHO
THF
THF
Scheme 8. Illustration of the hydroxyalkylation methodology developed by GAIS et al. 
2.4.2 Application of the hydroxyalkylation reaction to the synthesis of azaspirocycles 
The hydroxyalkylation methodology developed in the GAIS group was used to perform the 
titanium mediated γ-hydroxyalkylation of cyclic allylic sulfoximines (Scheme 9). 
Me
HO
S Ph
NMe
O
(  )n
S
O NMe
Ph
(  )n
1. n-BuLi
2. ClTi(Oi-Pr)3
3. MeCHO
THF Me
HO
S Ph
NMe
O
(  )n
+
Scheme 9. Titanium-mediated γ-hydroxyalkylation of cyclic allylic sulfoximines with 
acetaldehyde 
34: 47%, ≥98% de 
35: 66%, ≥98% de 
27
27b
28 36
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Lithiation of 27 followed by treatment of the lithiated allyl sulfoximines with 2.1 equivalents 
of ClTi(Oi-Pr)3 furnished the corresponding bis(allyl)titanium complexes admixed with 
ClTi(Oi-Pr)3 and Ti(Oi-Pr)4. This mixture was reacted with acetaldehyde in high 
regioselectivity (≥95%) and good diastereoselectivity (74–84% de) at the γ-position to afford 
homoallylic alcohols 28 and 36 (Table 2). 28a had to be purified by preparative HPLC to 
obtain the diastereomerically pure major diastereomer, whereas 28b could be obtained in pure 
form through crystallization from the mixture of diastereoisomers. 
Table 2. Results of the hydroxyalkylation reactions 
n Starting material Products Total yield  (28 + 36) 
Yield  
28
1 27a 28a + 36a 85%, 84% de 78%, ≥98% de 
2 27b 28b + 36b 86%, 74% de 75%, ≥98% de 
2.4.3 Rationalization of the stereoselectivity outcome 
In the case of the 5-membered ring (n=1), the minor diastereoisomer was isolated and its 
stereochemistry was determined using NOE experiments (Figure 10, Table 3).  
In both cases Hc and Hd show a strong NOE effect whereas Hc and Hb do not. This clearly 
indicates that the double bond is Z-configurated. The value of the coupling constant between 
Ha and Hb (9.9 Hz for 28a and 9.6 Hz for 36a) accounts for anti orientation. Knowing the 
absolute configuration of the major product from an X-ray analysis of a later intermediate, it 
was possible to deduce the absolute configuration of the minor isomer. 
Hb
Ha CH3
OH
SHcHd
Hd
Hb
HaH3C
HO
S Hc Hd
Hd
O NCH3
Ph
OH3CN
Ph
RR
S
S R
R
Figure 10. Structure of both diastereoisomers in the case of n=1 
36a: minor 28a: major 
Theoretical part 
17
Table 3. Decisive criteria for the structure determination of the minor isomer 36a 
Information 28a Information 36a Interpretation 
JHa-Hb = 9.9 Hz JHa-Hb = 9.6 Hz Ha and Hb are in anti orientation 
NOE: Hc↔Hd observed 
NOE: Hc↔Hb not observed
NOE: Hc↔Hd observed 
NOE: Hc↔Hb not observed
Z-configurated double bond 
Based on previous results37 the existence of two equilibrating bis(alkenyl)titanium complexes 
37 and epi-37 can be postulated (Scheme 10). The equivalent of titaniumtetraisopropoxide 
which is formed during the titanation step probably coordinates to one of the sulfoximine 
N-atoms and thus generates a free coordination site at titanium. The aldehyde coordinates and 
via the depicted transition states the first allylic unit is delivered. In case of 37 the phenyl 
group of the sulfoximine moiety is in a favorable exo-position. That is why 37 is assumed to 
react faster with acetaldehyde than epi-37, leading to the major diastereoisomer 28a. The 
(R)-configuration of the sulfonimidoyl group plays a key role and leads to a Si-Si process via 
a cyclic six-membered transition state. As intermediary product the mono(alkenyl)titanium 
complexes 38 and epi-38 are formed. Similar to Ti(Oi-Pr)4 the excess amount of ClTi(Oi-Pr)3
probably generates a free coordination site in 38 or epi-38. Via similar transition states the 
complexes react a second time with acetaldehyde under formation of two molecules of 
homoallylic alcohol 28a and 36a. 
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2.5 Formation of carbamates from homoallylic alcohols 28a and 28b 
2.5.1 Results 
Treatment of the enantio- and diastereopure homoallylic alcohol 28 with trichloroacetyl 
isocyanate followed by cleavage of the corresponding intermediate N-trichloroacetyl 
carbamate 39 with (NH4)2CO3 in MeOH furnished carbamate 40 (Scheme 11).17,18,27 
Me
HO
S Ph
NMe
O
(  )n
S
O NMe
Ph
(  )n
Me
O
O
H2N
Me
O
S Ph
NMe
O
(  )n
O
N
H
Cl3C
O
Cl3C
O
N C O
Me
O
S Ph
NMe
O
(  )n
O
H2N +
(NH4)2CO3
MeOH
CH2Cl2
Scheme 11. Formation of carbamate 40 from alcohol 28
In the case of n=1, only the Z-isomer of 40a was detected, whereas in the case of n=2 an 
isomerization took place which gave a Z/E-mixture of 40b (Table 4). 
Table 4. Yield of carbamate 40 from alcohol 28
n Starting material Yield (Z)-carbamate Yield (E)-carbamate 
1 28a Z-40a: 84% E-40a: - 
2 28b Z-40b: 73% E-40b: 9% 
28 39
Z-40 E-40
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2.5.2 Mechanism for the Z/E isomerization 
A Z/E-isomerization has been observed during the carbamate formation of similar alcohols.18
In that study the corresponding N-trichloroacetyl carbamate was shown to be a mixture of Z- 
and E-isomers. The authors suggested that isomerization of the Z-isomer to the more stable 
E-isomer occurs through a reversible addition of the N-atom of the trichloroacetyl carbamate 
group to the activated double bond after proton transfer to the basic sulfonimidoyl group. 
Although N-trichloroacetyl carbamate 39 was not isolated, an isomerization at this stage was 
excluded because of the following observation. In the case n=1 the use of concentrated 
aqueous ammonia for cleavage of the trichloroacetyl group led to a mixture of Z-40a and 
E-40a, whereas the use of (NH4)2CO3 furnished diastereopure Z-40a. E-40a was not detected. 
Another mechanism for the Z/E-isomerization can be envisaged. In this proposal, 
epimerization of the α-sulfonimidoyl carbanion occurs due to its configurational instability 
(Scheme 12). 
First N-trichloroacetyl carbamate Z-41 is deprotonated by ammonia or (NH4)2CO3 at the 
N-atom, then an aza-MICHAEL addition takes place to give α-sulfonimidoyl carbanion 43, 
which is not configurationally stable and isomerizes rapidly to epi-43. At this stage a retro-
MICHAEL addition of carbanions 43 and epi-43 can occur leading to deprotonated 
N-trichloroacetyl carbamates Z-42 and E-42, respectively. After re-protonation and 
deprotection of the N-trichloroacetyl group, the double bond isomers E-40b and Z-40b are 
isolated. 
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Scheme 12. Mechanism for the Z/E-isomerization of 40b 
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2.6 Aza-MICHAEL addition  
2.6.1 Results 
A highly diastereoselective aza-MICHAEL addition of 40 with generation of the tertiary C
atom and formation of the sulfonimidoyl-substituted protected 1,3-amino alcohol (oxazinone) 
was achieved by the carbamate method (Scheme 13).17,18,27
Me
O
( )n
NH
O
S
O NMe
PhMe
HO
S Ph
NMe
O
( )n
Me
O
S Ph
NMe
O
( )n
O
H2N
Cl3C N
O
C O
1.
2. (NH4)2CO3, MeOH
CH2Cl2 n-BuLi
Scheme 13. Diastereoselective aza-MICHAEL addition 
Treatment of alcohol 28 with trichloroacetyl isocyanate, followed by deprotection of the 
corresponding N-trichloroacetyl carbamate 39 with (NH4)2CO3 in MeOH furnished carbamate 
40. The crude carbamate 40 was subjected to a treatment with n-BuLi and gave oxazinone 29
after a highly diastereoselective aza-MICHAEL addition (Table 5).  
Table 5. Yields and diastereoselectivities of oxazinone 29 from alcohol 28
n Yield of oxazinone 29 (from alcohol 28) 
1 29a: 79% (from 28a), ≥98% de
2 29b: 77% (from 28b), ≥98% de
2.6.2 Discussion 
Formation of diastereomerically pure oxazinone 29b (n=2) from the mixture of carbamates 
Z-29b and E-29b points to a stereoselective cyclization of both carbamates with the same 
sense and with similar degrees of asymmetric induction (stereoconvergence). We did not test 
28 40 29
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this hypothesis with our carbamates, but we based our reflection on studies carried out by 
GAIS et al. with Z-44 and E-44 (Scheme 14).18
Treatment of Z-44 with n-BuLi under the same conditions as used in the case of E-44 resulted 
in a highly stereoselective cyclization reaction (≥ 95% de) to give oxazinone 45 as a single 
diastereoisomer in good yields. 
i -Pr
O
Ph
O
H2N
i -Pr
O
Ph
S
O NMe
Ph
O
H2N
S
O
NMePh
i -Pr
O
Ph
S
O NMe
Ph
NH
O
n-BuLi
n-BuLi
Scheme 14. Stereoconvergence of the aza-MICHAEL addition starting from a mixture of 
E/Z-carbamates 
These results confirm that the formation of E/Z-mixtures in the case of carbamate 40b is not 
detrimental to the success of the highly stereoselective aza-MICHAEL addition leading to 
oxazinone 29b. 
The stereochemical aspects of the intramolecular aza-MICHAEL addition have to be 
investigated (Scheme 15). The formation of oxazinone 29 from the corresponding carbamate 
starts most probably with the deprotonation of the amino group and formation of the lithium 
salt 40-Li. This lithium salt undergoes cyclization to give the C-lithiated sulfoximine 29-LiC. 
Since the acidity of the carbamate-NH is much higher than those of alkyl sulfoximines, 
lithiated sulfoximine 29-LiC would be expected to undergo transmetalation with formation of 
the O-lithiated oxazinone 29-LiO. This transmetalation may be crucial for the success of the 
intramolecular amination, since the lithiated oxazinone 29-LiO, should be less prone to retro-
MICHAEL addition than the lithiated sulfoximine 29-LiC.18
Z-44
45: ≥95% de 
E-44
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Scheme 15. Cyclization of sulfonimidoyl-substituted lithiated homoallylic carbamates 
We were able to obtain an X-ray crystal structure of 29a, which permitted to confirm the 
configuration of the three contiguous stereogenic centers (Figure 11). 
Figure 11. Structure of 29a in the crystal 
The highly selective formation of bicyclic oxazinones 29 from 40 implies that the C=C double 
bond of the lithiated carbamates is attacked by the N-atom from the Si face (Figure 12). This 
can be explained by invoking transition state models of type TS-1 for the Z-isomers Z-40a
and Z-40b and TS-3 for the E-isomer E-40b, resulting in the bicyclic oxazinones with the cis 
ring fusion. The alternative transition state models TS-2 and TS-4 which would give isomeric 
bicyclic oxazinones with a trans ring fusion, are highly strained and destabilized by an 
unfavorable approach of the nitrogen atom to the MICHAEL system.18
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Figure 12. Transition state models for the aza-MICHAEL addition of 40-Li
2.7 Possible structural variations of the carbocycle and the side chain 
R1
O
( )n
NH
O
S
O NMe
Ph
R2
Figure 13. Variation of the carbocycle and side-chain substitution pattern 
The size of the carbocycle ( )n as well as the substituent R2 are determined by the structure of 
the allylic sulfoximine, whereas the susbtituent R1 is introduced by the aldehyde in the 
hydroxyalkylation reaction (Figure 13). 
Based on previous results of GAIS et al., which are the possible variations of the target 
molecule? 
TS-1 
TS-3 
TS-2 
TS-4 
Si-side attack Re-side attack 
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2.7.1 Variations of the carbocycle 
The size of the carbocycle depends on the allylic sulfoximine being used (Scheme 16). In this 
work, we used successfully the five-membered and the six-membered allylic sulfoximines 
27a (n=1) and 27b (n=2), respectively. 
Other cyclic allylic sulfoximines having for example a four-membered ring (n=0), a seven-
membered (n=3) or an eight-membered ring (n=4) are available.33
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Scheme 16. Variations of the carbocycle 
KÜPKER prepared the bicyclic sulfoximine 46 using N,S-dimethylsulfoximine 15 and ketone 
47 (Scheme 17).38
S
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MeN Ph
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Scheme 17. Synthesis of allylic sulfoximine 46
The use of the allylic sulfoximine 46 could perhaps give oxazinones of type 48 having a 
protected carbonyl group in the carbocycle (Scheme 18). 
46
(R)-15
47
(R)-15
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Scheme 18. Possible synthesis of functionalized oxazinones 
2.7.2 Hydroxyalkylation with other aldehydes 
Since the γ-hydroxyalkylation of titanated allylic sulfoximines had been introduced, a number 
of different aldehydes have been used leading to a range of substituted homoallylic alcohols. 
We carried out the reaction with acetaldehyde, but it should be possible to carry out the 
reaction with a variety of aldehydes.26,37,38
It should be noticed that the use of a chiral aldehyde does not influence the 
diastereoselectivity of the reaction (Figure 14).38
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Figure 14. Examples of aldehydes successfully used in the γ-hydroxyalkylation of titanated 
allylic sulfoximines 
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3. The Ring-closing metathesis route 
3.1 The plan 
Having achieved an efficient synthesis of the functionalized carbocycle 29 which carries three 
contiguous stereogenic centers and the tertiary carbon atom bearing a nitrogen atom, we 
focused on the construction of the heterocycle having a double bond at the β,γ- position. 
The ring-closing metathesis (RCM) belongs to the best methods for the construction of 
complex cyclic molecules,39 particulary natural products. This well-developed methodology 
should be applied for the synthesis of azaspirocycle 49 from oxazinone 29a (Figure 15). 
Me
HNHO
γ
β
Figure 15. Azaspirocycle 49 containing a double bond in the heterocycle 
3.2 Synthesis of amino alcohol 49 from sulfoximine 29a 
Sulfoximine 29a was successfully transformed into the desired azaspirocycle 49 in 5 steps 
with 36% overall yield (Scheme 19). 
The sulfoximine moiety of 29a was replaced by an I-atom, which was then substituted by 
propenyl cuprate to give alkene 51. Allylation of the nitrogen atom followed by a ring-closing 
metathesis furnished tricycle 53. Deprotection of the carbamate led to the desired spirocycle 
49. 
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Scheme 19. Synthesis of azaspirocycle 49 from sulfoximine 29a
In the following chapters the steps leading to azaspirocycle 49 will be detailed. 
3.3 Iodide substitution 
It is known that the sulfoximine group can be replaced by chlorine or iodine.18 This can be 
achieved by reaction with chloro- and iodoformic esters, respectively. Because of their 
potential conversion to the corresponding alkylzinc iodides40 and ready cross-coupling 
reaction27, we decided to synthesize the iodo derivative 50 (Scheme 20). 
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Scheme 20. Replacement of the sulfoximine group by an I-atom 
We could successfully synthesize iodide 50 from sulfoximine 29a by the haloformate method. 
Chloroformate 54 reacts in situ with an excess of sodium iodide to give the corresponding 
iodoformate 56,41 which can acylate the nitrogen of the sulfoximine group. It generates the 
29a 51
52
50
5349
29a 50: 76% SR-55
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corresponding N-acylaminosulfoxonium salt 57 which undergoes a facile substitution by the 
I- ion because of the nucleofugacity of the aminosulfoxonium group (Scheme 21). 
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Scheme 21. Possible mechanism for the iodide substitution of the sulfoximine group 
The conversion of sulfinamide SR-55 (≥ 98% ee in regard to the S atom) to the starting 
(R)-(+)-N,S-dimethyl-S-phenylsulfoximine (R)-15 (≥ 98% ee) has already been described in 
the literature: 
Reaction of methylmagnesium chloride with sulfinamide (R)-55 gives sulfoxide 25 (≥ 98% 
ee).42 Now there are two possibilities to obtain the sulfoximine. On one hand sulfoxide 25 can 
be treated with Boc-azide in presence of iron dichloride to furnish the Boc-protected 
sulfoximine 58.43 On the other hand sulfoxide 25 can be treated with Ts-azide in presence of 
copper to give the Ts-protected sulfoximine 59.44 Deprotection of 58 and 59 with 
trifluoroacetic acid and sulphuric acid, respectively, gives sulfoximine 26. Sulfoximine 26 can 
be cleanly N-methylated under ESCHWEILER-CLARK conditions to give enantiomerically pure 
(R)-15 (Scheme 22).30
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56
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50 SR-55
Theoretical part 
31
Ph
S N
O
O
O
Me
Cl
Me
Ph
S Me
OMeMgCl
Ph
S
Me
N OBoc
Ph
S
Me
N OTs
Ph S Me
HN O
Ph S Me
MeN O
BocN3
FeCl2
TsN3
Cu
H2SO4
CF3COOH
CH2O
HCOOH
Scheme 22. Recycling of sulfinamide 55 into sulfoximine (R)-15
3.4 Cuprate substitution 
Organocopper reagents are used frequently in organic chemistry as alkylating agents. They 
are prepared in situ and show in general a higher functional group tolerance than 
corresponding Grignard or organolithium reagents.45
Organocopper reagents are softer than Grignard reagents because copper is less 
electropositive than magnesium. Therefore the C-Cu bond is less polarized than the C-Mg 
bond, giving the carbon atom less of a partial negative charge suggesting less nucleophilicity 
for carbon. 
55
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Scheme 23. Cuprate substitution on β-amido iodide 50
Treatement of 50 with the vinyl cuprate 60 gave a mixture of unidentified products together 
with terminal alkene 61, which was isolated in best cases in only 40% yield. Purification was 
difficult because of the many impurities. All attempts to optimize the yield of 61 failed. 
Interestingly, the reaction of 50 with the propenyl cuprate 62 gave the desired alkene 51 in 
82% yield (Scheme 23). 
Later KÖHLER reported cuprate substitution on a similar β-amido iodide (Scheme 24).27
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Scheme 24. Cuprate substitution on a β-amido iodide 
50
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51: 82% 
61: ~ 40% 
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3.5 Ring-Closing Metathesis 
The ring-closing metathesis is a very useful tool for the synthesis of cyclic natural products 
and was already successfully applied to the synthesis of azaspirocycles (Figure 16). 
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Figure 16. Construction of azaspirocycles using ring-closing metathesis 
TANNER et al. developed a method for the synthesis of spirocyclic alkaloids combining [2,3] 
sigmatropic rearrangement and ring-closing metathesis. RCM of the corresponding diene 
gave 63, which was used as precursor for a formal total synthesis of (±)-
perhydrohistrionicotoxin 5.46
WRIGHT et al. proposed an approach to the spirocyclic core of halichlorine 4 and pinnaic acid 
7 by ring-closing metathesis. They showed that the protection of the amine function as its 
methyl carbamate was important to obtain the ring-closing metathesis product 64 in high 
yield.47
KIBAYASHI et al. proposed an alternative route to the azatricyclic core skeleton of FR901483 
based on bridgehead vinylation via an anti-Bredt iminium ion and ring-closing metathesis to 
furnish 65.48
SIMPKINS et al. developed a chiral base desymmetrization followed by a ring-closing 
metathesis route to chiral azaspirocycles of type 66, aiming at the synthesis of core structures 
related to pinnaic acid 7 and halichlorine 4.49
HUNTER et al. used ring-closing metathesis to provide the crucial spirocycle 67 in the 
construction of the ring-system of lepadiformine 3.50
63 64 65
66 67
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Based on these results an efficient ring-closing metathesis of diene 52 was carried out in 
CH2Cl2 (0.01 M) using 5 mol% of catalyst 68, which gave tricycle 53 in excellent yield 
(Scheme 25). 
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Scheme 25. Ring-closing metathesis for the construction of the heterocycle 
At this stage, the carbocycle, the spiro carbon atom and the heterocycle were built up. The 
remaining step was the deprotection of the carbamate. It was achieved by refluxing tricycle 53
under strongly basic aqueous conditions, which gave amino alcohol 49 (Scheme 26).51
O N
Me
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MeOH, H2O
reflux, 3 d
Scheme 26. Deprotection of the carbamate under basic conditions 
3.6 Structural variations of the target molecule 
Only 49 was synthesized but it should be possible to obtain other derivatives as well (Figure 
17). Changing the ring size of the allylic sulfoximine would allow to control the size of the 
carbocycle, and the substituent R1 could be varied by using different aldehydes in the 
γ-hydroxyalkylation reaction. 
Instead of using propenylcuprate (which gives m = 1), it should also be possible to use allyl 
cuprate (which would give m = 2) for example. 
52 53: 95% 
53 49: 72%  
68
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Instead of using allyl bromide for the alkylation of the N-atom (which gives p = 1) also 
homoallyl bromide (which would give p = 2) could be employed. 
HO HN
R1
( )n
( )m
Hydroxyalkylation
Allylic sulfoximine
Cuprate substitution
( )p
Alkylation at the
nitrogen atom
Figure 17. Possible variations of the target molecule 
A new method for the asymmetric synthesis of azaspirocycles having a double bond in the 
heterocycle has been developed. Azaspirocycle 49 having the double bond at the β,γ-position 
has been successfully prepared and it should be possible to obtain azaspirocycles with 
different ring sizes and with the double bond at other positions in the heterocycle. 
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4. Cycloalkylation and removal of the sulfoximine group 
4.1 The plan 
 4.1.1 Target molecule 
Oxazinone 29 already contains the carbocycle with three contiguous stereogenic centers and 
the tertiary carbon atom bearing a nitrogen atom in the α position. It was of interst to see 
whether an access to azaspirocycles carrying a functional group at the δ-position of the 
nitrogen atom could also be opened (Figure 18). 
Me
NO
O
R
δ
( )n
( )m
Figure 18. Target molecule 
 4.1.2 Dilithiated sulfoximines in the literature 
Previously GAIS et al. showed that sulfoximines similar to 29 can be deprotonated using 2 
equivalents of n-butyllithium. At first the nitrogen atom is deprotonated then the carbon atom 
bearing the sulfoximine group. Reaction with electrophiles occurs at the stabilized 
α-sulfonimidoyl carbanion (Scheme 27).18
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Scheme 27. Alkylation of a dilithiated sulfoximine 
R = C(Me,H)OH, Me, CH2OBn, CO2Me 
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This route was developed to provide a new access to enantio- and diastereopure β-substituted 
and β,β-disubstituted δ-hydroxy β-amino acids and to γ-amino alcohols.18
 4.1.3 From dilithiated sulfoximines to the synthesis of the heterocycle 
It was planed to achieve a cycloalkylation reaction, which should proceed as follows: 
sulfoximine 29 should be doubly deprotonated at the N-atom and the α-position to the 
sulfoximine group leading to the corresponding dianion, which should react with a 
biselectrophile of type 69 giving tricycle 70 (Scheme 28). 
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Scheme 28. Cycloalkylation reaction 
4.2 Cycloalkylation: Similar examples in the literature 
4.2.1 With sulfone and carbamate 
SASAKI et al. described the synthesis of two different types of cyclic α-amino acids: 
cycloalkylglycines and N-heterocyclic α-amino acids through reaction of sulfonyl anions 
and/or carbamate anions with dihaloalkanes (Scheme 29).52
By addition of an appropriate base, two distinct types of anion can be formed, carbamate and 
sulfonyl anions. Since a sulfonyl anion should be much more reactive than a carbamate anion, 
creation of such dianionic species followed by addition of an α,ω-dihaloalkane would first 
afford monoalkylation products. 
Then two different routes are possible. Cyclization can take place either by reaction with the 
carbamate anion to give an N-heterocyclic compound (route a) or by reaction with the tertiary 
sulfonyl anion to give a cycloalkyl compound (route b). No information is given about the 
diastereoselectivity in regard to the newly created stereogenic center. 
69
70
29 
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Scheme 29. Versatile method for the synthesis of N-heterocyclic α-amino acids and 
cycloalkylglycines by SASAKI et al. 
4.2.2 With sulfone and amide 
NÁJERA et al. reported the diastereoselective preparation of indolizidines by dialkylation of a 
chiral pyrrolidinone at the nitrogen atom and at the α-sulfonyl position by using several 1,3- 
and 1,4-biselectrophiles, after deprotonation with 2 equivalents of NaH. The methodology 
was applied to the synthesis of (–)-δ-coniceine (Scheme 30).53,54
They assumed that first of all the N-atom reacted with the biselectrophile. This notion was 
supported by isolation of around 40% of elimination product in reaction a). Elimination is not 
possible with biselectrophiles used in reaction b) and c). 
82-90% 
over two steps 
47-90% 
over two steps 
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Scheme 30. Diastereoselective synthesis of indolizidine derivatives by NÁJERA
4.2.3 With sulfoxide/sulfone and sulfonamide 
RAGHAVAN et al. planed the construction of the piperidine ring of allosedamine via 
dialkylation of the dianion derived from a β-aminosulfoxide with a suitable 
1,3-biselectrophile (Scheme 31).55
Generation of the dianion using LDA and its subsequent treatment with 1,3-diiodopropane, 
with the intention of elaborating the piperidine ring, was not successful. The products isolated 
were the N-allylation product and the elimination product. Attempted formation of the 
piperidine ring starting from the corresponding sulfone failed also. Again the N-allylated and 
the elimination product were the only compounds obtained. 
However it could be argued that the use of LDA is not compatible with the existence of the 
dianion, so that at first only deprotonation at the nitrogen atom occurs and this anion reacts 
with the 1,3-diiodopropane. Then, with the remaining LDA, elimination takes place either to 
give the N-allylated products or the elimination products. 
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Scheme 31. Attempted cycloalkylation of β-aminosulfoxide and -sulfone by RAGHAVAN et al. 
4.3 Cycloalkylation: Results 
The synthesis of the heterocycle through cycloalkylation of the C,N-dianions of 29 with 
ditosylates of the type TsO-(CH2)m+2-OTs was studied (Scheme 32). 
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Scheme 32. Cycloalkylation of C,N-dianions 
Treatment of the 5-membered cyclic sulfoximine 29a with 2.2 equivalents n-BuLi in THF at 
low temperatures generated the corresponding (C,N)-dianion which was stable in solution. 
Upon treatment with TsO-(CH2)3-OTs tricycle 71 having a 6-azaspiro[4.5]decane skeleton 
was formed with high diastereoselectivity (Table 6). 
Double deprotonation of the 6-membered cyclic sulfoximine 29b and treatment of the 
corresponding (C,N)-dianion with TsO-(CH2)2-OTs afforded tricycle 72 having a 
1-azaspiro[4.5]decane skeleton with high selectivity. 
32% 16%
30% 14%
71: n=1, m=1 
72: n=2, m=0 
73: n=2, m=1
29a: n=1
29b: n=2 
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Finally, reaction of the (C,N)-dianion derived from the 6-membered cyclic sulfoximine 29b 
with TsO-(CH2)3-OTs furnished tricycle 73 having a 1-azaspiro[5.5]undecane skeleton with 
high diastereoselectivity. 
Table 6. Result of the cycloalkylation reactions 
Starting 
material Product 
Isolated 
yield 
Chemical 
yield de 
29a 71 75% 75% ≥ 98% 
29b 72 57% 73% ≥ 98% 
29b 73 59% 72% ≥ 98% 
4.4 Cycloalkylation: Discussion 
4.4.1 Determination of the configuration at the newly formed stereogenic center 
The determination of the configuration of the newly formed stereogenic center was 
accomplished using the coupling constants and NOE experiments (Figure 19). 
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Figure 19. Determination of the configuration of the newly formed stereogenic center 
At first, using as a major argument the 3J coupling constants between Ha and the vicinal 
hydrogen atoms, it is possible to determine the position of Ha in the heterocycle. 
In case of tricycles 71 and 73, the 6-membered ring heterocycle seems to adopt a chair 
conformation, in which Ha is in axial position and the sulfoximine group in equatorial 
position. In case of tricycle 72, the 5-membered ring heterocycle seems to adopt an envelope 
71 72 73
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or a half-chair conformation, in which Ha is in pseudo-axial and the sulfoximine in pseudo-
equatorial position. 
Considering the bulkiness of the sulfoximine group, it is not surprising that this substituent 
adopts an equatorial or pseudo-equatorial position.
Then, using NOE experiments, we were able to determine the spacial environment of Ha. In 
the three cases, Ha showed an NOE with Hb and/or Hc. Since we know the absolute 
configuration at the other carbon atoms and Hb and Hc point to the concave face formed by 
the oxazinone ring and the heterocycle, Ha has to be on the same side. Thus we were able to 
determine the configuration of the newly formed stereogenic center (Table 7). 
Table 7. Decisive criteria for the determination of the configuration 
Compounds 
3J coupling constants 
of Ha
Coupling constants 
between Hb and Hd
Decisive NOE 
71 13.2 Hz 3.3 Hz J = 10.2 Hz 
NOE: Ha ↔ Hb 
          Ha ↔ Hc
72 11.6 Hz 8.4 Hz J = 10.4 Hz NOE: Ha ↔ Hb
73 12.9 Hz 4.1 Hz J = 4.4 Hz 
NOE: Ha ↔ Hb 
          Ha ↔ Hc
Finally an X-ray crystal structure analysis of 71 confirmed the configuration deduced from 
the NMR experiments (Figure 20). 
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Figure 20. Structure of 71 in the crystal 
4.4.2 Rationalization of the observed conversions 
Dilithiation of the 5-membered ring oxazinone 29a and reaction with a biselectrophile gave 
tricycle 71 in 75% yield. The same procedure applied to the corresponding 6-membered 
oxazinone 29b furnished 72 and 73 in 57% and 59%, respectively. The yields based on 
conversion of 71, 72 and 73 were almost the same. 
In order to understand the reason why the conversion was lower in the case of oxazinone 29b, 
experiments with deuterated acetic acid were carried out (Scheme 33). 
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Scheme 33. Dilithiation of oxazinones followed by deuteration
H3C
NO
O
S
Ph
ON
CH3
29a
29b
Theoretical part 
44
Oxazinones 29a and 29b were deprotonated with 2.2 eq. of n-BuLi and the mixtures were 
treated with deuterated acetic acid. 29a was only deuterated at the α-position of the 
sulfoximine group, whereas in the case of 29b deuteration at the ortho position of the phenyl 
ring was also observed. 
It is known in the literature that phenylsulfoximines can be deprotonated at the ortho position 
of the phenyl ring. The directed ortho lithiation reaction is a very powerful method for the 
functionalization of aromatic compounds. PAPAMICAËL and DUPAS showed that the 
sulfoximine group is an excellent ortho directing group in lithiation reactions. Several 
electrophiles like methyl iodide were used to afford the corresponding ortho functionalized 
aryl sulfoximines in good yields (Scheme 34).56
S
O NMe
S
O NMe1. n-BuLi [1.2]
2. MeI
95 %
Me
Scheme 34. Sulfoximine as ortho directing group in a lithiation reaction 
By the undesired ortho lithiation of the phenyl ring in case of 29b some of the n-BuLi is 
consumed and consequently upon work up starting material is recovered. Therefore in the 
6-membered ring case, yields are not as good as in the the 5-membered ring case. Anyway the 
yields based on conversion are good for this highly diastereoselective cycloalkylation 
reaction. 
4.4.3 Rationalization of the stereoselectivity outcome 
The selective formation of the S-configured tricycles can be rationalized by assuming a 
chelate structure for the (C,N)-dianion, in which the nitrogen and the oxygen of the 
sulfoximine group coordinate to the lithium cations (Scheme 35). The ditosylate preferably 
attacks at the Si-side of the α-carbon of the sulfoximine group giving 70 rather than epi-70
steming from a Re-side attack. The preference of the Si-side attack seems to be due to the 
carbocycle and the phenyl group pointing towards and thus shielding the Re-side. Then the 
heterocycle is closed by substitution of the remaining tosylate group by the carbamate 
nitrogen. 
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Scheme 35. Attempted rationalization of the selectivity of the cycloalkylation 
In an attempt to optimize the conversion of 29b, an interesting observation was made 
(Scheme 36). The use of 2.2 equivalents n-BuLi gave the S-configured tricycle 72, whereas 
the use of 3.0 equivalents n-BuLi gave the epimeric sulfoximine epi-72 having the 
R-configuration at the carbon atom in α-position to the sulfoximine group. 
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In order to explain this result, we postulate that at first oxazinone 29b is doubly deprotonated 
with 2 equivalents of n-BuLi, then cyclization occurs to give tricycle 72, which should thus be 
the kinetic product (Scheme 37). The remaining equivalent of n-BuLi deprotonates 72 at the 
α-position to the sulfoximine group to give carbanion 72-Li, which is most likely endowed 
with a pyramidalized C atom. α-Sulfonimidoyl carbanions are configurationally labile, and 
thus, carbanion 72-Li is expected to undergo an isomerization with formation of the epimeric 
carbanion epi-72-Li. The epimer should be thermodynamically prefered over 72-Li because of 
the relief of steric interaction between the sulfoximine group and the carbocycle. Finally, 
protonation of 72-Li preferentially occurs from the direction of pyramidalization and gives 
epi-72. 
Another experiment confirmed this mechanism. Treatment of 72 (≤ 98% de) with 1.2 
equivalents of n-BuLi gives epi-72 (≤ 98% de). Thus 72 seems to be the kinetic product and 
epi-72 the thermodynamic one. 
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Scheme 37. Diastereoselective isomerization of 72 to epi-72
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74: 74% 
≥ 98% de
SR-55
4.5 Chloride substitution of the sulfoximine group of the tricycle 
4.5.1 Results 
The application of tricycles 71, 72, epi-72 and 73 to the synthesis of azaspirocyclic natural 
products requires a substitution of the sulfoximine group. This was accomplished, for 
example, by the treatment of sulfoximine 71 with ClCO2CH(Cl)Me in CH2Cl2 at room 
temperature. Chloride 74 was formed in high diastereoselectivity and good yield as well as 
sulfinamide 55 (Scheme 38). 
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Scheme 38. Chloride substitution of a secondary sulfoximine 
4.5.2 Determination of the absolute configuration  
The configuration of 74 was determined by a combination of TOCSY and NOE experiments. 
First TOCSY experiments were carried out in order to assign the signals of the protons, 
particulary the CH2-groups of the carbocycle and of the heterocycle. Then on the basis of 
coupling constants and through NOE experiments the configuration at the C-atom carrying 
the chlorine atom could be assigned (Figure 21). 
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Figure 21. Configuration of 74
According to the coupling constants the heterocycle seems to adopt a chair conformation and 
Ha should be in axial position (Table 8). According to NOE experiments Ha must point in the 
same direction than Hb and Hc. 
71
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Table 8. Decisive criteria for the determination of the absolute configuration of chloride 74
Information Interpretation 
3JHa-Hf = 11.9 Hz 
3JHa-He = 4.0 Hz 
Ha is in axial position 
NOE: Ha↔Hb 
NOE: Ha↔Hc
Ha must point in the same direction than Hb and Hc
The results of the NMR experiments are similar to those found in the case of sulfoximine 71, 
therefore it is not surprising that 74 has the same configuration than 71. However it was 
unexpected that the chlorine substitution proceeds selectively under retention of 
configuration. 
4.5.3 Mechanism of the substitution of secondary sulfoximines 
The mechanism of the substitution of sulfoximines with chloroformates is not known. 
Previously, both retention42 and inversion57 had been observed in the substitution of 
secondary sulfoximines (Scheme 39). 
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Scheme 39. Chlorine substitution of secondary sulfoximines 
The available evidence including the formation of sulfinamide 55 suggests an acylation of 
sulfoximine 71 at the N-atom with formation of the corresponding aminosulfoxonium salt. 
The formation of chloride 74 from 71 with complete retention of configuration could be result 
of different pathways. One can imagine a sequence of two SN2 reactions but there is no 
evident neighbouring group which could exercise an effect. On the other hand, it could be a 
54
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SN1 reaction with intermediate formation of a carbenium ion. However, it is difficult to see 
why the carbenuim ion should be attacked selectively from the Si side which seems to be the 
sterically more hindered one because of the carbocycle (Scheme 40). A third possibility 
would be a SNi mechanism. 
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Scheme 40. SN1 pathway for the chlorine substitution 
4.6 Reduction of the sulfoximine moiety 
An access to more simple azaspirocycles could be opened by reductive cleavage of the 
carbon-sulfur bond. It is known that the sulfoximine group has a low redox potential, so that it 
can be easily reduced. Different reducing agents were tested for this purpose, including 
aluminum amalgame, LDBB and RANEY nickel18 (Scheme 41, Table 9). 
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Scheme 41. Reduction of the sulfoximine group of 71
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Table 9. Screening of reducing agents for the reduction of the sulfoximine group of 71
Reducing agent Observations 
Al / Hg, THF, H2O 
Complete conversion 
Isolated yield: 40% 
Many impurities 
LDBB 
Complete conversion 
Desired product not observed 
Only destruction of the starting material 
RANEY nickel Complete conversion Isolated yield: 96% 
RANEY Nickel was the most suitable agent in this case and we were able to isolate 75 in 
excellent yield. 
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5. Functionalization by generation of an N-acyliminium 
ion 
5.1 The plan 
Having achieved syntheses of azaspirocycles with functional groups at the β,γ-position in the 
heterocycle using ring-closing metathesis, and at the δ-position using cycloalkylation, it was 
of interest whether an access to azaspirocycles carrying a functional group at the α- and/or 
β-position could also be opened. 
We aimed at the preparation of 76 and 78, which are precursors of the N-acyliminium ion 77, 
in order to functionalize easily the α- and/or β-position (Scheme 42). 
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Scheme 42. Structure of precursors 76 and 78 for the N-acyliminium ion 77
5.2 Importance and reactivity of N-acyliminium ions
5.2.1 Importance of N-acyliminium ions 
Reactions between N-acyliminium ions and nucleophiles, also described as amidoalkylation 
or MANNICH type condensations, have been frequently used to introduce susbtituents at the 
α-carbon of an amine (Scheme 43).58
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Scheme 43. Amidoalkylation reaction 
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A substantial number of valuable and pertinent contributions about N-acyliminium ions have 
appeared in the literature covering significant improvements in the accessibility of precursors 
and generation of the reactive species. The control of diastereo- and enantioselectivity of the 
addition reacton has also been a main focus. 
The N-acyliminium ion synthetic method has already been successfully applied to the 
syntheses of chiral pyrrolidines, chiral piperidines, chiral bicyclic lactams and others. 
5.2.2 Formation and reactivity of N-acyliminium ions 
Because of their limited stability and high reactivity, N-acyliminium ions for synthetic 
applications are frequently generated in situ from α-haloalkyl-, α-hydroxyalkyl-, α-alkoxy- or 
α-acyloxyalkyl-substituted amides, lactams, or carbamates.59
LEWIS acids (BF3.OEt2, TiCl4, or SnCl4) and silylating agents (Me3SiOTf) are routinely used 
to assist the formation of the electrophile intermediate. 
The formation of the N-acyliminium ion, which is generally assumed to be the rate-
determining step, is followed by in situ trapping with nucleophiles such as Grignard reagents, 
organocopper reagents, allyltin reagents, allylsilanes and silyl enol ethers. 
This process is known as the α-amidoalkylation reaction. Generally the rate of the 
amidoalkylation reaction increases with the stability of the N-acyliminium ion that is formed 
(Scheme 44). 
R1 N
O
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R4
X R3 +Y
-XY
R1 N
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R3 Nu
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*
R1 = H, alkyl, alkoxy, aryl, aryloxy
R2 = R3 = R4 = H, alkyl, aryl
Scheme 44. General reaction pathway for the α-amidoalkylation 
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5.3 Synthesis of precursors 76 and 78 for the N-acyliminium ion 77 
We were successful in the synthesis of 76 and 78, which are both precursors of 
N-acyliminium ion 77. The syntheses of 76 and 78 were accomplished in three steps starting 
from oxazinone 29a (Scheme 45). 
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Scheme 45. Synthesis of 76 and 78
In the following chapters the steps leading to 76 and 78 will be detailed. 
5.3.1 Synthesis of the protected acetal 
• First plan / The cuprate route 
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I
O
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76% "72%"
Br O
O
t-BuLi, CuI
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Scheme 46. The cuprate route to acetal 79
29a 79 
76 
≥ 98% de
78 
29a 50 79 
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The first step is the substitution of the sulfoximine group of 29a by iodide, which was 
described previously. Then the iodo atom should be substituted by an alkyl group containing a 
protected aldehyde (Scheme 46). 
The commercially available 2-(2-bromoethyl)-1,3-dioxolane was chosen for the synthesis. 
The procedure for the conversion of a bromide into the corresponding cuprate is well 
established. At first the bromide has to be treated with 2 equivalents of t-butyllithium to 
furnish via lithium-bromine exchange the corresponding organolithium compound, which can 
then be transformed into the GILLMAN cuprate using 0.5 equivalent of copper(I). 45,60,61,62
Iodides are even better substrates for the conversion to the corresponding cuprate because of 
their better capacity to undergo lithium-halogen exchange. 
The problem encountered with the cuprate substitution from 50 to 79 was the upscale. In fact 
the yield of 79 decreased dramatically on a “larger” scale. An alternative for the synthesis of 
79 had to be found. 
• Second plan / The double lithiation route 
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NHO
O
O
O
O NH
S
O
Me Ph
O NMe
65% 90%H3C
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O
S
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CH3
O
O
Raney
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1. n-BuLi [2.2]
Br O
O2.
Scheme 47. The double lithiation route to acetal 79
The alternative for the synthesis of 79 takes benefit of the cycloalkylation methodology 
developed for the functionalization of the heterocycle at the δ-position (see chapter 4, Scheme 
47). 
At first the α-position of the sulfoximine group was alkylated with 2-(2-bromoethyl)-1,3-
dioxolane and then the sulfoximine group was replaced by a hydrogen atom. 
The double lithiation of 29a followed by the alkylation of the corresponding dianion with 
2-(2-bromoethyl)-1,3-dioxolane gave the diastereomerically pure sulfoximine 80 in 65% 
yield. However 10% of the starting sulfoximine were recovered. For the reduction of the 
29a 80 
≥ 98% de 
79 
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sulfoximine group RANEY Nickel was used and the reaction furnished the desired product 79
in excellent yield. 
5.3.2 Deprotection and cyclization 
Deprotection-cyclization of acetal 79 was performed (Scheme 48) under acidic conditions. In 
the presence of H2SO4 and MeOH 76 was isolated in good yield. This reaction proceeds most 
probably via the formation of the N-acyliminium ion 77 (Scheme 42). 
Deprotection of acetal 79 (p-TsOH) in absence of a nucleophile gave under elimination of H+
the desired enamide 78 in good yield. 
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Scheme 48. Deprotection and cyclization of the cyclic acetal 
The configuration of 76 was determined by a combination of TOCSY and NOE experiments. 
First TOCSY experiments were carried out in order to assign the signals of the protons, 
particulary the CH2-groups of the carbocycle and of the heterocycle. Then on the basis of 
coupling constants and through NOE experiments the configuration at the C-atom carrying 
the methoxy group could be assigned (Figure 22). 
H3C
NO
O OCH3
a b
c
Figure 22. Configuration of 76
79 
76: 69% 
≥ 98% de 
78: 74%
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According to the coupling constants the heterocycle seems to adopt a chair conformation, Ha
should be in equatorial position and the methoxy group in axial position (Table 10). 
According to NOE experiments Ha must point in the same direction than the carbocycle. 
Table 10. Decisive criteria for the determination of the configuration of acetal 76
Information Interpretation 
3JHa-Hd = 4.0 Hz 
3JHa-Hd´ = 1.8 Hz 
Ha is in equatorial position 
and OCH3 (Hb) is in axial position 
NOE: Hb↔Hd 
NOE: Hb↔Hc
Hb must point in the same direction than the carbocycle (Hc)
5.4 Applications and structural variations 
Acetal 76 and enamide 78 are precursors of N-acyliminium ion 77. These compounds should, 
thus, be versatile intermediates for the functionalization at the α- and/or β-position to the 
N-atom. 
(N,O)-acetal 76 could react with a LEWIS acid to give the N-acyliminium ion 77, which would 
react at the α-position to the nitrogen atom with nucelophiles (Scheme 49). One example is 
reported in the next chapter, using BF3.OEt2 as LEWIS acid and allyltrimethylsilane as 
nucleophile. Details about this reaction will be given in the next section. 
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Scheme 49. Functionalization at the α-position using precursor 76
Enamide 78 is also an interesting precursor; it could lead to the functionalization of the α- and 
β-position. Similar to enamines, such enamides can react with nucleophiles at the α-position 
and with electrophiles at the β-position. 
LEWIS acid 
76 77 
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Several reactions are reported in the literature (Scheme 50). Via a dihydroxylation reaction (a) 
two hydroxy groups could be introduced. Epoxidation followed by ring-opening with MeOH 
would lead to an (N,O)-acetal having a hydroxy group at the β-position (b).The introduction 
of a bromo and iodo atom at the β-position could be achieved by treatment with NBS (c) and 
ICl (d), respectively. It should also be possible to introduce an azide at the β-position (e), and 
finally, reduction of the double bond would lead to a saturated azaspirocycle (f). 
It has to be pointed out that in the case of (b), (c), (d) and (e), the presence of the (N,O)-acetal 
moiety gives rise to further functionalizations and variations at the α-position. 
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Reaction Reagents 
a63 OsO4, NMO 
b64 Oxone, NaHCO3, MeOH 
c65 NBS, MeOH 
d66 ICl, MeOH 
e67 NaN3, (NH4)2Ce(NO3)6, MeOH 
f68 H2, Pd, EtOH 
Scheme 50. Enamide 78: A potential intermediate for a modular functionalization at the α- 
and/or β-position. 
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6. Studies toward the synthesis of halichlorine and pinnaic 
acid 
6.1 Total and formal syntheses of halichlorine and pinnaic acid in the 
literature 
Several groups have reported their efforts towards the synthesis of halichlorine 4 and pinnaic 
acid 7 (Figure 23). In 1999, DANISHEFSKY et al. reported the first asymmetric synthesis of this 
two alkaloids and it is so far the only one for halichlorine.9 In 2004, HEATHCOCK et al. 
reported the total synthesis of (±)-4 and (±)-7.12 KIBAYASHI et al. (2004)13, ZHAO et al. 
(2005)14 and MARTIN et al. (2005)15 published formal total syntheses of halichlorine 4 and 
pinnaic acid 7. In 2007, ZHAO et al. reported a new enantioselective total synthesis of pinnaic 
acid 7 inspired by their formal total synthesis.10 In the same year ARIMOTO et al. published a 
new asymmetric total synthesis of pinnaic acid 7.11
N
Me
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Figure 23. Halichlorine 4 and pinnaic acid 7
In order to plan a formal total synthesis, the intermediates already described in the literature 
were studied with much attention, and for each synthesis the most interesting structure was 
selected (Figure 24). 
4 
7 
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Figure 24. Interesting target molecules for our formal total synthesis plans 
A closer look at the structures of 81, 82, 83, 84 and 86 shows a common skeleton, in which 
the stereocenter in α-position to the N-atom of the heterocycle is already present. This is not 
the case in molecule 85. Finally, two different approaches have been considered. The first one 
includes the construction of the stereocenter in α-position to the N-atom of the heterocycle, 
the second one avoids the construction of this stereocenter. 
6.2 Formal total synthesis including the construction of the stereocenter in 
α-position to the N-atom of the heterocycle 
6.2.1 The plan 
The first challenge is the installation of the new stereogenic center in α-position to the 
N-atom of the heterocycle. Of course the formal total synthesis should take advantage of the 
methodology developed previously. Two different ways to introduce the allyl group at the 
α-position were identified. The first one is the diastereoselective lithiation of 75 alpha to the 
N-atom and reaction of the corresponding lithiated species with allyl bromide. The second 
81 
DANISHEFSKY9
82 
HEATHCOCK12
83 
ARIMOTO11
84
ZHAO10,14
86 
KIBAYASHI13
85 
MARTIN15
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one is the reaction of 76 with a LEWIS acid to form in situ the N-acyliminium ion and its 
reaction with allyltrimethylsilane. In both cases we expected to get 87 (Scheme 51). 
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1. Diastereoselective
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2. Br
1. Formation of the
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2. SiMe3
Scheme 51. Possible access to alkene 87
There were two open questions. Does the reaction work with our system, and if it works, will 
the desired configuration be obtained? 
Given that the synthesis of 87 succeeded with the desired configuration, we envisaged the 
synthesis shown in Scheme 52. 
75 87
76 87
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Scheme 52. Planed formal total synthesis of halichlorine and pinnaic acid 
a) At first oxazinone 87 should be hydrolyzed to give the amino alcohol 88. 
b) Then the amino function should be protected selectively. Afterwards the hydroxy group of 
88 should be transformed into a good leaving group; tosylation was thought to be a good 
choice. The tosylation should be performed under modified MITSUNOBU conditions by using 
p-TsOH as a nucleophile. This should give tosylate 89 with inversion of configuration.69
c) At this stage another inversion of configuration had to take place. It is known that cyanide 
substitution of secondary tosylates proceeds via an SN2 mechanism. Thus nitrile 90 should 
result. 
d) The nitrile function of 90 should be reduced into the corresponding primary alcohol. This 
transformation is known with DIBAL-H in a two steps procedure. The aldehyde is isolated to 
avoid the formation of the primary amine. Then the hydroxy group should be protected to 
give 91.70
e) The double bond of 91 should be easily oxidized to the aldehyde or transformed into the 
primary alcohol under formation of 92. 
87 88 89
9091
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6.2.2 Stereoselective deprotonation in α-position to the N-atom  
• Principle
The removal of a proton from a carbon bearing a heteroatom to give an α-heteroatom 
carbanion is a synthetically useful and mechanistically interesting reaction (Scheme 53). 
Formation of such organometallic species can be promoted by a local inductive effect when 
the heteroatom is the positive end of a dipole.71,72
LiZ
Y
CH2
Z
Y
CH3 RLi E
Z
Y
CH2
E
Y = must be able to stabilize a positive charge (NCH3, O, S)
Z = must be able to stabilize a negative charge (N, O, S)
E = electrophile
Scheme 53. General representation of a dipole-stabilized carbanion and subsequent reaction 
with an electrophile 
BEAK et al. have been working since a long time in this field, and particulary in the 
development of methodologies for the enantioselective synthesis by lithiation adjacent to 
N-atoms and electrophile incorporation (Scheme 54).73 According to their report about the 
lithiation-substitution of bicyclic carbamates it seems that lithiations of such carbamates 
proceed with removal of the proton nearest to the carbonyl oxygen in reactions which are 
kinetically as well as thermodynamically favored. The fact that the bicyclic carbamates are 
lithiated with greater efficiency than the corresponding Boc-protected amines also suggests 
that constraining the position of the proton to be removed to an appropriate angle to the 
carbamate increases the efficiency of lithiation. The distance between the carbamate carbonyl 
group and the proton to be removed appears to be important. 
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Scheme 54. Lithiation-substitution of bicyclic carbamates by BEAK et al. 
• Application to the synthesis of natural products 
BERA et al. have applied this methodology in an enantioselective synthesis of the 1-
azaspiro[5.5]undecane ring system of histrionicotoxin alkaloids (Scheme 55).74 In order to 
explain the high diastereoselectivity, it was assumed that the carbonyl group pointing 
backwards first complexes with sec-butyllithium to direct the lithiation to the same face of the 
ring system. 
NO
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44% 20%
1. sec-BuLi/TMEDA
2. allyl bromide
THF, 0 °C
Scheme 55. Application to the synthesis of azaspirocycles 
• Results and discussion
Tricycle 75 was treated with sec-butyllithium in presence of TMEDA, then allylbromide was 
added (Scheme 56). Unfortunately at –40 °C no conversion was observed and starting tricycle 
75 was recovered. Increasing the temperature to 0 °C led to consumption of the starting 
material but the desired alkene 87 was not observed. Amide 93 was isolated and results from 
the attack of sec-butyllithium to the carbamate carbonyl group. 
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Scheme 56. Tentative of α-lithiation to the N-atom of 75 
BEAK et al. reported that the installation of sterically demanding isopropyl and tert-butyl 
groups nearby the carbamate carbonyl group is necessary to prevent addition of 
sec-butyllithium.73 In case of 75 the addition of sec-butyllithium to the carbamate carbonyl 
group seems to be favored over the lithiation adjacent to the nitrogen.  
6.2.3 Addition to N-acyliminium ions 
• Principle
As discussed in chapter 5, reactions between N-acyliminium ions and nucleophiles have been 
frequently utilized to introduce substituents at the α-carbon of an amine. Because of their 
limited stability and high reactivity, N-acyliminium ions are frequently generated in situ 
(Scheme 57).58,59
75
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87
93 
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Scheme 57. α-amidoalkylation reaction 
• Application to the synthesis of natural products 
FORSYTH et al. applied this methodology to the synthesis of the 1-aza-[4.5.0]-spirobicyclic 
core of halichlorine 4 and pinnaic acid 7 (Scheme 58).75 The in situ formation and 
stereoselective allylation of cyclic iminium ions represents a facile reaction sequence for the 
synthesis of substituted cyclic N-acylamine derivatives from acyclic carbamates. The 
stereoselectivity of the allylation is consistent with allyl attack occuring on the Si-face of the 
iminium ion. 
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Scheme 58. In situ formation and stereoselective allylation of an iminium ion 
• Results and discussion
On the way to halichlorine 4 and pinnaic acid 7, the introduction of an allyl group in α-
position to the N-atom of the heterocycle was required. 
The reaction of 76 with BF3.OEt2 followed by the addition of allyltrimethylsilane to the in situ 
formed iminium ion 77 led to epi-87 in 71% yield with high diastereoselectivity (≥98% de). 
An elimination of 76 with formation of enamide 78 was also observed. epi-87 and 78 were 
isolated in a ratio of 3:1 (Scheme 59). 
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Scheme 59. Synthesis of alkene epi-87 from acetal 76 
The configuration of epi-87 was determined by a combination of TOCSY and NOE 
experiments (Figure 25). First TOCSY experiments were carried out in order to assign the 
signals of the protons, particulary the CH2-groups of the carbocycle and of the heterocycle. 
According to NOE experiments Ha, Hc and He point in the same direction. 
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Figure 25. Determination of the configuration of the newly formed sterogenic center 
in epi-87
Unfortunately, the route via the N-acyliminium ion did not allow the establishment of the 
desired configuration of alkene 87. Such reactions are known to proceed via a SN1 
mechanism. Carbenium ions have been already detected directly in NMR studies and are also 
chemically proven by experimental observations.76
SPECKAMP et al. investigated the reaction of optically pure (+)-94 with allyltrimethylsilane, 
1-phenyl-1-(trimethylsiloxy)ethene and furane, mediated by different LEWIS acids, and 
obtained in all cases completely racemized products (Scheme 60).77 This clearly indicates that 
such reactions proceed via the SN1 mechanism. 
That no SN2 reaction was found can be attributed to the methoxy group, which is a relatively 
poor leaving group. Therefore a single-step substitution of this group is not likely. 
When optically pure (+)-94 was mixed with boron trifluoride etherate in absence of a carbon 
nucleophile, it appeared to racemize rather slowly. Although, after stirring the mixture for 
NOE: Ha ↔ Hb
NOE: Hc ↔ He
76 epi-87: 71% 
≥ 98% de
78: 22%
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24 h at room temperature, the starting material, recovered in nearly quantitative yield, had 
almost completely racemized. 
MeO
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Scheme 60. Rationalization of the SN1 mechanism 
In the case of 76 it is not a SN2 reaction, probably for the same reasons as in SPECKAMP’s
case. The methoxy group is a poor leaving group and a single-step substitution of this group is 
not very favored. We tried to rationalize the selectivity of the reaction but we could not find a 
reason why the attack of allyltrimethylsilane at the iminium ion should occur preferentially 
from the Re-side (Scheme 61). 
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Scheme 61. Rationalization of the formation of 87, epi-87 and 78
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The reaction is highly diastereoselective, but leads to the undesired configuration in terms of 
the formal total synthesis. 
FUJISAWA et al. prepared both enantiomers of amines from a single chiral α-acyloxy amide of 
type 95 via N-acyliminium ions by simply varying the LEWIS acid (Scheme 62, Table 11). 
The reasons for this influence of the LEWIS acid are not clear but might be attributed to a 
different coordination geometry between the intermediate N-acyliminium ion and the LEWIS
acid. Finally the ability of the LEWIS acid to form a complex with the oxygen atom in the 
chiral auxiliary might alter the side for the nucleophile attack. The judicious choice of the 
leaving group is crucial for enhanced selectivity.78
N
Ph
OMe
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O
N
Ph
OMe
O
N
Ph
OMe
O1. Lewis acid
2. 
CH2Cl2, -78°C -> rt
LG = leaving group
SiMe3
Scheme 62. Influence of the leaving group and of the LEWIS acid 
Table 11. Results of the influence of the leaving group and of the LEWIS acid 
LEWIS acid Starting material 95Leaving group (LG) Yield (96+ epi-96) Ratio 96: epi-96
BF3.OEt2 OAc 66% 74:26 
BF3.OEt2 OH 85% 72:28 
SnCl4 OAc 91% 16:84 
SnCl4 OH 87% 46:54 
In the case of alkenes 87 and epi-87 it seems to be difficult to totally invert the 
stereoselectivity. Alkene epi-87 was obtained as a single isomer in the reaction of acetal 76
with BF3.OEt2 as a LEWIS acid and OMe as a leaving group. Although in view of this 
encouraging study a change in favor of alkene 87 might be possible. 
YAMAMOTO et al. showed that the reaction of 6-membered α-ethoxycarbamate 97 with 
organocopper-boron trifluoride reagents proceeds partly via an SN2-type displacement, 
95
96 epi-96
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whereas the reaction with allyltributyltin afforded preferentially the product formed via the 
SN1-type displacement (Scheme 63, Table 12).79
O N
O
OEtC7H15
Me
*
O N
O
RC7H15
Me O N
O
RC7H15
Me
Scheme 63. SN1 vs SN2 displacement: Influence of the organometallic 
Starting 
material Conditions R trans-98 cis-98 Total yield 
trans-97 Allyltributyltin BF3.OEt2
allyl 83% 17% 95% 
trans-97 Bu2CuLi BF3.OEt2
Bu 29% 71% 68% 
cis-97 Bu2CuLi BF3.OEt2
Bu 74% 26% 85% 
Table 12. Illustration of the influence of the organometallic in the SN type displacement 
6.3 Formal total synthesis avoiding the construction of the stereocenter in 
α-position to the N-atom of the heterocycle 
6.3.1 The plan 
It was not possible to build up the stereocenter in α-position to the N-atom having the desired 
configuration for the formal total synthesis of halichlorine 4 and pinnaic acid 7. An alternative 
avoiding the construction of this stereocenter could take advantage of the formal total 
synthesis reported by the MARTIN´s group (Scheme 64).15
97 trans-98 cis-98
Organometallic 
reagent 
LEWIS acid 
R= allyl, Bu 
Theoretical part 
71
Me
NHO
I
O
Me
NHO
O
Me
NH2HO
BocHN
HO H
Me
BocHN
TsO H
Me
BocHN
NC H
Me
BocHN
H
Me
HO
BocHN
H
Me
TBDPSO
Halichlorine
Pinnaic acid
a) b)
c)
d)e)
f)
g)
Scheme 64. Planed synthesis of the MARTIN´s intermediate 
a) We have already shown that iodide 50 can be substituted by a cuprate; in this case we 
would have to use a cuprate with a homoallyl substituent to obtain alkene 99. 
b) At this stage the carbamate would have to be deprotected under strongly basic conditions to 
obtain the amino alcohol 100. 
c) Then the amino function of 100 should be converted into the corresponding Boc carbamate 
101. 
d) The hydroxy group of 101 would have to be transformed into a good leaving group; 
tosylation should be a good choice. The tosylation should be carried out under modified 
MITSUNOBU conditions by using p-toluenesulfonic acid as a nucleophile. This should give 
tosylate 102.69
e) At this stage another inversion of configuration should be realized; it is known that cyanide 
substitution of secondary tosylates proceeds via an SN2 mechanism. Nitrile 103 should result. 
50 99 100
101102103
104 85
4
7
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f) The nitrile function of 103 would have to be reduced to the corresponding primary alcohol 
104. The reduction should work with DIBAL-H in two steps with isolation of the 
intermediary aldehyde to avoid formation of the primary amine.70
g) The last step would be the silylation of alcohol 104 to obtain the corresponding TBDPS 
protected alcohol 85, which has already been described by the MARTIN´s group. 
The synthesis of 85 would represent a formal total synthesis of halichlorine 4 and pinnaic acid 
7.15
6.3.2 Results and discussion 
The first step of the planed synthesis of 85 caused problems because the desired alkene 99 has 
never been the major product of the reaction (Scheme 65). Oxazinone 105 was always 
identified as the major product, whereas alkene 99 was only observed in small amounts 
according to the 1H NMR spectra of the crude mixtures. 
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Scheme 65. Attempted substitution of the I-atom of 50 by a homoallyl group 
Since alkene 99 and oxazinone 105 could not be obtained in pure form, oxazinone 105 was 
synthesized by reduction of sulfoximine 29a with RANEY nickel, in order to confirm the 
structure and obtain a full characterization (Scheme 66). Treatment of sulfoximine 29a with 
freshly prepared RANEY nickel in THF/H2O furnished oxazinone 105 in 74% yield. 
105 
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50 
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Scheme 66. Reduction of sulfoximine 29a with RANEY nickel 
In order to exclude a mistake during the preparation of the cuprate, some titrations and tests 
were carried out. t-Butyllithium and homoallyllithium were titrated with diphenylacetic 
acid.80 The freshly prepared homoallylmagnesium bromide was titrated using benzyl alcohol 
and phenantrolin.81
After preparation of the cuprates, a Gilman test using Michler´s ketone was carried out to 
make sure that no homoallyllithium or homoallylmagnesium bromide remained (Scheme 
67).82
Br
MgBr
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Mg [1.1]
t-BuLi [2]
CuI [0.5]
CuI [0.5]
CuMgBr
2
CuLi
2
Scheme 67. Preparation of homoallylcuprates 
Considering the example of TAKAHATA et al., it was quite surprising that the substitution of 
iodide 50 with homoallylcuprate failed (Scheme 68).83
I
NH
Cbz
NH
Cbz
CuMgBr
2
82%
Scheme 68. Substitution of a primary iodide by homoallylcuprate by TAKAHATA et al. 
It is known that alkylcuprates are less stable than alkenylcuprates, which is due to their ability 
to undergo a β-hydride elimination. 
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The difference between TAKAHATA´s results and ours results from a competition between two 
pathways: substitution and β-hydride elimination. 
In TAKAHATA´s case, R2 equals alkyl and R3 equals H, whereas in the case of iodide 50 R2
and R3 equal alkyl. Iodide 50 is a hindered substrate and substitutions are known to be more 
difficult in those cases.  
The reaction temperature has to be higher than for substrates having R3 equals H. But, if the 
temperature increases, the chances for β-hydride elimination on the alkyl cuprate increase 
also. Homoallylcuprate undergoes a β-hydride elimination more easily than other 
alkylcuprates because of the formation of butadiene (Scheme 69). 
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Scheme 69. Competition between substitution and β-hydride elimination in the reaction of 
primary alkyliodides and alkylcuprates 
Moreover it is known that complex metal hydrides of copper react very well with alkyl 
halides to give the corresponding alkane (Scheme 70).84 This could explain the isolation of 
the dehalogenated 105. 
LinCuHn+1 + C10H21I C10H22100%
Scheme 70. Reaction of complex metal hydrides of copper with alkyliodide 
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6.3.3 Using the double lithiation methodology 
 
The reaction of doubly lithiated oxazinones with biselectrophiles was described previously 
(Chapter 4). By using this methodology the substitution of iodide 50 by homoallylcuprate 
could be avoided. 
 
Only one experiment was carried out. Dilithiation of oxazinone 29a with 2 equivalents of n-
butyllithium followed by addition of homoallylbromide gave no conversion. The use of 
homoallyltosylate could perhaps give better results (Scheme 71). 
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Scheme 71. Studies towards the synthesis of alkene 99 
 
 
6.4 Outlook 
 
Another possibility for the construction of the stereogenic center in α-position to the N-atom 
of the heterocycle would be a route involving the reduction of an N-acyliminium ion (Scheme 
72). 
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Such reactions are described in the literature using different reducing reagents like silanes or 
borohydrides.85,86 
O NH
Me
O
O N
Me
O R
O N
Me
O R
*[reduction][condensation]
O
R
Scheme 72. A new route involving the reduction of N-acyliminium ion 107
In the following explanations the terms Si-face and Re-face are not used, because they are 
different for 77 and 107. The terms frontside and backside are preferred to enable an easier 
comparison (Scheme 73). 
If the reaction works, which facial selectivity will be observed? In the case of the addition of 
allyltrimethylsilane to N-acyliminium ion 77, the nucleophile attacks exclusively from the 
backside. 
There is hope that in the case of N-acyliminium ion 107, the reducing agent will also prefer to 
attack from the backside, so that the desired configuration could be obtained. 
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Scheme 73. Comparison between the addition to iminium ion and the reduction of iminium 
ion in regard to the stereochemistry 
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7. Synthesis of protected δ-hydroxy-β-amino acids 
7.1 Introduction to β-amino acids 
7.1.1 Importance of β-amino acids 
Proteinogenic α-amino acids are constituents of all enzymes which control the metabolism in 
living matter and are thus an essential prerequiste for life. In contrary, most β-amino acids 
only occur as constituents of distinct natural products, such as peptides, alkaloids or 
terpenoids. These compounds are often characterized by potent biological and physiological 
activities that are crucially based on their β-amino acid substructures. As a consequence, 
many natural products with a β-amino acid moiety are potential lead structures for the 
development of new drugs.87
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Figure 26. Negamycin 108 and the sperabillins 109
We are particulary interested in δ-hydroxy-β-amino acids. Negamycin 108 and the 
sperabillins A-D 109 are natural products, which show a δ-hydroxy-β-amino acid subunit 
(Figure 26).87
Negamycin 108 is an unusual hydrazido dipeptide which was isolated in 1970 from 
Streptomyces purpeofuscus and shows activity against multiple drug resistant bacteria by 
inhibition of the procaryotic protein biosynthesis with miscoding activity. 
Sperabillins A-D 109 were isolated from cultures of the bacterium Pseudimonas fluorescens 
YK-473, and are effective against several bacteria including antibiotic resistant ones. 
108 
109 
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7.1.2 Retrosynthesis of β-amino acids 
Because of the importance of β-amino acids a number of synthetic approaches has been 
developed. There are three general strategies for their construction (Scheme 74).87
The first one is the MICHAEL addition of a N-nucleophile. A chiral information can be 
introduced via the N-nucleophile (e. g. chiral lithium amide), via a chiral MICHAEL system (e. 
g. EVANS auxiliary strategy) or via a chiral catalyst (e. g. TADDOL). 
The second general method is the MANNICH reaction, which can be carried out 
stereoselectively by using chiral imines or chiral enolates. The use of a chiral catalyst is an 
efficient method, for example a chiral LEWIS acid (e. g. BOX ligand and copper) or a chiral 
organocatalyst (e. g. proline). 
The last approach is the homologation of α-amino acids like the ARNDT-EISTERT reaction or 
the use of cyanohydrins. In this case the chiral information is derived from the α-amino acid. 
R1
N
X
O
R2
Scheme 74. Retrosynthetic approaches to the synthesis of β-amino acid subunits 
These three methods are the most general ones. Of course a lot of further synthetic approaches 
have been developed in the last decades opening an access to various target systems. 
7.2 Toward a selective protection of δ-hydroxy β-amino acids 
7.2.1 Methodology developed by GAIS et al. 
The approach should take advantage of the methodology developed by Gais and co-workers 
(Scheme 75).17,18,51 The route involves a facile substitution of the sulfoximine group of 110 by 
a chlorine atom to give β-aminochlorides of type 111. Then the introduction of a cyano group 
Aza-MICHAEL
addition 
MANNICH
reaction 
Homologation of α-
amino acids 
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was achieved through treatment of 111 with KCN, which gave the corresponding β-amino 
nitriles 112 in very good yield. Finally hydrolysis of 112 followed by Boc-protection of 113 
afforded lactones of type 114. 
This method works well for acyclic and for cyclic (R2---R3) substrates. 
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NHBoc
Scheme 75. Strategy towards protected β-amino acids of type 114 by the GAIS group 
7.2.2 The plan 
We were interested in the possibility to protect the amino acid part of 113 as a β-lactam in the 
presence of the hydroxy group. This would be an entry to functionalized spirocyclic β-lactams 
(Scheme 76). 
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Scheme 76. Lactone vs. lactam 
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SHARMA et al. described the synthesis of monocyclic β-lactams via cyclodehydration of 
β-amino acids incorporating a hydroxy group using POCl3 (Scheme 77).88
HO HN
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O
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NEt3
CH2Cl2
R=H, R1=CH3, n=1
R=H, R1=CH3, n=2
R=CH3, R1=H, n=1
R1
R R
R1
Scheme 77. SHARMA´s approach to β-lactams 
7.3 Results 
Substitution of the sulfoximine group of 29a led to the β-amino chloride 115. Replacement of 
the chlorine atom by cyanide gave the β-amino nitrile 116. Hydrolysis of 116 under basic 
condition afforded the unprotected β-amino acid 117. Boc-protection and cyclization of 117
gave the desired Boc-protected aminolactone 118 in good yield. Unfortunately the synthesis 
of β-lactam 119 via a cyclodehydration reaction did not succeed. 
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Scheme 78. Attempted selective protection of the δ-hydroxy β-amino acid 117 
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In the following chapters the synthesis of 118 and the attempted synthesis of 119 will be 
discussed in detail.  
 
7.3.1 Substitution of the sulfoximine group by a chlorine atom 
 
The first step was the substitution of the sulfoximine group of 29a by a chlorine atom. The 
nitrogen atom of the sulfoximine group was acylated, then the liberated chlorine atom 
underwent a substitution reaction with the activated aminosulfoxonium salt giving the desired 
chloride 115 (Scheme 79). 
It has already been shown by Gais et al. that chiral auxiliary 15 can be recovered 
enantiomerically pure in good yields from sulfinamide 55.42 
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Scheme 79. Chlorine substitution of sulfoximine 29a 
 
 
7.3.2 Substitution of the chlorine atom by cyanide 
 
The second step was the substitution of the chlorine atom of 115 by cyanide. This reaction 
worked well, nitrile 116 was obtained from chloride 115 in 94% yield (Scheme 80).18,27 
Earlier KÖHLER investigated the “direct” substitution of sulfoximines similar to 29a by 
cyanide but he did not succeed.89 
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Scheme 80. Cyanide substitution of chloride 115 
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7.3.3 Cyclization to the lactone 
Under highly basic conditions both the nitrile function of 116 and the cyclic carbamate were 
hydrolyzed under formation of the hydroxyl substituted amino acid. After neutralization the 
unprotected δ-hydroxy β-amino acid 117 was isolated. Treatement of 117 with Boc-anhydride 
in the presence of triethylamine afforded Boc-protection of the amino function and the 
activation of the carboxy group, which led to cyclization with formation of lactone 118. 
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Scheme 81. Cyclization to the Boc-protected lactone 118
7.3.4 Cyclization to the β-lactam 
When unprotected δ-hydroxy-β-amino acid 117 was treated with POCl3 in the presence of 
triethylamine, which are the conditions SHARMA et al. used for their cyclodehydration, no 
lactame 119 was formed. The unprotected amino acid 117 could partly be recovered. 
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Scheme 82. Attempted cyclization of amino acid 117 to the β-lactam 119
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8. Synthesis of cycloalkenyl oxiranes 
8.1 Introduction to vinyl oxiranes 
 8.1.1 Vinyl oxiranes as structural element in natural products 
Vinyl oxiranes are found as structural element in natural products, for example in (+)-
posticlure 120 and in leukotriene A4 (LTA4) 121 (Figure 27). 
(+)-Posticlure 120 is a novel trans-epoxide pheromone from the virgin females of the tussock 
moth Orgyia postica. 
Leukotrienes are a family of biologically active metabolites of arachidonic acid known to play 
a role in a number of different pathophysiological processes. Leukotriene A4 (LTA4) 121 is a 
chemically reactive conjugated triene epoxide product derived from 5-lipoxygenase 
oxygenation of arachidonic acid. 
OC9H19
C4H9 OHC (CH2)3CO2H
O
Figure 27. Examples of natual products having a vinyl epoxide building block 
8.1.2 Vinyl epoxides as interesting starting materials for further transformations 
Vinyl epoxides are useful electrophiles which can react with a range of nucleophiles. Since 
they are a subset of allylic electrophiles, nucleophilic substitutions can take place through SN2 
and SN2´ attack, and the ability to control the regioselectivity is critical (Figure 28). 
O
R
a)
b)c)
Figure 28. Positions for nucleophilic attack on vinyl epoxides 
120 121 
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Normally, soft nucleophiles prefer the SN2´ reaction variant via route a), while hard ones 
participate in the SN2 attack at the allylic position via route b), although several exceptions are 
known. During these nucleophilic attacks the vinyl moiety acts as a regiochemical directing 
element, and attack following route c) is usually not observed. As the epoxide moiety is a 
small strained-ring system, it is perhaps not surprising that vinyl oxiranes participate in 
several useful rearrangement reactions. 
1,4-Additions (SN2´ pathway) of carbon nucleophiles to vinyl epoxides are well documented 
and can be accomplished by several different techniques. Palladium-catalyzed allylic 
alkylation of these substrates with soft carbon nucleophiles (pKa 10–20) proceeds under 
neutral conditions and with excellent regioselectivities. For example cyclization of the sulfone 
using catalytic amounts of Pd(PPh3)4 and bis(diphenylphosphino)ethane (dppe) under high 
dilution conditions gives the corresponding macrocycle which is an intermediate in a total 
synthesis of the antitumor agent roseophilin (Scheme 83). 
TBSO
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MeO2C
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MeO2C
PhO2S
Pd(PPh3)4 [0.1]
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85 %
Scheme 83. Example for SN2´ pathway 
The SN2 reaction alternative is often the major pathway when hard nucleophiles are 
employed. γ,δ-Epoxy acrylates can be opened regio- and stereselectively at the γ-position with 
AlMe3/H2O. This method has been used for iterative construction of polypropionate chains 
and tertiary stereocenters (Scheme 84). 
BnO CO2EtO
BnO CO2Et
Me
OH
Me3Al [10]
H2O [6]
96 %
Scheme 84. Example for SN2 pathway 
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8.2 Introduction to cycloalkenyl oxiranes 
Chiral vinyl oxiranes are valuable intermediates in organic synthesis. Their asymmetric 
synthesis has been accomplished by several methods, including the epoxidation of allylic 
alcohols in combination with an oxidation and olefination, the epoxidation of dienes, the 
chloroallylation of aldehydes in combination with 1,2-elimination, and reactions between 
sulfur ylides and aldehydes. Although some of these methods are very efficient for the 
synthesis of alkenyl oxiranes, all of them fail for the preparation of cycloalkenyl oxiranes. 
There are only a few examples of diastereoselective and enantioselective syntheses of 
cycloalkenyl oxiranes in the literature. 
 8.2.1 Diastereoselective syntheses of cycloalkenyl oxiranes 
WHITE et al. published in 1990 the diastereoselective syntheses of cis- and trans-vinyl 
epoxides from enynols, and in one case the method was applied to a cyclic system (Scheme 
85). Reaction of 122 with the highly activated RIEKE zinc provided dienol Z-123 having a Z
double bond. Reduction of 122 with LiAlH4 gave dienol E-123 having an E double bond. The 
allylic double bonds of dienols Z-123 and E-123 were selectively epoxidized using VO(acac)2
and t-BuOOH to yield epoxyalcohols (±)-cis-124 and (±)-trans-124, respectively.90
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Scheme 85. Diastereoselective syntheses of cycloalkenyl oxiranes by WHITE et al. 
122 
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EBERBACH et al. developed a DARZEN condensation of aldehyde 125, which afforded oxirane 
126 with exclusively or predominant trans-arrangement of the phenyl and cycloalkene groups 
(Scheme 86).91
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Scheme 86. DARZEN condensation to cycloalkenyl epoxides by EBERBACH et al. 
 8.2.2 Enantioselective syntheses of cycloalkenyl oxiranes 
GAIS et al. published the synthesis of cycloalkenyl oxiranes in three steps from cyclic allylic 
sulfoximines. Treatment of derivatives of cyclic allylic sulfoximines of type (S)-27, bearing a 
tris(diethylamino)titanium group in the α-position, with aldehydes gave the sulfoximine-
substituted homoallylic alcohols 127 with high regio- and diastereoselectivity. The 
sulfoximine group of 127 could be stereoselectively replaced by a Cl-atom with formation of 
the corresponding chlorohydrins 128, which upon base treatment gave cycloalkenyl oxirane 
cis-129. The epoxides were enantio- and diastereomerically pure (Scheme 87).42
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Scheme 87. Asymmetric synthesis of cis-cycloalkenyl oxiranes by GAIS et al. 
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METZNER et al. reported a one-pot epoxidation reaction in which a chiral sulfide, an allyl 
halide, and an aromatic aldehyde were allowed to react to give a trans-vinyl epoxide. This is 
an efficient approach, as the sulfonium salt is formed and deprotonated in situ to afford the 
corresponding ylide, which reacts with the aldehyde. They published only one cyclic 
example: the trans-product was isolated in moderate yield, moderate diastereoselectivity and 
very good enantioselectivity (Scheme 88).92
I S CH3H3C
O
PhPhCHO 60 %
Scheme 88. Asymmetric synthesis of trans-cycloalkenyloxiranes using sulfur ylides and 
aldehydes by METZNER et al. 
SHIBASAKI et al. published the regioselective catalytic asymmetric epoxidation of 
α,β,γ,δ-unsaturated amides with the Gd-(S)-binol-Ph3As=O complex. Only one cyclic 
example was reported, but yield and enantioselectivity are good and very good, respectively 
(Scheme 89).93
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Scheme 89. Catalytic asymmetric epoxidation of α,β,γ,δ-unsaturated amides by 
SHIBASAKI et al. 
8.3 REDDY´s synthesis of cycloalkenyl aziridines 
In the GAIS group REDDY described the synthesis of cycloalkenyl aziridines from cyclic 
vinylic sulfoximines (S)-31 (Scheme 90).25
He was able to synthesize cycloalkenyl aziridines as cis/trans mixtures in good yield and 
enantioselectivity (Table 13). 
40% de (trans) 
90% ee (trans) 
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Scheme 90. Synthesis of cycloalkenyl aziridines from vinylic sulfoximines 
Table 13. REDDY´s results concerning the synthesis of cycloalkenyl aziridines 
n Product Yield (cis+trans) cis:trans (de) eecis eetrans
1 130a 70% 60:40 (20%) 79% 90% 
2 130b 73% 60:40 (20%) 76% 56% 
3 130c 71% 60:40 (20%) 78% 57% 
4 130d 66% 50:50 (0%) 70% 25% 
Using REDDY´s procedure it should be possible to synthesize cycloalkenyl oxiranes by 
replacing the iminoester with aldehydes. 
8.4 Synthesis of cycloalkenyl oxiranes 
Treatment of the cyclic vinyl sulfoximines 31 with MEERWEIN reagent (Me3OBF4) and 
reaction with aldehydes in presence of DBU led to cyclic alkenyloxiranes 131a-f. 
The reaction was carried out with different vinyl sulfoximines and aldehydes. The 
cycloalkenyl oxiranes 131a-f were isolated in moderate yields, high diastereoselectivity and 
low enantioselectivity (Table 14). 
(S)-31
130a-d 
Theoretical part 
89
Table 14. Synthesis of cycloalkenyl oxiranes from aldehydes and cyclic vinyl sulfoximines 
S O
O
NMePh 1. (CH3)3OBF4
2. DBU
3.( )n ( )n
H
O
R
R
Product n R Yield (cis+trans) dr (de) ertrans (eetrans) 
131a 1 H 42% 94:6 (88%) 66 :34 (32%) 
131b 2 H 44% 91:9 (82%) 60:40 (20%) 
131c 1 Br 27% 93:7 (86%) 63:37 (26%) 
131d 2 Br 33% 93:7 (86%) 57:43 (14%) 
131e 1 NO2 34% 94:6 (88%) 66:44 (22%) 
131f 2 NO2 38% 94:6 (88%) 55:45 (10%) 
8.5 Discussion 
8.5.1 Mechanism 
According to REDDY´s work about the cycloalkenyl aziridines, the first step should be the 
activation of the N-methyl sulfoximine group of the vinyl sulfoximines 31 with MEERWEIN
reagent leading to the corresponding (dimethylamino)sulfoxonium salts 132.25
Upon treatment with DBU the salt 132 is deprotonated to generate the corresponding cyclic 
aminosulfoxonium ylides 133, which can react with aldehydes via an addition/ring-closing 
mechanism to give the desired cycloalkenyl oxiranes 131 (Scheme 91). 
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Scheme 91. Possible mechanism for the formation of cycloalkenyl oxiranes 131 from vinyl 
sulfoximines and aldehydes 
8.5.2 Rationalization of the stereoselectivity outcome 
It was assumed that the allylic aminosulfoxonium ylides are not configurationally stable in 
regard to the center in α-position to the sulfur atom, so that both epimers 133 and epi-133 are 
in fast equilibrium (Scheme 92). The first step is the addition of the ylide to the aldehyde, 
which occurs from the Si-side or from the Re-side of the aldehyde. Reaction of 133 and epi-
133 with an aldehyde leads to four theoretically possible betaines trans-134, ent-trans-134, 
cis-134, ent-cis-134. This step is reversible so that the betaines are in equilibrium with the 
ylides. At this stage a new C–C bond is created, only the ring-closure is missing. 
According to the literature the ring-closure of alcoholates with a leaving group in α-position 
should proceed via a SN2 mechanism. The two bulky groups, the aromatic ring derived from 
the aldehyde and the cycloalkenyl group derived from the vinyl sulfoximine, seem to play key 
roles. A closer look to the NEWMAN projections, having the nucleophile and the leaving group 
in anti orientation shows that in trans-134 and ent-trans-134 these two bulky groups are also 
in anti orientation, whereas in the case of cis-134 and ent-cis-134 they are in gauche
orientation. Therefore it seems likely that the cyclization of trans-134 and ent-trans-134 is 
31 132 133 
134 
131 
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thermodynamically more favored than the cyclization of cis-134 and ent-cis-134, which is 
supposed to have a transition state higher in energy. 
Cyclization of trans-134 and ent-trans-134 gives oxiranes trans-131 and ent-trans-131, 
respectively, whereas cyclization of cis-134 and ent-cis-134 gives oxiranes cis-131 and ent-
cis-131, respectively. 
Unfortunately, the reaction gives only poor enantioselectivity. This can be explained with a 
very low discrimination during the attack of the ylide to the aldehyde. 
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Scheme 92. Attempted rationalization of the stereoselectivity
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8.6 Conclusion and outlook 
Cycloalkenyl oxiranes are interesting building blocks but the methodologies to synthesize 
them are limited. A highly diastereoselective synthesis of cycloalkenyl oxiranes was 
achieved, unfortunately the enantioselectivity was poor and the yields low. 
Yields and enantioselectivity might be improved by the use of other vinyl sulfoximines 
having a different group at the nitrogen atom, which would change the bulkyness and/or the 
polarity. 
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9. Conclusion and outlook 
In summary a modular asymmetric synthesis of azaspirocycles using the sulfoximine group as 
a chiral auxiliary has been developed. A range of azaspirocycles showing flexibility in the 
ring sizes, as well as in the choice of the substituents were synthesized.  
An efficient, modular and diastereoselective strategy for the synthesis of the carbocycle using 
the titanium-mediated γ-hydroxyalkylation as a key step was developed. Cyclic allylic 
sulfoximines 27 were transformed into homoallylic alcohols of type 28 while constructing 
two new stereogenic centers and a double bond (Scheme 93). 
Me
HO
S Ph
NMe
O
( )n
S
O NMe
Ph
( )n
Scheme 93. Titanium-mediated γ-hydroxyalkylation 
The key step for the installation of the tertiary carbon atom bearing the amino group is based 
on the use of chiral vinyl sulfoximines as Michael acceptors. The intramolecular aza-
MICHAEL addition led to diastereomerically pure oxazinones of type 29 in high yields 
(Scheme 94). 
Me
O
( )n
NH
O
S
O NMe
PhMe
O
S Ph
NMe
O
( )n
O
H2N
Scheme 94. Intramolecular aza-MICHAEL addition 
Having achieved an efficient synthesis of functionalized carbocycles 29, which contain three 
contiguous stereogenic C atoms, we focused on the synthesis of the heterocycle. A modular 
75-78%, ≥98% de 
89-92%, ≥98% de
27 28
40  29 
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route to the heterocycle which permitted flexible control of the ring size and substitution 
pattern could be developed (Scheme 95). 
H3C
NHO
O
S
Ph
O NCH3
( )n
H3C
HNHO
H3C
NO
O
( )n
( )p
R2
H3C
NO
O
H3C
NO
O
H3C
NO
O R1
α
α
β
β
δ
γ
Scheme 95. Modular construction and functionalization of the heterocycle 
Synthesis of azaspirocycle 53 having functionalization at the β,γ-position was achieved by 
ring-closing metathesis. 
Using the N-acyliminium ion strategy we were able to synthesize 76, 78, and 87 having 
functionalities at the α and α,β-position. 
Cycloalkylation reactions permitted the synthesis of 71, 72, 73, 74 having a variety of 
substituents at the δ-position, as well as the synthesis of the unfunctionalized azaspirocycle 
75. 
76: R1=OMe 
87: R1=allyl 
78
53
71: n=1, p=0, R2=S* 
72: n=2, p=0, R2=S* 
73: n=2, p=1, R2=S* 
74: n=1, p=0, R2=Cl 
75
S* = S
MeN O
Ph
29 
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An attempt was made to extend this methodology to the synthesis of the azaspirocyclic core 
of halichlorine 4 and pinnaic acid 7. Three different approaches were investigated, however 
these routes were unsuccessful and work is on-going. In one instance, the desired C-C bond 
forming reaction proceeded but led to the undesired diastereoisomer. As the synthesis of 
azaspirocycles developed here is very modular, an alternate route could be in theory be easily 
investigated. 
In conclusion the chemistry described here opens a broad avenue for the stereoselective 
preparation of highly substituted azaspirocycles, being of interest for the synthesis of natural 
products and derivatives thereof. 
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B. Experimental Part 
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1. General remarks 
GENERAL INFORMATIONS
All the synthetic operations including reactions, work-ups and chromatographic separations 
were carried out in a well ventilated hood according to the current safety regulations.  
All reactions involving air- or moisture sensitive compounds were carried out under argon 
using SCHLENK and vacuum line techniques. The glassware employed for those manipulations 
was oven-dried, and then cooled under argon. Reagents and solvents were transferred under 
argon using cannulae or syringes.94
SOLVENTS
Solvents used for moisture-sensitive reactions were dried and purified according to the 
standard techniques or purchased from commercial suppliers.95
♦CH2Cl2 was distilled from CaH2 under argon. 
♦THF was predried with KOH, filtered through basic Al2O3 (2 times) and distilled 
from sodium-benzophenone under argon. 
♦Toluene was distilled from sodium under argon. 
♦DMF was purchased from commercial suppliers (<50 ppm H2O). 
♦MeOH was purchased from commercial suppliers (HPLC quality) and stored over 
molecular sives 4Å. 
♦Acetone was purchased from commercial suppliers (HPLC quality). 
Ethyl acetate (EtOAc), diethyl ether (Et2O), n-hexane, cyclohexane and n-pentane for column 
chromatography were distilled before use. Isopropanol (i-PrOH) and methanol (MeOH) were 
purchased from commercial suppliers (HPLC quality) for column chromatography. 
REAGENTS
All reagents were purchased from commercial suppliers and were used without purification, 
except ClTi(Oi-Pr)3, which was distilled prior to use. 
Organolithium reagents and GRIGNARD reagents were titrated with diphenylacetic acid and 
benzylalcohol/phenantrolin, respectively.80,81
Experimental part 
98
NMR SPECTRA
NMR spectra were recorded at room temperature using the following spectrometers: Varian 
VXR 300, Varian Inova 400, and Varian Unity 500. 
♦ 1H NMR spectra
The chemical shifts are given in ppm relative to tetramethylsilane (δ = 0.00 ppm) as internal 
standard and referenced to residual solvents signals (methanol, δ = 3.31 ppm; benzene, 
δ = 7.16 ppm; chloroforme, δ = 7.26 ppm).96 The following abbreviations are used to 
designate the multiplicity of the peaks in the 1H NMR spectra: s = singlet, d = doublet, 
t = triplet, q = quadruplet, qui = quintuplet, m = multiplet, b = broad and combinations 
thereof. If the assignement could not have been done, the hydrogens are denoted with 
multipicity (CH, CH2, CH3) as determined from 2D NMR spectra as well as DEPT and APT 
pulse sequences. 
♦ 13C NMR spectra
The chemical shifts are given in ppm relative to tetramethylsilane (δ = 0.00 ppm) as internal 
standard and referenced to residual solvents signals (methanol, δ = 49.00±0.01 ppm; benzene, 
δ = 128.06±0.02 ppm; chloroforme, δ = 77.16±0.06 ppm).96 The 13C NMR spectra are 
denoted with u = up and d = down as determined from APT pulse sequence. If the 
assignement could not have been done, the carbons are denoted with hydrogen multipicity (C, 
CH, CH2, CH3) as determined from from 2D NMR spectra as well as DEPT and APT pulse 
sequences. 
MS 
Following spectrometers were used for the recording of mass spectra: 
for MS (EI): Finnigan SSQ 7000, 70 eV.  
for MS (CI): Finnigan SSQ 7000, 100 eV.  
for HRMS (High resolution mass spectra): Varian MAT 95, EI, 70 eV. 
Only peaks of m/z > 80 and intensity > 10%, except for decisive one, are listed. 
IR 
IR spectra were recorded on a Perkin Elmer FTIR 1760 S spectrometer as KBr pellets (KBr), 
neat (capillary) or in chloroform (CHCl3). Absorptions are given in wavenumbers (cm–1). 
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Only peaks of ν > 600 cm–1 are listed, s = strong (70–100% absorption), m = medium (30–
70% absorption) and w = weak (10–30% absorption). 
ELEMENTAL ANALYSIS
Elemental analyses were performed on a Heraeus CHN-O-Rapid instrument. All values are 
given in mass percentages. 
OPTICAL ROTATION
Perkin-Elmer Model 241, measurements were made at approximately 22 °C, specific rotations 
are in (deg·mL)/(dm·g), and the concentration c is in g.10-2. mL. 
MELTING POINTS
Melting points were measured in open glass capillaries with a Büchi apparatus, the values are 
uncorrected. 
CHROMATOGRAPHY
♦ Thin layer chromatography (TLC)
Support: Merck silica gel 60 F254 plates were used. 
Detection: First the TLC plates were submitted to UV (λ = 254 nm) and then one of the 
following color reagents was used: 
- Anisaldehyde: 6 mL anisaldehyde, 3 mL concentrated H2SO4 and 250 mL EtOH 
- Ninhydrin: 1 g ninhydrin, 25 mL acetic acid and 475 mL n-BuOH 
- KMnO4: 3 g KMnO4, 20 g K2CO3, 5 mL 5% NaOH, 300 mL H2O 
♦ Column chromatography
Purification by flash column chromatography was carried out in glass columns using Merck 
silica gel 60, particle size 0.040–0.063 mm (230–400 mesh). 
♦ High performance liquid chromatography (HPLC) 
Analytical HPLC on achiral phases was performed on a Waters 600E instrument with UV 
detector 481 (254 nm) at 22 °C. 
Analytical HPLC on chiral phases was performed on a HP 1050 instrument with MW detector 
(230 nm, 254 nm) at 24 °C. 
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Preparative HPLC were performed on a Varian SD-1 instrument with a Prostar 320 detector 
(254 nm) and a Knauer detector (RI). 
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2. Construction of the carbocycle having an amino-
substituted tertiary C atom 
2.1 Synthesis of the cyclic allylic sulfoximines 
2.1.1 (–)-(R)-(S-Cyclopent-1-enylmethyl)-N-methyl-S-phenylsulfoximine (27a) 
S6
1
O NCH3
7
8
5
4 3
2 11
10
9
Allylic sulfoximine 27a was prepared according to the procedure described in the literature. 
The analytical data were in agreement with those reported.33
1H NMR (300 MHz, CDCl3): δ = 1.81 (qui, 3J3-4 = 3J5-4 = 7.4 Hz, 2 H, H-4), 2.15–2.45 (m, 
4 H, H-3, H-5), 2.72 (s, 3 H, H-7), 3.97 (s, 2 H, H-6), 5.42–4.46 (m, 1 H, H-2), 7.48–7.64 (m, 
3 H, H-10, H-11), 7.79–7.84 (m, 2 H, H-9). 
13C NMR (75 MHz, CDCl3): δ = 23.6 (u, C-4), 29.8 (d, C-7), 32.7 (u, CH2), 35.0 (u, CH2), 
58.8 (u, C-6), 129.0 (d, C-10), 129.6 (d, C-9), 131.8 (u, C-1), 132.8 (d, C-11), 135.4 (d, C-2), 
137.3 (u, C-8). 
Optical rotation for (S)-27a, literature: [α]D = +62.3 ° (c 1.37, acetone). 
Optical rotation for (R)-27a, found: [α]D = –66.2 ° (c 1.46, acetone). 
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2.1.1 (–)-(R)-(S-Cyclohexyl-1-enylmethyl)-N-methyl-S-phenylsulfoximine (27b) 
S7
1
O NCH3
8
9
6
5
4
3
2 12
11
10
Allylic sulfoximine 27b was prepared according to the procedure described in the literature. 
The analytical data were in agreement with those reported.33  
1H NMR (300 MHz, CDCl3): δ = 1.42–1.57 (m, 4 H, CH2), 1.79–1.98 (m, 3 H, CH2), 2.06–
2.19 (m, 1 H, CH2), 2.71 (s, 3 H, H-8), 3.75 (s, 2 H, H-7), 5.29–5.35 (m, 1 H, H-2), 7.50–7.63 
(m, 3 H, H-11, H-12), 7.78–7.84 (m, 2 H, H-10). 
13C NMR (75 MHz, CDCl3): δ = 21.5 (u, CH2), 22.6 (u, CH2), 25.6 (u, CH2), 28.8 (u, CH2), 
29.8 (d, C-8), 65.0 (u, C-7), 126.6 (u, C-1), 128.9 (d, C-11), 129.8 (d, C-10), 132.7 (d, C-12), 
132.9 (d, C-2), 137.0 (C-9). 
Optical rotation for (S)-27b: [α]D = +65.5 ° (c 1.13, acetone). 
Optical rotation for (R)-27b, found: [α]D = –74.3 ° (c 1.30, acetone). 
2.2 Titanium mediated γ-hydroxyalkylation of cyclic allylic sulfoximines 
with acetaldehyde 
2.2.1 γ-Hydroxyalkylation of allylic sulfoximine 27a  
To a solution of allylic sulfoximine 27a (4.71 g, 20 mmol) in dry THF (200 mL) at –78 °C 
was added n-BuLi (13.2 mL of 1.6 M solution in n-hexane, 21 mmol). After stirring the 
mixture for 10 min at –78 °C, neat ClTi(Oi-Pr)3 (10.1 mL, 42 mmol) was added. The resulting 
mixture was stirred for 10 min at –78 °C, allowed to warm to 0 °C, and stirred for 45 min at 
this temperature. It was then cooled to –78 °C once more, whereupon acetaldehyde (5.6 mL, 
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100 mmol) was added. The mixture thus obtained was allowed to warm up to room 
temperature within 12 h. The solution was then poured into saturated aqueous (NH4)2CO3
(50 mL) and H2O (50 mL) was added. The mixture was extracted with EtOAc (3 × 200 mL). 
The combined organic phases were dried with MgSO4, concentrated in vacuum and the 
residue was submitted to 1H NMR to determine the diastereoselectivity (84% de). The crude 
mixture was filtered over silica gel with EtOAc and the solvent was removed in vacuum. The 
resulting oil was purified by HPLC (Kromasil Si–100, L = 250 mm, ∅ = 40 mm, Et2O/i-
PrOH, 95:5, UV 254 nm and RI detectors, Rf(28a)<Rf(36) to obtain diastereomerically pure 
alcohol 28a (4.36 g, 78%) as a colorless solid and diasteromerically pure alcohol 36 (384 mg, 
7%) as a colorless oil. 
For the determination of the diastereoselectivity with the 1H NMR spectrum of the crude 
mixture H-1 signals were used.  
• Analytical data of the major isomer 
(R)-1-((S,Z)-2-(((R)-N-Methylphenylsulfonimidoyl)methylene)cyclopentyl)ethanol (28a) 
H3C9
7 6
2
5 4
3
1
S
N
HO8
11 14
1312
H3C
10
O
1H NMR (400 MHz, CDCl3): δ = 1.34 (d, 3J7-9 = 6.1 Hz, 3 H, H-9), 1.60–1.72 (m, 3 H, H-4, 
H-5, H-8), 1.72–1.95 (m, 2 H, H-4’, H-5’), 2.30–2.42 (m, 1 H, H-3), 2.62–2.73 (m, 4 H, H-10, 
H-3’), 3.49–3.59 (dq, 3J6-7 = 9.9 Hz, 3J9-7 = 6.0 Hz, 1 H, H-7), 3.61–3.69 (m, 1 H, H-6), 6.25 
(m, 1 H, H-1), 7.52–7.63 (m, 3 H, H-13, H-14), 7.87–7.92 (m, 2 H, H-12). 
13C NMR (100 MHz, CDCl3): δ = 21.4 (u, CH2), 23.8 (d, C-9), 29.1 (d, C-10), 30.2 (u, CH2), 
34.1 (u, C-3), 50.6 (d, C-6), 69.4 (d, C-7), 123.7 (d, C-1), 128.7 (d, C-12), 129.3 (d, C-13), 
132.7 (d, C-14), 139.6 (u, C-11), 163.7 (u, C-2). 
IR (capillary): ν = 3345 (w), 3203 (w), 3060 (w), 2965 (s), 2875 (m), 2800 (w), 2236 (w), 
1628 (m), 1448 (m), 1371 (w), 1234 (s), 1146 (s), 1110 (s), 1081 (s), 1012 (m), 963 (w), 925 
(m), 858 (m), 801 (m), 734 (s), 693 (m) cm–1. 
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MS (EI): m/z (%) = 279 [M+] (3), 262 (20), 235 (18), 189 (25), 187 (15), 157 (13), 156 (59), 
155 (46), 154 (10), 129 (22), 126 (10), 125 (100), 124 (11), 123 (14), 110 (12), 109 (25), 108 
(14), 107 (88), 97 (10), 91 (12), 81 (15). 
Elemental Analysis:  
C12H21NO2S (279.4) C H N 
Calculated 64.48 7.58 5.01 
Found 64.29 7.40 4.92 
Melting point: 65 °C. 
Optical rotation: [α]D = +96.3 ° (c 1.16, CH2Cl2). 
• Analytical data of the minor isomer 
(S)-1-((R,Z)-2-(((R)-N-Methylphenylsulfonimidoyl)methylene)cyclopentyl)ethanol (36) 
H3C9
7 6
2
5 4
3
1
S
N
HO8
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1312
H3C
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O
1H NMR (400 MHz, CDCl3): δ = 1.32 (d, 3J7-9 = 6.0 Hz, 3 H, H-9), 1.58–1.85 (m, 4 H, H-4, 
H-5), 2.33–2.44 (m, 1 H, H-3), 2.62–2.73 (m, 4 H, H-3’, H-10), 3.46–3.56 (dq, 3J6-7 = 9.6 Hz, 
3J9-7 = 6.0 Hz, 1 H, H-7), 3.61–3.70 (bt, 3J7-6 = 9.0 Hz, 1 H, H-6), 6.14 (bd, 4J = 1.1 Hz, 1 H, 
H-1), 7.52–7.63 (m, 3 H, H-13, H-14), 7.79–7.85 (m, 2 H, H-12). 
13C NMR (100 MHz, CDCl3): δ = 21.4 (u, C-4), 23.6 (d, C-9), 29.2 (d, C-10), 30.1 (u, C-5), 
34.4 (u, C-3), 50.3 (d, C-6), 68.4 (d, C-7), 122.7 (d, C-1), 128.4 (d, C-12), 129.4 (d, C-13), 
132.7 (d, C-14), 139.4 (u, C-11), 164.0 (u, C-2). 
IR (CHCl3): ν = 3971 (w), 3455 (m), 3184 (w), 3061 (w), 2967 (s), 2875 (s), 2803 (m), 1629 
(s), 1447 (s), 1372 (m), 1302 (w), 1237 (s), 1150 (s), 1109 (s), 1081 (s), 1011 (m), 964 (m), 
933 (w), 878 (s), 854 (s), 817 (m), 753 (s), 692 (s), 664 (w) cm–1.  
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MS (EI): m/z (%) = 279 [M+] (19), 262 (33), 249 (12), 235 (12), 189 (13), 187 (10), 157 (11), 
156 (53), 155 (27), 154 (10), 129 (12), 126 (11), 125 (100), 123 (15), 110 (12), 109 (24), 108 
(11), 107 (54), 91 (11), 81 (18). 
2.2.2 γ-Hydroxyalkylation of allylic sulfoximine 27b  
To a solution of allylic sulfoximine 27b (4.99 g, 20 mmol) in dry THF (200 mL) at –78 °C 
was added n-BuLi (13.2 mL of 1.6 M solution in n-hexane, 21 mmol). After stirring the 
mixture for 10 min at –78 °C, ClTi(Oi-Pr)3 (10.1 mL, 42 mmol) was added neat. The resulting 
mixture was stirred for 10 min at –78 °C, allowed to warm to 0 °C, and stirred for 45 min at 
this temperature. It was then cooled to –78 °C once more, whereupon acetaldehyde (5.6 mL, 
100 mol) was added. The mixture thus obtained was allowed to warm up to room temperature 
over 12 h. The solution was then poured into saturated aqueous (NH4)2CO3 solution (50 mL) 
and water (50 mL) was added. The mixture was extracted with EtOAc (3 × 200 mL). The 
combined organic phases were dried with MgSO4, concentrated in vacuum and submitted to 
1H NMR to determine the diastereoselectivity (74% de). The crude mixture was filtered over 
silica gel with EtOAc and solvent was removed in vacuum. The resulting material was 
purified by washing with Et2O (3 × 40 mL) to obtain diastereomerically pure alcohol 28b
(4.40 g, 75%) as a colorless solid. 
For the determination of the diastereoselectivity with the 1H NMR spectrum of the crude 
mixture H-1 signals were used (δH-1 = 6.17 ppm for the minor isomer). 
Analytical data of (R)-1-((S,Z)-2-(((R)-N-
Methylphenylsulfonimidoyl)methylene)cyclohexyl)ethanol (28b) 
H3C
9
8 7 2
1
S
N
HO10
12 15
1413
H3C
11
O
6
5
4
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1H NMR (300 MHz, CDCl3): δ = 1.35 (d, 3J8-9 = 5.9 Hz, 3 H, H-9), 1.27–1.60 (m, 4 H, CH2), 
1.68–1.81 (m, 1 H, CH2), 1.82–1.95 (m, 1 H, CH2), 2.05–2.13 (m, 1 H, CH2), 2.35–2.55 (m, 
1 H, CH2), 2.60 (s, 3 H, H-11), 3.60–3.70 (m, 1 H, H-7), 3.90–4.05 (dq, 3J9-8 = 5.9 Hz, 3J7-
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8 = 11.9 Hz, 1 H, H-8), 5.27 (bs, 1 H, H-10), 6.30 (bd, 4J = 2.0 Hz, 1 H, H-1), 7.52–7.64 (m, 
3 H, H-14, H-15), 7.86–7.93 (m, 2 H, H-13). 
13C NMR (75 MHz, CDCl3): δ = 20.3 (u, CH2), 23.2 (d, C-9), 27.4 (u, CH2), 28.3 (u, CH2), 
29.2 (d, C-11), 33.0 (u, CH2), 45.8 (d, C-7), 67.1 (d, C-8), 126.7 (d, C-1), 128.9 (d, C-13), 
129.3 (d, C-14), 132.7 (d, C-15), 139.7 (u, C-12), 160.7 (u, C-2). 
IR (KBr): ν = 3467 (s), 3059 (m), 2934 (s), 1863 (s), 2796 (m), 1611 (s), 1447 (s), 1376 (m), 
1229 (s), 1130 (s), 1070 (s), 928 (m), 853 (s), 820 (s), 751 (m), 689 (s), 602 (s) cm–1.  
MS (EI): m/z (%) = 293 [M+] (3), 201 (12), 171 (11), 169 (16), 156 (78), 138 (11), 125 (100), 
123 (28), 107 (25), 95 (24). 
Elemental Analysis: 
C16H23NO2S (293.4) C H N 
Calculated 65.49 7.90 4.77 
Found 65.31 8.15 4.80 
Melting point: 111 °C. 
Optical rotation: [α]D = +11.2 ° (c 1.00, CH2Cl2). 
2.3 Synthesis of the carbamate from the alcohol  
 2.3.1 Carbamate from alcohol 28a 
To a solution of alcohol 28a (1.26 g, 3.90 mmol) in CH2Cl2 (50 mL) at room temperature was 
added trichloroacetyl isocyanate (0.60 mL, 5.07 mmol). The solution was stirred until TLC 
showed complete conversion (5 h). Then MeOH (25 mL) and (NH4)2CO3 (1.87 g, 19.5 mmol) 
were added and the mixture was stirred at room temperature for 12 h. Saturated aqueous 
NH4Cl (30 mL) was added and the mixture was extracted with CH2Cl2 (3 × 60 mL). The 
combined organic phases were dried with MgSO4 and the solvents were removed in vacuum. 
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The residue was purified by column chromatography on silica gel (EtOAc) to give carbamate 
Z-40a (1.06 g, 84%) as a colorless solid. 
Analytical data of (R)-1-((S,Z)-2-(((R)-N-
Methylphenylsulfonimidoyl)methylene)cyclopentyl)ethyl carbamate (Z-40a) 
H3C
9
7 6 2
5 4
3
1
S
N
O8
O
H2N
10
12
15
1413
H3C
11
O
1H NMR (400 MHz, CDCl3): δ = 0.98–1.17 (m, 1 H, CH2), 1.23–1.40 (m, 5 H, H-9, CH2), 
1.42–1.58 (m, 1 H, CH2), 1.70–1.85 (m, 1 H, CH2), 2.32–2.47 (m, 1 H, CH2), 2.68 (s, 3 H, H-
11), 4.00–4.09 (m, 1 H, H-6), 4.84–4.98 (dq, 3J6-7 = 9.4 Hz, 3J9-7 = 6.2 Hz, 1 H, H-7), 6.05 (bs, 
2 H, H-10), 6.56 (bd, 4J = 1.7 Hz, 1 H, H-1), 6.95–7.12 (m, 3 H, H-14, H-15), 8.00–8.07 (m, 
2 H, H-13). 
13C NMR (100 MHz, CDCl3): δ = 19.0 (d, C-9), 21.1 (u, CH2), 28.9 (u, CH2), 29.1 (d, C-11), 
34.4 (u, CH2), 45.8 (d, C-6), 69.8 (d, C-7), 123.8 (d, C-1), 129.0 (d, CH), 129.1 (d, CH), 131.7 
(d, CH), 140.4 (u, C-12), 158.0 (u, C), 160.6 (u, C). 
IR (KBr): ν =  3424 (s), 3176 (m), 3061 (w), 2965 (s), 2874 (m), 2801 (m), 1722 (s), 1608 
(m), 1450 (m), 1381 (s), 1325 (s), 1236 (s), 1149 (s), 1076 (s), 852 (s), 797 (m), 752 (m), 692 
(m) cm–1. 
MS (EI): m/z (%) = 322 [M+] (3), 278 (31), 263 (17), 262 (100), 125 (30), 107 (11). 
HRMS:  
C16H22N2O3S  (322.4) [M+] 
Calculated 322.13512 
Found 322.13518 
Melting point: 45 °C 
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Optical rotation: [α]D = +17.7 ° (c 1.02, CH2Cl2). 
 2.3.2 Carbamate from alcohol 28b 
To a solution of alcohol 28b (700 mg, 2.39 mmol) in CH2Cl2 (20 mL) at room temperature 
was added trichloroacetyl isocyanate (0.37 mL, 3.11 mmol). The solution was stirred until 
TLC showed complete conversion (5 h). Then MeOH (10 mL) and (NH4)2CO3 (1.15 g, 
12.0 mmol) were added and the mixture was stirred at room temperature for 12 h. Saturated 
aqueous NH4Cl (20 mL) was added and the mixture was extracted with CH2Cl2 (3 × 50 mL). 
The combined organic phases were dried with MgSO4 and the solvents were removed in 
vacuum. The residue was purified by column chromatography on silica gel (EtOAc) to give 
carbamate Z-40b (587 mg, 73%, Rf = 0.2) as a colorless solid and carbamate E-40b (72 mg, 
9%, Rf = 0.35) as a colorless oil. 
• Analytical data of the major isomer (Z) 
(R)-1-((S,Z)-2-(((R)-N-Methylphenylsulfonimidoyl)methylene)cyclohexyl)ethyl 
carbamate (Z-40b) 
H3C
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1H NMR (400 MHz, CDCl3): δ = 1.06–1.20 (m, 1 H, CH2), 1.21–1.39 (m, 4 H, H-9, CH2), 
1.40–1.52 (m, 2 H, CH2), 1.61–1.70 (m, 1 H, CH2), 1.84–1.94 (m, 1 H, CH2), 2.01–2.11 (m, 
1 H, H-3), 2.41–2.52 (ddt, 3J = 13.5 Hz, 3J = 5.0 Hz, 4J = 1.9 Hz, 1 H, H-3´), 2.68 (s, 3 H, H-
12), 3.67 (m, 1 H, H-7), 4.90 (bs, 2 H, H-11), 5.05–5.15 (dq, 3J7-8 = 10.4 Hz, 3J9-8 = 6.0 Hz, 
1 H, H-8), 6.29 (d, 4J = 1.6 Hz, 1 H, H-1), 7.53–7.63 (m, 3 H, H-15, H-16), 7.91–7.97 (m, 
2 H, H-14). 
13C NMR (100 MHz, CDCl3): δ = 18.9 (d, C-9), 20.4 (u, CH2), 28.2 (u, CH2), 28.4 (u, CH2), 
29.4 (d, C-12), 33.7 (u, C-3), 41.6 (d, C-7), 69.7 (d, C-8), 125.6 (d, C-1), 128.8 (d, C-14), 
129.1 (d, C-15), 132.3 (d, C-16), 140.6 (u, C-13), 157.0 (u, C), 159.7 (u, C). 
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IR (KBr): ν =  3480 (s), 3172 (w), 3059 (w), 2935 (s), 2865 (s), 2801 (m), 1720 (s), 1612 (s), 
1451 (s), 1381 (s), 1326 (s), 1238 (s), 1144 (s), 1111 (s), 1072 (s), 1010 (s), 921 (w), 854 (s), 
816 (m), 754 (m), 692 (m) cm–1. 
MS (EI): m/z (%) = 336 [M+] (6), 292 (12), 276 (25), 156 (100), 138 (16), 137 (11), 125 (50), 
123 (15), 121 (13), 93 (20), 91 (14). 
HRMS:  
C17H24N2O3S  (336.4) [M+] 
Calculated 336.15077 
Found 336.15075 
Melting point: 52–54 °C 
Optical rotation: [α]D = +182.1°  (c 1.06, EtOAc). 
• Analytical data of the minor isomer (E) 
(R)-1-((S,E)-2-(((R)-N-Methylphenylsulfonimidoyl)methylene)cyclohexyl)ethyl 
carbamate (E-40b) 
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1H NMR (400 MHz, CDCl3): δ = 1.25 (d, 3J8-9 = 6.3 Hz, 3 H, H-9), 1.32–1.56 (m, 3 H, CH2), 
1.59–1.80 (m, 3 H, CH2), 1.97–2.09 (m, 1 H, H-3), 2.26–2.35 (m, 1 H, H-7), 2.64 (s, 3 H, H-
12), 2.96–3.06 (m, 1 H, H-3´), 4.80 (bs, 2 H, H-11), 4.92–5.02 (dq, 3J7-8 = 9.6 Hz, 3J9-
8 = 6.0 Hz, 1 H, H-8), 6.44 (bs, 1 H, H-1), 7.50–7.59 (m, 3 H, H-15, H-16), 7.90–7.96 (m, 
2 H, H-14). 
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13C NMR (100 MHz, CDCl3): δ = 18.7 (d, C-9), 21.3 (u, CH2), 26.3 (u, CH2), 27.0 (u, CH2), 
28.8 (d, C-12), 29.6 (u, C-3), 50.8 (d, C-7), 70.0 (d, C-8), 125.3 (d, C-1), 128.4 (d, C-14), 
129.1 (d, C-15), 132.5 (d, C-16), 140.2 (u, C-13), 156.0 (u, C), 160.5 (u, C).  
IR (KBr): ν =  3906 (w), 3747 (w), 3675 (w), 3418 (s), 3194 (m), 3056 (w), 2936 (s), 2866 
(m), 2801 (w), 2344 (w), 1798 (m), 1723 (s), 1621 (m), 1449 (m), 1384 (s), 1322 (m), 1237 
(s), 1144 (s), 1108 (s), 1070 (s), 1004 (m), 923 (w), 855 (s), 819 (w), 755 (m), 693 (m), 602 
(m) cm–1. 
MS (EI): m/z (%) = 336 [M+] (11), 276 (22), 244 (21), 227 (37), 200 (15), 197 (14), 196 (46), 
195 (24), 181 (10), 167 (15), 156 (100), 141 (12), 138 (14), 137 (14), 125 (94), 123 (13), 121 
(14), 119 (10), 109 (12), 107 (11), 105 (12), 95 (29), 93 (26), 91 (30). 
2.4 Intramolecular aza-MICHAEL addition 
2.4.1 (4R,4aS,7aR)-4-Methyl-7a-(((R)-N-
methylphenylsulfonimidoyl)methyl)hexahydrocyclopenta[d][1,3]oxazin-2(1H)-one (29a) 
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To a solution of alcohol 28a (1.97 g, 6.11 mmol) in CH2Cl2 (50 mL) at room temperature was 
added trichloroacetyl isocyanate (1.09 mL, 7.94 mmol). The solution was stirred until TLC 
showed complete conversion (5 h). Then MeOH (25 mL) and (NH4)2CO3 (2.93 g, 30.5 mmol) 
were added and the mixture was stirred at room temperature for 12 h. Saturated aqueous 
NH4Cl (30 mL) was added and the mixture was extracted with CH2Cl2 (3 × 60 mL). The 
combined organic phases were dried with MgSO4 and the solvents were removed in vacuum. 
The crude carbamate 40a was taken in THF (50 mL), the solution was cooled to –78 °C and 
n-BuLi (5.0 mL of 1.6 M solution in n-hexane, 7.94 mmol) was added. Then the mixture was 
allowed to warm to room temperature within 12 h. Saturated aqueous NH4Cl (50 mL) was 
added and the mixture was extracted with CH2Cl2 (3 × 60 mL). The combined organic phases 
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were dried with MgSO4 and solvent was removed in vacuum. The 1H NMR spectrum of the 
crude mixture gave no indication of the presence of any other diastereomer. Washing of the 
solid residue with Et2O (3 × 20 mL) gave sulfoximine 29a as a colorless solid. Purification of 
the mother liquor by column chromatography (EtOAc/i-PrOH, 9:1) afforded additional 29a
(1.55 g, 79% combined yield) as a colorless solid. 
1H NMR (500 MHz, CDCl3): δ  = 1.31 (d, 3J7-9 = 6.1 Hz, 3 H, H-9), 1.44–1.53 (m, 1 H, H-
5), 1.61–1.75 (m, 2 H, H-4, H-6), 1.75–1.85 (m, 1 H, H-4’), 1.86–1.99 (m, 2 H, H-3, H-5’), 
2.63–2.70 (m, 4 H, H-11, H-3’), 3.26 (dd, 2J1’-1 = 14.3 Hz, 4J = 1.2 Hz, 1 H, H-1), 3.54 (d, 2J1-
1’ = 14.3 Hz, 1 H, H-1’) 3.95–4.04 (dq, 3J9-7 = 9.6 Hz, 3J6-7 = 10.2 Hz, 1 H, H-7), 6.89 (s, 1 H, 
H-10), 7.56–7.66 (m, 3 H, H-14, H-15), 7.83–7.87 (m, 2 H, H-13). 
13C NMR (100 MHz, CDCl3): δ = 19.0 (d, C-9), 22.8 (u, C-4), 27.1 (u, C-5), 29.7 (d, C-11), 
38.5 (u, C-3), 49.4 (d, C-6), 63.3 (u, C-2), 65.7 (u, C-1), 75.0 (d, C-7), 128.5 (d, C-13), 129.6 
(d, C-14), 133.0 (d, C-15), 139.6 (u, C-12), 154.2 (u, C-8). 
IR (KBr): ν = 3684 (w), 3651 (w), 3402 (m), 3351 (s), 3061 (w), 2967 (m), 2939 (m), 2890 
(m), 2796 (w), 2345 (w), 1712 (s), 1582 (w), 1450 (m), 1390 (m), 1364 (m), 1316 (m), 1236 
(s), 1176 (w), 1133 (m), 1093 (m), 1061 (m), 1013 (m), 974 (w), 892 (m), 862 (m), 772 (m), 
747 (m), 692 (w), 653 (m), 619 (w) cm–1. 
MS (EI): m/z (%) = 323 [M++1] (21), 294 (13), 170 (11), 169 (21), 168 (100), 154 (13), 140 
(56), 125 (55), 124 (55), 114 (13), 108 (26), 107 (34), 106 (16), 95 (11), 94 (15), 91 (18), 82 
(11), 81 (43). 
Elemental Analysis: 
C16H22N2O3S (322.4) C H N 
Calculated 59.60 6.88 8.69 
Found 59.90 6.96 8.74 
Melting point: 148 °C (decomposition). 
Optical rotation: [α]D = –103.3 ° (c 1.09, CH2Cl2). 
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 2.4.2 (4R,4aS,8aR)-4-Methyl-8a-(((R)-N-
methylphenylsulfonimidoyl)methyl)hexahydro-1H-benzo[d][1,3]oxazin-2(4H)-one (29b) 
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To a solution of alcohol 28b (1.94 g, 6.62 mmol) in CH2Cl2 (60 mL) at room temperature was 
added trichloroacetyl isocyanate (1.18 mL, 8.61 mmol). The solution was stirred until TLC 
showed complete conversion (5 h). Then MeOH (30 mL) and (NH4)2CO3 (3.18 g, 33.0 mmol) 
were added and the mixture was stirred at room temperature for 12 h. H2O (30 mL) was added 
and the mixture was extracted with CH2Cl2 (3 × 100 mL). The combined organic phases were 
dried with MgSO4 and the solvents were removed in vacuum. The crude carbamate 40b was 
taken in THF (50 mL), the solution was cooled to –78 °C and n-BuLi (5.4 mL of 1.6 M 
solution in n-hexane, 8.60 mmol) was added. Then the mixture was allowed to warm to room 
temperature within 12 h. Saturated aqueous NH4Cl (50 mL) was added and the mixture was 
extracted with CH2Cl2 (3 × 60 mL). The combined organic phases were dried with MgSO4
and the solvent was removed in vacuum, the 1H NMR spectrum of the crude mixture gave no 
indication of the presence any other diastereomer. Washing of the solid residue with Et2O (3 ×
20 mL) gave sulfoximine 29b as a colorless solid. Purification of the mother liquor by column 
chromatography (EtOAc/i-PrOH, 95:5) afforded additional 29b (1.72 g, 77%, combined 
yield) as a colorless solid. 
1H NMR (400 MHz, CDCl3): δ  = 1.04–1.21 (m, 2 H, CH2), 1.32 (d, 3J8–9 = 6.3 Hz, 3 H, H-
9), 1.43–1.59 (m, 4 H, CH2), 1.65–1.81 (m, 2 H, CH2), 2.54–2.62 (m, 1 H, CH2), 2.71 (s, 3 H, 
H-12), 3.06 (dd, 3J1´-1 = 14.3 Hz, 4J = 1.4 Hz, 1 H, H-1), 3.93 (d, 3J1´-1 = 14.6 Hz, 1 H, H-1´), 
4.58 (dq, 3J9–8 = 6.3 Hz, 3J7–8 = 10.4 Hz, 1 H, H-8), 7.56–7.68 (m, 4 H, H-11, H-15, H-16), 
7.85–7.90 (m, 2 H, H-14). 
13C NMR (100 MHz, CDCl3): δ = 18.9 (d, C-9), 19.7 (u, CH2), 22.2 (u, CH2), 22.8 (u, CH2), 
29.6 (d, C-12), 33.5 (u, CH2), 43.2 (d, C-7), 55.8 (u, C-2), 62.4 (u, C-1), 71.7 (d, C-8), 128.6 
(d, C-14), 129.5 (d, C-15), 133.1 (d, C-16), 139.7 (u, C-13), 152.2 (u, C-10). 
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IR (KBr): ν = 3356 (s), 3256 (m), 3059 (w), 2934 (m), 2876 (m), 2795 (w), 1707 (s), 1618 
(m), 1449 (m), 1390 (m), 1324 (m), 1237 (s), 1178 (w), 1141 (m), 1102 (m), 1075 (m), 1046 
(w), 1010 (m), 929 (w), 904 (w), 875 (w), 832 (m), 749 (m), 695 (m), 636 (m), 606 (m) cm–1.  
MS (CI, methane): m/z (%) = 337 [M++1] (100), 210 (14), 182 (12), 170 (27), 156 (10). 
Elemental Analysis:  
C17H24N2O3S (336.5) C H N 
Calculated 60.69 7.19 8.33 
Found 61.00 7.13 8.41 
Melting point: 152 °C (decomposition). 
Optical rotation: [α]D = –77.1 ° (c 1.08, CH2Cl2). 
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3. The Ring-closing metathesis route 
3.1 (4R,4aS,7aR)-7a-(Iodomethyl)-4-
methylhexahydrocyclopenta[d][1,3]oxazin-2(1H)-one (50) 
H3C
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1-Chloroethyl chloroformate 54 (338 µL, 3.10 mmol) was added at room temperature to a 
mixture of sulfoximine 29a (500 mg, 1.55 mmol) and NaI (1.16 g, 7.75 mmol) in CH3CN 
(7 mL). The mixture was stirred at room temperature until TLC indicated almost a complete 
conversion of the sulfoximine (3 h). Concentration in vacuum and purification of the residue 
by column chromatography on silica gel (EtOAc/cyclohexane, 4:1) afforded the desired 
iodide 50 (348 mg, 76%) as a brown solid. 
Rf(iodide 50) = 0.45 and Rf(sulfinamide 55) = 0.9 in EtOAc. 
1H NMR (400 MHz, CDCl3): δ = 1.39 (d, 3J7-9 = 6.3 Hz, 3 H, H-9), 1.49–1.58 (m, 1 H, CH2), 
1.59–1.70 (m, 1 H, CH2), 1.75–1.87 (m, 2 H, CH2), 1.94–2.08 (m, 3 H, H-6, CH2), 3.35 (d, 
2J1´-1 = 10.4 Hz, 1 H, H-1), 3.41 (d, 2J1-1´ = 10.4 Hz, 1 H, H-1´), 4.02 (dq, 3J9-7 = 6.3 Hz, 3J6-
7 = 10.2 Hz, 1 H, H-7), 5.92 (bs, 1 H, H-10). 
13C NMR (100 MHz, CDCl3): δ = 19.1 (u, C-9), 20.7 (u, C-1), 23.0 (u, CH2), 28.1 (u, CH2), 
40.1 (u, CH2), 47.4 (d, C-6), 63.5 (u, C-2), 76.2 (d, C-7), 155.3 (u, C-8). 
IR (CHCl3): ν = 3250 (m), 3123 (m), 2956 (s), 2879 (m), 1712 (s), 1455 (m), 1393 (s), 1323 
(s), 1205 (m), 1092 (m), 1059 (m), 1007 (m), 968 (w), 918 (w), 873 (w), 765 (m), 637 (w), 
612 (w) cm–1. 
MS (EI): m/z (%) = 295 [M+] (1), 154 (100), 110 (45), 81 (11).  
Experimental part 
115
Elemental Analysis: 
C9H14INO2 (295.1) C H N 
Calculated 36.63 4.78 4.75 
Found 36.53 4.85 4.61 
Melting point: 85 °C.
Optical rotation: [α]D = +2.03 ° (c 0.935, CH2Cl2). 
3.2 (4R,4aS,7aS)-7a-Allyl-4-methylhexahydrocyclopenta[d][1,3]oxazin-
2(1H)-one (60) 
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To a suspension of CuI (210 mg, 1 mmol) in THF (2 mL) was added vinylmagnesium 
bromide (2 mL of 1 M solution in THF, 2 mmol) at –30 °C. The turbid solution was stirred 30 
min at this temperature whereby it turned black. The cuprate solution was added to a solution 
of 50 in THF (2 mL) at –30 °C, which turned black. After 2 h at –30 °C the mixture was 
allowed to warm to room temperature within 12 h. TLC showed complete conversion. 
Saturated aqueous (NH4)2CO3 (30 mL) and 10 mL concentrated aqueous NH3 were added and 
the aqueous layer was extracted with CH2Cl2 (3 × 15 mL). The combined organic phases were 
dried with MgSO4 and the solvent was removed in vacuum. The residue was purified by flash 
chormatography on silica gel (EtOAc/cyclohexane, 1:1) to give the desired alkene 60 as 
(16 mg, 40%) as a colorless oil. 
1H NMR (300 MHz, CDCl3): δ = 1.36 (d, 3J7-9 = 6.2 Hz, 3 H, H-9), 1.40–2.02 (m, 7 H, H-3, 
H-4, H-5, H-6), 2.15–2.37 (m, 2 H, H-1), 3.92–4.06 (dq, 3J6-7 = 9.9 Hz, 3J9-7 = 6.2 Hz, 1 H, H-
7), 5.12–5.27 (m, 2 H, H-12), 5.72–5.90 (m, 2 H, H-10, H-11). 
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13C NMR (75 MHz, CDCl3): δ = 19.2 (d, C-9), 22.5 (u, CH2), 27.6 (u, CH2), 39.2 (u, CH2), 
45.9 (u, C-1), 46.9 (u, C-6), 63.6 (u, C-2), 75.9 (d, C-7), 120.6 (u, C-12), 132.0 (d, C-11), 
156.1 (u, C-8).  
3.3 (4R,4aS,7aS)-7a-(But-2-enyl)-4-
methylhexahydrocyclopenta[d][1,3]oxazin-2(1H)-one (62) 
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To a suspension of CuI (1.16 g, 6.07 mmol) in THF (3 mL)  was added 1-propenylmagnesium 
bromide (24.3 mL of 0.5 M solution in THF, 12.1 mmol) at –30 °C. The turbid solution was 
stirred 30 min at this temperature whereby it turned yellow–brown. The cuprate solution was 
added to a solution of 50 in THF (3 mL) at –30 °C, which turned red, then orange and then 
yellow–brown color. After 2 h at –30 °C the mixture was allowed to warm to room 
temperature within 12 h. During this time it turned black. TLC showed complete conversion. 
Saturated aqueous (NH4)2CO3 (30 mL) and 10 mL concentrated aqueous NH3 were added and 
the aqueous layer was extracted with CH2Cl2 (3 × 15 mL). The combined organic phases were 
dried with MgSO4 and solvent was removed in vacuum. The residue was purified by flash 
chormatography on silica gel (EtOAc/cyclohexane, 1:1) to give the desired alkene 62 as a Z/E
mixture in ratio 2:1 (208 mg, 82%) as a colorless oil. 
1H NMR (300 MHz, CDCl3) Z-62: δ = 1.33 (d, 3J7-9 = 6.2 Hz, 3 H, H-9), 1.41–1.52 (m, 
>1 H, CH2), 1.60–2.00 (m, >9 H, H-3, H-4, H-5, H-6, H-13), 2.05–2.38 (m, >2 H, H-1), 3.97 
(dq, 3J6-7 = 10.1 Hz, 3J9-7 = 6.0 Hz, >1 H, H-7), 5.35–5.50 (m, >1 H, H-11), 5.66–5.80 (tdq, 
3J11-12 = 10.9 Hz, 3J13–12 = 6.7 Hz, 4J1-12 = 1.2 Hz, 1 H, H-12), 6.10 (bs, 1 H, H-10). 
13C NMR (75 MHz, CDCl3) Z-62: δ = 13.1 (d, C-13), 19.2 (d, C-9), 22.6 (u, CH2), 27.7 (u, 
CH2),  38.5 (u, CH2), 39.3 (u, C-1), 47.0 (d, C-6), 64.2 (u, C-2), 76.0 (d, C-7), 123.7 (d, C-11), 
129.0 (d, C-12), 156.3 (u, C-8). 
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1H NMR (300 MHz, CDCl3) E-62: (Only distinct signals are given) δ = 1.32 (d, 3J7-
9 = 6.2 Hz, 3 H, H-9), 5.51–5.66 (m, 1 H, H-12) 6.04 (bs, 1 H, H-10). 
13C NMR (75 MHz, CDCl3) E-62: δ = 18.1 (d, C-13), 19.2 (d, C-9), 22.5 (u, CH2),  27.5 (u, 
CH2), 39.0 (u, CH2), 44.5 (u, C-1), 46.7 (d, C-6), 63.8 (u, C-2), 75.9 (d, C-7), 124.4 (d, C-11), 
131.3 (d, C-12), 156.3 (u, C-8). 
IR (capillary): ν = 3851 (m), 3743 (m), 3251 (m), 3121 (w), 2949 (m), 2353 (s), 1710 (s), 
1549 (m), 1461 (w), 1394 (m), 1318 (m), 1083 (m), 790 (w) cm–1.  
MS (EI): m/z (%) = 210 [M++1] (19), 209 [M+] (0.3), 154 (63), 110 (100), 93 (13). 
Elemental Analysis:  
C12H19NO2 (209.1) C H N 
Calculated 68.87 9.15 6.69 
Found 69.25 9.08 7.05 
3.4 (4R,4aS,7aS)-1-Allyl-7a-(but-2-enyl)-4-
methylhexahydrocyclopenta[d][1,3]oxazin-2(1H)-one (52) 
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To a solution of alkene 62 (208 mg, 0.99 mmol) in DMF (5 mL) at room temperature was 
added NaH (63 mg of 50% in mineral oil, 1.31 mmol), the mixture was stirred for 30 min and 
allyl bromide (113 µL, 1.31 mmol, 1.3 eq) was added. It was stirred for further 12 h. Then 
DMF was removed in vacuum and the residue was purified by column chromatography on 
silca gel (EtOAc/cyclohexane, 1:2) to give diene 52 as a Z/E mixture in ratio 2:1 (211 mg, 
85%) as a colorless oil. 
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1H NMR (300 MHz, CDCl3) Z-52: Only distinct signals are given. δ = 1.30 (d, 3J7-9 = 6.2 Hz, 
>3 H, H-9), 1.38–1.51 (m, >1 H, CH2), 1.61 (bd, 3J11-12 = 6.9 Hz, 3 H, H-12), 1.70–2.13 (m, 
>6 H, H-6, CH2), 2.21-2.44 (m, >2 H, H-1), 3.50–3.64 (m, >1 H, H-13), 3.82-3.93 (m, >1 H, 
H-7), 4.15–4.27 (m, >1 H, H-13´), 5.07–5.22 (m, >2 H, H-15), 5.23–5.36 (m, >1 H, H-10), 
5.60–5.73 (m, 1 H, H-11), 5.86–6.01 (m, >1 H, H-14). 
13C NMR (75 MHz, CDCl3) Z-52: Only distinct signals are given. δ = 13.3 (d, C-12), 18.8 
(d, C-9), 23.1 (u, CH2), 28.2 (u, CH2), 35.6 (u, C-1), 39.5 (u, CH2), 47.2 (u, C-13), 47.9 (d, C-
6), 69.4 (u, C-2), 74.6 (d, C-7), 115.9 (u, C-15), 123.6 (d, C-10), 128.2 (d, C-11), 134.8 (d, C-
14), 156.5 (u, C-8). 
1H NMR (300 MHz, CDCl3) E-52: Only distinct signals are given. δ = 1.63 (bd, 3J11-
12 = 5.2 Hz, 3 H, H-12), 5.46-5.58 (m, 1 H, H-11). 
13C NMR (75 MHz, CDCl3) E-52: Only distinct signals are given. δ = 18.1 (d, C-9), 28.3 (u, 
CH2), 39.4 (u, CH2), 41.8 (u, C-1), 47.1 (u, C-13), 47.6 (d, C-6), 74.7 (d, C-7), 124.4 (d, C-
11), 130.7 (d, C-14). 
IR (capillary): ν = 3080 (w), 3018 (w), 2956 (m), 2880 (m), 1701 (s), 1538 (w), 1438 (m); 
1397 (m), 1309 (m), 1237 (m), 1106 (m), 1067 (m), 970 (m), 920 (m), 772 (m), 716 (w), 643 
(w) cm-1.  
MS (EI): m/z (%) = 250 [M++1] (4), 195 (13), 194 (100), 150 (67). 
HRMS:  
C15H23NO2 (249.3) [M++1] 
Calculated 250.18053 
Found 250.18070 
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3.5 (3aS,4R,111S)-4-Methyl-2,3,3a,4,8,11-
hexahydrocyclopenta[d]pyrido[1,2-c][1,3]oxazin-6(1H)-one (53) 
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To a solution of diene 52 (211 mg, 0.85 mmol) in CH2Cl2 (85 mL, 0.01 M) at room 
temperature was added Grubbs II catalyst 68 (37 mg, 0.042 mmol, 5 mol%). The mixture was 
stirred at room temperature. After 1h TLC showed a complete conversion. Then DMSO 
(0.2 mL) was added and the mixture was stirred at room temperature for 1 h. Solvent was 
removed in vacuum and the residue was purified by column chromatography on silica gel 
(Et2O) to give the desired tricycle 53 (166 mg, 95%) as a colorless oil. 
1H NMR (400 MHz, CDCl3): δ = 1.35 (d, 3J7-9 = 6.3 Hz, 3 H, H-9), 1.43–1.92 (m, 5 H, H-6, 
CH2), 1.95–2.19 (m, 4 H, H-1, CH2), 3.51–3.60 (m, 1 H, H-10), 3.99 (dq, 3J9-7 = 6.3 Hz, 3J6-
7  = 9.9 Hz, 1 H, H-7), 4.65–4.75 (m, 1 H, H-10), 6.65–6.79 (m, 2 H, H-11, H-12). 
13C NMR (100 MHz, CDCl3): δ = 18.9 (d, C-9), 22.4 (u, CH2), 27.8 (u, CH2), 36.3 (u, CH2), 
37.3 (u, C-1), 41.9 (u, C-10), 50.3 (d, C-6), 63.1 (u, C-2), 74.3 (d, C-7), 122.9 (d, CH), 124.2 
(d, CH), 154.6 (u, C-8). 
IR (capillary): ν = 3859 (w), 3364 (m), 2964 (s), 1693 (s), 1609 (m), 1413 (s), 1308 (m), 
1265 (m), 1198 (w), 1128 (m), 1067 (m), 751 (m), 662 (w), 621 (w) cm-1.  
MS (EI): m/z (%) = 207 [M+] (100), 192 (18), 164 (11), 163 (12), 162 (62), 150 (17), 148 
(17), 146 (13), 134 (23), 124 (12), 120 (37), 107 (13), 106 (21), 95 (11), 94 (13), 93 (11), 81 
(12), 80 (17). 
HRMS: 
C15H27NO2 (207.3) [M+] 
Calculated 207.12593 
Found 207.12606 
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Optical rotation: [α]D = –72.2 ° (c 1.58, CH2Cl2) 
3.6 (R)-1-((1S,5S)-6-Azaspiro[4.5]dec-8-en-1-yl)ethanol (49) 
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A mixture of tricycle 53 (113 mg, 0.546 mmol), CsOH (0.705 g, 8.18 mmol), MeOH (3 mL) 
and H2O (3 mL) was stirred at reflux temperature for 3 d. The solution was carrefully 
neutralized to pH = 7 by using concentrated aqueous HCl (3N). Then methanol was removed 
in vacuum and water was removed by lyophilization to give colorless salts. The salts were 
triturated in a mixture of CHCl3/MeOH (1:1) to extract the organic compounds. After 
repeating this process (3 × 10 mL), the organic layers were combined and dried with MgSO4. 
The solvent was removed in vacuum and the residue was purified by column chromatography 
on silica gel (CHCl3/MeOH/NEt3, 90:10:1) to give the desired amino alcohol 49 (71 mg, 
72%) as a colorless oil. 
1H NMR (300 MHz, CDCl3): δ = 1.23 (d, 3J7-9 = 8.9 Hz, 3 H, H-9), 1.27–1.60 (m, 2 H, CH2), 
1.64–1.85 (m, 5 H, H-6, CH2), 1.86–1.98 (m, 1 H, H-11), 2.61 (bd, 2J11-11´ = 17.8 Hz, 1 H, H-
11´), 3.52 (bs, 2 H, H-1), 3.90 (dq, 3J6-7 = 9.9 Hz, 3J9-7 = 6.2 Hz, 1 H, H-7), 5.30 (bs, 2 H, H-8, 
H-10), 5.64–5.80 (m, 2 H, H-12, H-13). 
13C NMR (75 MHz, CDCl3): δ = 23.0 (d, C-9), 23.5 (u, CH2), 29.5 (u, CH2), 36.1 (u, CH2), 
37.9 (u, C-11), 40.6 (u, C-1), 56.7 (d, C-6), 62.3 (u, C-2), 68.7 (d, C-7), 122.9 (d, CH), 125.4 
(d, CH). 
IR (capillary): ν = 3950 (w), 3902 (w), 3813 (w), 3729 (w), 3664 (w), 3369 (s), 3024 (m), 
2958 (s), 2801 (m), 2726 (w), 2676 (w), 2560 (w), 2470 (w), 2401 (w), 1629 (s), 1569 (s), 
1452 (s), 1330 (m), 1260 (w), 1219 (m), 1175 (w), 1137 (s), 1109 (m), 1062 (s), 1010 (m), 
958 (m), 931 (m), 881 (m), 812 (m), 713 (w), 658 (s), 606 (w) cm-1. 
  
Experimental part 
121
MS (EI): m/z (%) = 181 [M+] (40), 180 (100), 162 (61), 120 (13), 108 (37), 106 (11), 95 (11), 
94 (10). 
HRMS: 
C11H19NO (181.3) [M+] 
Calculated 181.14666 
Found 181.14664 
Optical rotation:  [α]D = –33.0 ° (c 1.62, CH2Cl2). 
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4. Cycloalkylation and removal of the sulfoximine 
4.1 General procedure for the cycloalkylation (GP1) 
n-BuLi (1.38 mL of 1.6 M solution in n-hexane, 2.2 mmol) was added to a solution of the 
oxazinone (1.0 mmol) in THF (40 mL). The mixture was allowed to warm slowly to –10 °C 
within 1 h, cooled to –50 °C, and then treated with the ditosylate (1.1 mmol). The mixture 
was then allowed to warm to room temperature over 12 h. Then saturated aqueous NH4Cl 
(40 mL) was added and the mixture was extracted with CH2Cl2 (3 × 40 mL). The combined 
organic phases were dried with MgSO4. The solvents were removed in vacuum and the 
residue was purified by column chromatography on silica gel. 
4.2 (3aS,4R,11S,111R)-4-Methyl-11-((R)-N-
methylphenylsulfonimidoyl)octahydrocyclopenta[d]pyrido[1,2-
c][1,3]oxazin-6(1H)-one (71) 
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According to GP1, sulfoximine 29a (505 mg, 1.57 mmol) was treated with n-BuLi (2.16 mL 
of 1.6 M solution in n-hexane, 3.46 mmol) and 1,3-propanediol di-p-tosylate (665 mg, 1.73 
mmol) to give after work up and column chromatography (EtOAc/cyclohexane, 2:1) the 
diastereomerically pure tricycle 71 (426 mg, 75%) as a colorless solid. 
1H NMR (400 MHz, CDCl3): δ = 1.43 (d, 3J7-9 = 6.1 Hz, 3 H, H-9), 1.46–1.79 (m, 5 H, H-4, 
H-5, H-11, H-12), 1.88–2.22 (m, 3 H, H-4´, H-3, H-11´), 2.28–2.39 (m, 1 H, H-5´), 2.55 (s, 
3 H, H-13), 2.62–2.73 (m, 1 H, H-3´), 2.86–2.97 (m, 1 H, H-10), 3.20–3.28 (dd, 3J12-
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1 = 13.2 Hz, 3J12´-1 = 3.3 Hz, 1 H, H-1), 3.76–3.85 (m, 1 H, H-1), 3.91–4.07 (m, 2 H, H-10´, 
H-7), 7.53–7.64 (m, 3 H, H-16, H-17), 7.74–7.80 (m, 2 H, H-15). 
13C NMR (100 MHz, CDCl3): δ = 19.6 (d, C-9), 23.4 (u, CH2), 23.6 (u, CH2), 23.9 (u, CH2), 
29.9 (d, C-13), 30.3 (u, C-5), 34.4 (u, C-3), 42.1 (u, C-10), 49.2 (d, C-6), 67.8 (d, C-1), 71.0 
(u, C-2), 75.3 (d, C-7), 129.3 (d, C-15), 129.6 (d, C-16), 132.7 (d, C-17), 137.7 (u, C-14), 
156.2 (u, C-8). 
IR (KBr): ν = 3854 (w), 3062 (w), 2958 (m), 2874 (m), 2801 (w), 1700 (s), 1447 (m), 1392 
(s), 1336 (w), 1302 (m), 1272 (s), 1233 (s), 1144 (s), 1108 (m), 1075 (m), 1036 (m), 955 (w), 
855 (m), 777 (m), 751 (m), 695 (m), 608 (m) cm–1.  
MS (EI): m/z (%) = 362 [M+] (13), 208 (14), 182 (10), 164 (100), 163 (41), 148 (18), 125 
(10). 
Elemental Analysis: 
C19H26N2O3S (362.5) C H N 
Calculated 62.96 7.23 7.73 
Found 63.18 7.43 7.63 
Melting point:  135–137 °C.
Optical rotation: [α]D = –60.3 ° (c 0.970, CH2Cl2). 
4.3 (1S,7R,7aS,111R)-7-Methyl-1-((R)-N-
methylphenylsulfonimidoyl)octahydrobenzo[d]pyrrolo[1,2-c][1,3]oxazin-
5(1H)-one (72) 
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According to GP1, sulfoximine 29b (100 mg, 0.30 mmol) was treated with n-BuLi (0.41 mL 
of 1.6 M solution in n-hexane, 0.66 mmol) and ethylene glycol di-p-tosylate (122 mg, 
0.33 mmol) to give after work up and column chromatography (EtOAc/cyclohexane, 2:1) the 
diastereomerically pure tricycle 72 (64 mg, 57%) as a colorless solid and remaining starting 
material 29b (22 mg, 22%). 
1H NMR (400 MHz, CDCl3): δ = 1.20–1.36 (m, 1 H, CH2), 1.40 (d, 3J8-9 = 6.3 Hz, 3 H, H-9), 
1.51–1.78 (m, 5 H, CH2), 1.80–1.95 (m, 1 H, H-7), 2.23–2.47 (m, 3 H, CH2), 2.64 (s, 3 H, H-
13), 3.24–3.52 (m, 3 H, H-1, H-12, CH2), 3.82–3.92 (m, 1 H, H-11´), 4.58–4.68 (dq, 3J7-
8 = 10.4 Hz, 3J9-8 = 6.3 Hz, 1 H, H-8), 7.53–7.66 (m, 3 H, H-16, H-17), 7.76–7.81 (m, 2 H, H-
15). 
13C NMR (100 MHz, CDCl3): δ = 18.9 (d, C-9), 19.3 (u, CH2), 21.6 (u, CH2), 22.5 (u, CH2), 
25.2 (u, CH2), 29.3 (d, C-13), 29.8 (u, CH2), 40.8 (u, C-11), 44.0 (d, C-7), 67.5 (u, C-2), 71.8 
(d, C-1), 73.0 (d, C-8), 128.9 (d, C-15), 129.4 (d, C-16), 132.8 (d, C-17), 139.0 (u, C-14), 
152.5 (u, C-10). 
IR (KBr): ν = 3055 (w), 2933 (s), 2864 (m), 2800 (w), 1688 (s), 1422 (s), 1378 (w), 1332 
(m), 1267 (w), 1217 (m), 1143 (m), 1105 (m), 1075 (m), 994 (w), 957 (w), 881 (w), 855 (m), 
754 (m), 692 (m), 612 (m) cm–1.
MS (EI): m/z (%) = 362 [M+], 285 (24), 284 (41), 241 (18), 240 (60), 208 (17), 207 (97), 206 
(10), 183 (13), 182 (100), 164 (34), 163 (28), 162 (24), 153 (11), 148 (22), 138 (25), 136 (11), 
135 (28), 134 (22), 125 (26), 122 (15), 120 (15), 109 (11), 108 (12), 107 (18), 106 (12), 95 
(15), 91 (11), 81 (11), 80 (12). 
Elemental Analysis: 
C19H26N2O3S (362.5) C H N 
Calculated 62.96 7.23 7.73 
Found 62.80 7.37 7.70 
Melting point: 193 °C (decomposition). 
Optical rotation: [α]D = +11.2 ° (c 1.00, CH2Cl2). 
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4.4 (1R,7R,7aS,111R)-7-Methyl-1-((R)-N-
methylphenylsulfonimidoyl)octahydrobenzo[d]pyrrolo[1,2-c][1,3]oxazin-
5(1H)-one (epi-72) 
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Preparation by spirocyclization of 29b
n-BuLi (0.56 mL of 1.6 M solution in n-hexane, 0.90 mmol) was added to a solution of the 
oxazinone 29b (100 mg, 0.30 mmol) in THF (5 mL). The mixture was allowed to warm to –
10 °C within 1 h, cooled to –50 °C, and then treated with ethylene glycol di-p-tosylate 
(244 mg, 0.67 mmol). The mixture was then allowed to warm to room temperature within 12 
h. Then saturated aqueous NH4Cl (5 mL) was added and the mixture was extracted with 
CH2Cl2 (3 × 10 mL). The combined organic phases were dried with MgSO4. The solvents 
were removed in vacuum and the residue was purified by column chromatography (EtOAc) to 
give the diastereomerically pure tricycle epi-72 (73 mg, 67%) as a colorless solid. 
Preparation by epimerization of 72
To a solution of tricycle 72 (68 mg, 0.19 mmol) in dry THF (4 mL) at –50 °C was added n-
BuLi (0.14 mL of 1.6 M solution in n-hexane, 0.23 mmol). The mixture was allowed to warm 
up to room temperature within 12 h. Then saturated aqueous NH4Cl (5 mL) was added and 
the mixture was extracted with CH2Cl2 (3 × 10 mL). The combined organic phases were dried 
with MgSO4. The solvents were removed in vacuum and the residue was purified by column 
chromatography (EtOAc) to give the diastereomerically pure tricycle epi-72  (58 mg, 85%) as 
a colorless solid. 
1H NMR (300 MHz, CDCl3): δ = 1.16–1.40 (m, 3 H, CH2), 1.45 (s, 3 H, H-9), 1.48–1.62 (m, 
1 H, CH2), 1.63–1.81 (m, 2 H, CH2), 1.82–1.93 (m, 1 H, CH2), 2.05–2.32 (m, 3 H, CH2), 2.70 
(s, 3 H, H-13), 2.99–3.09 (bd, 3J8-7 = 10.6 Hz, 1 H, H-7), 3.29–3.40 (dt, J = 9.7 Hz, 
J = 2.2 Hz, 1 H, H-11), 3.50 (d, 3J12-1 = 7.2 Hz, 1 H, H-1), 4.04 (q, J = 9.4 Hz, 1 H, H-11´), 
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4.68 (dq, 3J7-8 = 10.6 Hz, 3J9-8 = 6.2 Hz, 1 H, H-8), 7.55–7.66 (m, 3 H, H-16, H-17), 7.79–7.87 
(m, 2 H, H-15). 
13C NMR (75 MHz, CDCl3): δ = 18.7 (d, C-9), 19.9 (u, CH2), 23.8 (u, CH2), 24.4 (u, CH2), 
25.5 (u, CH2), 29.2 (d, C-13), 35.9 (u, CH2), 28.2 (d, C-7), 44.0 (u, C-11), 66.7 (u, C-2), 68.1 
(d, C-1), 73.1 (d, C-8), 129.5 (d, CH), 129.7 (d, CH), 133.0 (d, C-17), 138.3 (u, C-14), 152.9 
(u, C-10). 
IR (KBr): ν = 3371 (w), 2943 (m), 2807 (w), 2243 (w), 1688 (s), 1419 (s), 1330 (w), 1250 
(m), 1197 (w), 1140 (m), 1074 (m), 914 (m), 867 (w), 731 (s), 644 (w) cm–1. 
MS (EI): m/z (%) = 362 [M+] (9), 183 (11), 182 (100), 164 (14), 163 (11). 
Elemental Analysis: 
C19H26N2O3S (362.5) C H N 
Calculated 62.96 7.23 7.73 
Found 62.90 7.11 7.62 
Melting point: 184–186 °C 
Optical rotation:  [α]D = –88.4 ° (c 0.925, CH2Cl2). 
4.5 (1S,8R,8aS,121R)-8-Methyl-1-((R)-N-
methylphenylsulfonimidoyl)octahydro-1H-benzo[d]pyrido[1,2-
c][1,3]oxazin-6(2H)-one (73) 
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According to GP1, oxazinone 29b (100 mg, 0.30 mmol) was treated with n-BuLi (0.41 mL of 
1.6 M solution in n-hexane, 0.66 mmol) and 1,3-propanediol di-p-tosylate (127 mg, 0.33 
mmol) to give after work up and column chromatography (EtOAc/cyclohexane, 2:1) the 
diastereomerically pure tricycle 73 (66 mg, 59%) as a colorless solid and remaining starting 
material 29b (18 mg, 18%). 
1H NMR (400 MHz, CDCl3): δ = 1.24–1.42 (m, 1 H, H-4), 1.47–1.72 (m, 10 H, H-4´, H-5, 
H-6, H-9, H-12, H-13), 1.88–1.98 (m, 1 H, H-6´), 2.09–2.22 (m, 2 H, H-3, H-13´), 2.37–2.46 
(m, 1 H, H-3´), 2.57 (s, 3 H, H-14), 2.91–3.01 (m, 1 H, H-11), 3.51–3.59 (dd, 3J = 12.9 Hz, 
3J = 4.1 Hz, 1 H, H-1), 3.70–3.78 (m, 1 H, H-7), 4.11–4.19 (m, 1 H, H-11´), 4.21–4.30 (dq, 
3J9-8 = 6.9 Hz, 3J7-8 = 4.4 Hz, 1 H, H-8), 7.53–7.64 (m, 3 H, H-17, H-18), 7.72–7.77 (m, 2 H, 
H-16). 
13C NMR (100 MHz, CDCl3): δ = 18.0 (u, CH2), 21.8 (u, CH2), 22.0 (u, CH2), 22.1 (d, C-9), 
23.6 (u, CH2), 27.1 (u, CH2), 27.2 (u, CH2), 29.8 (d, C-14), 39.06 (u, C-11), 39.12 (u, C-7), 
61.9 (u, C-2), 66.8 (d, C-1), 77.5 (d, C-8), 129.3 (d, CH), 129.5 (d, CH), 132.6 (d, C-18), 
137.3 (u, C-15), 154.5 (u, C-10). 
IR (KBr): ν = 3422 (m), 2932 (m), 2960 (m), 2792 (w), 1673 (s), 1444 (m), 1400 (s), 1261 
(m), 1228 (m), 1141 (s), 1100 (m), 1074 (m), 1051 (m), 937 (w), 861 (m), 749 (m), 696 (m), 
623 (m) cm–1. 
MS (EI): m/z (%) = 376 [M+] (23), 221 (12), 209 (20), 182 (16), 179 (15), 178 (100), 177 
(43), 176 (13), 162 (23), 150 (16), 149 (29), 148 (21), 139 (31), 136 (10), 134 (13), 125 (20), 
124 (11), 122 (11), 109 (19), 108 (13), 107 (28), 106 (13), 97 (14). 
HRMS: 
C20H28N2O3S (376.2) [M+] 
Calculated 376.18207 
Found 376.18208 
Melting point: 157–158 °C (decomposition). 
Optical rotation:  [α]D = –48.1 ° (c 0.905, CH2Cl2). 
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4.6 (3aS,4R,11S,111R)-11-Chloro-4-
methyloctahydrocyclopenta[d]pyrido[1,2-c][1,3]oxazin-6(1H)-one (74) 
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To a solution of sulfoximine 71 (70 mg, 0.193 mmol) in CH2Cl2 (2 mL) was added 1-
chloroethyl chloroformate (40 µL, 0.386 mmol) and the solution was stirred at rt for 2 d. The 
solvent was removed in vacuum and the residue was purified by column chromatography 
(EtOAc/cyclohexane, 1:2) to give chloride 74 (35 mg, 74%) as a colorless oil. 
Rf(chloride 74) = 0.5 and Rf(sulfinamide 55) = 0.75 in EtOAc/cyclohexane, 1:1. 
1H NMR (500 MHz, CDCl3): δ = 1.38 (d, 3J7-9 = 6.4 Hz, 3 H, H-9), 1.55–1.63 (m, 1 H, H-5), 
1.65–2.00 (m, 6 H, H-3, H-4, H-11, H-12), 2.03–2.12 (m, 1 H, H-5´), 2.13–2.19 (m, 1 H, H-
12´), 2.24–2.32 (m, 2 H, H-3´, H-6), 2.85–2.94 (m, 1 H, H-10), 3.86–3.92 (dd, 3J12-1 = 11.9 
Hz, 3J12´-1 = 4.0 Hz, 1 H, H-1), 3.93–4.01 (dq, 3J6-7 = 10.4 Hz, 3J9-7 = 6.4 Hz, 1 H, H-7), 4.10–
4.16 (m, 1 H, H-10´) 
13C NMR (125 MHz, CDCl3): δ = 19.5 (d, C-9), 24.4 (u, C-4), 25.0 (u, C-11), 30.3 (u, C-5), 
31.7 (u, C-3), 32.5 (u, C-12), 42.0 (u, C-10), 50.9 (d, C-6), 66.2 (d, C-1), 70.7 (u, C-2), 74.0 
(d, C-7), 155.7 (u, C-8). 
IR (KBr): ν = 2954 (m), 2877 (m), 1704 (s), 1452 (m), 1396 (m), 1333 (w), 1264 (m), 1148 
(m), 1038 (w), 949 (w), 913 (w), 634 (w) cm–1. 
MS (EI): m/z (%) = 245 [M++2] (11), 244 [M++1] (11), 243 [M+] (32), 209 (13), 208 (100), 
164 (34), 91 (17). 
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HRMS: 
C12H18ClNO2 (243.7) [M+] 
Calculated 243.10261 
Found 243.10257 
Optical rotation: [α]D = +38.2 ° (c 0.815, CH2Cl2). 
4.7 (3aS,4R,111S)-4-Methyloctahydrocyclopenta[d]pyrido[1,2-c][1,3]oxazin-
6(1H)-one (75) 
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Nickel aluminium alloy powder (50:50, 1.54 g, 17.9 mmol) was suspended in desalted H2O 
(60 mL) and treated with KOH until the evolution of H2 ceased. Subsequenly, the suspension 
was heated at 80 °C for 30 min. After the mixture had cooled to room temperature, the 
aqueous layer was decanted, and the RANEY nickel was washed with desalted H2O (10 × 50 
mL) and suspended in THF/H2O (4:1, 30 mL). Sulfoximine 71 (162 mg, 0.447 mmol) was 
added to the RANEY nickel and the mixture was stirred for 24 h at room temperature. The 
suspension was filtered over celite and saturated aqueous NaCl (15 mL) was added to the 
filtrate. The aqueous layer was extracted with EtOAc (2 × 20 mL) and the combined organic 
phases were dried with MgSO4. The solvents were removed in vacuum and the residue was 
filtered over silica gel (EtOAc) to give the desired tricycle 75 (90 mg, 96%) as a colorless oil. 
1H NMR (400 MHz, CDCl3): δ = 1.27–1.38 (m, 4 H, H-9, CH2), 1.39–1.84 (m, 10 H, H-6 
CH2), 1.91–2.03 (m, 1 H, CH2), 2.24–2.36 (m, 1 H, CH2), 2.75–2.85 (m, 1 H, H-10), 3.86–
3.96 (dq, 3J6-7 = 10.7 Hz, 3J9-7 = 6.3 Hz, 1 H, H-7), 4.21–4.30 (m, 1 H, H-10´). 
13C NMR (100 MHz, CDCl3): δ = 18.7 (d, C-9), 20.8 (u, CH2), 22.3 (u, CH2), 24.4 (u, CH2), 
26.9 (u, CH2), 34.2 (u, CH2), 36.8 (u, CH2), 42.8 (u, C-10), 51.4 (d, C-6), 65.4 (u, C-2), 74.0 
(d, C-7), 154.9 (u, C-8). 
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IR (KBr): ν = 2929 (s), 2877 (m), 1679 (s), 1517 (w), 1449 (m), 1415 (s), 1374 (w), 1332 
(m), 1266 (s), 1178 (m), 1147 (w), 119 (m), 1071 (m), 1042 (m), 977 (m), 893 (w), 760 (m), 
668 (w), 640 (w) cm–1. 
MS (EI): m/z (%) =  209 [M+] (41), 168 (10), 167 (100), 166 (17), 152 (74), 150 (17), 136 
(31), 122 (19), 108 (15), 97 (19). 
HRMS: 
C12H19NO2 (209.3) [M+] 
Calculated 209.14158 
Found 209.14167 
Optical rotation: [α]D = +18.5 ° (c 1.04, CH2Cl2). 
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5. N-Acyl iminium ion route 
5.1 (4R,4aS,7aR)-7a-((R)-3-(1,3-Dioxolan-2-yl)-1-((R)-N-
methylphenylsulfonimidoyl)propyl)-4-
methylhexahydrocyclopenta[d][1,3]oxazin-2(1H)-one (80) 
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n-BuLi (6.4 mL of 1.6 M solution in n-hexane, 10.2 mmol) was added to a solution of the 
oxazinone 29a (1.50 g, 4.64 mmol) in THF (150 mL). The mixture was allowed to warm to –
10 °C within 1 h, cooled to –50 °C, and then treated with 2-(2-bromoethyl)-1,3-dioxolane 
(0.60 mL, 5.12 mmol). The mixture was allowed to warm to room temperature within 12 h. 
Then saturated aqueous NH4Cl (150 mL) was added and the mixture was extracted with 
CH2Cl2 (3 × 100 mL). The combined organic phases were dried with MgSO4. The solvents 
were removed in vacuum and the residue was purified by column chromatography (EtOAc to 
EtOAc/i-PrOH, 9:1) to give the diastereomerically pure sulfoximine 80 (1.28 g, 65%) as a 
colorless oil and remaining starting material 29b (152 mg, 10%). 
1H NMR (400 MHz, CDCl3): δ = 1.30–1.45 (m, 1 H, CH2), 1.32 (d, 3J7-9 = 6.0 Hz, 3 H, H-9), 
1.53–1.67 (m, 3 H, H-12, CH2), 1.75–1.90 (m, 3 H, CH2), 1.97–2.12 (m, 3 H, H-6, H-11), 
2.72–2.87 (m, 1 H, CH2), 2.76 (s, 3 H, H-16), 3.34 (bd, 3J11-1 = 7.7 Hz, 1 H, H-1), 3.74–3.99 
(m, 5 H, H-7, H-14, H-15), 4.66 (t, 3J12-13 = 4.1 Hz, 1 H, H-13), 7.24 (bs, 1 H, H-10), 7.54–
7.66 (m, 3 H, H-19, H-20), 7.82–7.88 (m, 2 H, H-18). 
13C NMR (100 MHz, CDCl3): δ = 19.2 (d, C-9), 20.5 (u, C-11), 22.2 (u, CH2), 26.7 (u, CH2), 
29.7 (d, C-16), 32.8 (u, C-12), 39.1 (u, CH2), 46.6 (d, C-6), 64.7 (u, CH2), 65.0 (u, CH2), 68.2 
(u, C-2), 70.4 (d, C-1), 74.8 (d, C-7), 103.5 (d, C-13), 129.4 (d, CH), 129.6 (d, CH), 133.1 (d, 
C-20), 139.7 (u, C-17), 155.2 (u, C-8). 
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IR (CHCl3): ν = 3377 (w), 3275 (w), 2957 (m), 2883 (m), 1710 (s), 1446 (m), 1392 (m), 
1322 (m), 1235 (s), 1138 (s), 1078 (m), 861 (w), 760 (m), 713 (m) cm-1.  
MS (CI, isobutane): m/z (%) = 423 [M++1] (3), 269 (14), 268 (84), 224 (15), 206 (24), 181 
(10), 156 (100).  
Optical rotation: [α]D = –80.6 ° (c 1.16, CH2Cl2). 
5.2 Synthesis of (4R,4aS,7aS)-7a-(3-(1,3-Dioxolan-2-yl)propyl)-4-
methylhexahydrocyclopenta[d][1,3]oxazin-2(1H)-one (79) 
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Preparation by cuprate substitution of iodide 50
To a solution of 2-(2-bromoethyl)-1,3-dioxolane (0.32 mL, 2.72 mmol) in dry THF (20 mL) 
at –78 °C was added t-BuLi (3.63 mL of 1.6 M solution in n-pentane, 5.44 mmol). The 
mixture was stirred at this temperature for 2 h. Then it was added to a mixture of CuI 
(259 mg, 1.36 mmol) in THF (5 mL) and Me2S (1 mL) at –30 °C. The mixture was stirred at 
this temperature for 30 min. During this time it turned black. Then it was added to a solution 
of iodide 50 (100 mg, 0.34 mmol) in THF (2 mL) at –30 °C. The mixture was allowed to 
warm to room temperature within 2 h. TLC showed a complete conversion. Saturated aqueous 
(NH4)2CO3 (10 mL) and concentrated NH3 (10 mL) were added and the mixture was extracted 
with EtOAc (3 × 20 mL). The organic layer was dried with MgSO4 and the solvents were 
removed in vacuum. The residue was purified by column chromatography on silica gel 
(EtOAc) to give the desired acetal 79 (66 mg, 72%) as a colorless oil. 
Remark: Increasing the scale, the yield droped dramatically. 
Experimental part 
133
Preparation by reduction of sulfoximine 80
Nickel aluminium alloy powder (50:50, 10.0 g, 0.114 mol) was suspended in desalted H2O 
(500 mL) and treated with KOH until the evolution of H2 ceased. Subsequently, the 
suspension was heated at 80 °C for 30 min. After the mixture had cooled to room temperature, 
the aqueous layer was decanted, and the RANEY nickel was washed with desalted H2O 
(10 × 100 mL) and suspended in THF/H2O (4:1, 150 mL). Sulfoximine 80 (1.21 g, 
2.86 mmol) was added to the RANEY nickel and the mixture was stirred for 24 h at room 
temperature. The suspension was filtered over celite and NaCl was added to the filtrate. The 
aqueous layer was extracted with EtOAc (2 × 50 mL) and the combined organic phases were 
dried with MgSO4. The solvents were removed in vacuum and the residue was filtered over 
silica gel (EtOAc) to give the desired acetal 79 (692 mg, 90%) as a colorless oil. 
1H NMR (400 MHz, CDCl3): δ = 1.35 (d, 3J7-9 = 6.0 Hz, 3 H, H-9), 1.40–1.97 (m, 13 H, H-1, 
H-3, H-4, H-5, H-6, H-11, H-12), 3.82–3.87 (m, 2 H, H-15), 3.93–4.01 (m, 3 H, H-7, H-14), 
4.84 (t, 3J = 4.7 Hz, 1 H, H-13), 5.83 (bs, 1 H, H-10). 
13C NMR (100 MHz, CDCl3): δ = 18.1 (u, CH2), 19.2 (d, C-9), 22.6 (u, CH2), 27.7 (u, CH2), 
33.7 (u, CH2), 39.9 (u, CH2), 41.6 (u, CH2), 46.7 (d, C-6), 64.1 (u, C-2), 64.8 (u, C-14, C-15), 
75.9 (d, C-7), 104.0 (d, C-13), 156.1 (u, C-8).  
IR (CHCl3): ν = 3247 (m), 3115 (w), 2954 (s), 2882 (m), 1706 (s), 1458 (m), 1404 (m), 1317 
(m), 1220 (m), 1137 (m), 1048 (m), 941 (w), 756 (s), 666 (w) cm-1.  
MS (EI): m/z (%) = 269 [M+] (5), 226 (17), 154 (82), 153 (20), 136 (20), 127 (10), 110 (100), 
99 (12), 93 (11).  
HRMS: 
C14H23NO4 (269.3) [M+] 
Calculated 269.16271 
Found 269.16283 
Optical rotation: [α]D = +11.8 ° (c 1.80, CH2Cl2). 
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5.3 Synthesis of (3aS,4R,8R,111S)-8-Methoxy-4-
methyloctahydrocyclopenta[d]pyrido[1,2-c][1,3]oxazin-6(1H)-one (76) 
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To a solution of acetal 79 (100 mg, 0.37 mmol) in dry MeOH (4 mL) was added concentrated 
H2SO4 (3 drops). The mixture was stirred at room temperature until TLC showed a complete 
conversion (3 d). Then saturatued aqueous NaHCO3 (5 mL) was added and the aqueous layer 
was extracted with CH2Cl2 (3 × 10 mL). The organic layer was dried with MgSO4 and the 
solvents were removed in vacuum. The residue was purified by column chromatography on 
silica gel (EtOAc/cyclohexane, 1:2) to give diastereomerically pure (N,O)-acetal 76 (61 mg, 
69%) as a colorless oil. 
1H NMR (500 MHz, C6D6): δ = 0.71–0.79 (ddt, J = 15.3 Hz, J = 4.0 Hz, J = 2.1 Hz, 1 H, H-
1), 0.79–0.88 (m, 1 H, CH2), 1.01 (d, 3J7-9 = 6.1 Hz, 3 H, H-9), 1.03–1.14 (m, 2 H, H-12), 
1.18–1.36 (m, 5 H, H-1´, H-3, H-6), 1.36–1.46 (m, 1 H, H-11), 1.72–1.82 (m, 2 H, H-11´, H-
12´), 2.20–2.27 (ddd, J = 12.8 Hz, J = 8.2 Hz, J = 0.9 Hz, 1 H, H-3´), 3.19 (s, 3 H, H-13), 
3.49–3.57 (dq, 3J6-7= 10.4 Hz, 3J9-7= 6.1 Hz, 1 H, H-7), 5.98 (dd, 3J11-10= 4.0 Hz, 3J11´-
10= 1.8 Hz, 1 H, H-10). 
13C NMR (75 MHz, C6D6): δ = 15.2 (u, CH2), 18.5 (d, C-9), 20.9 (u, CH2), 23.6 (u, CH2), 
29.8 (u, C-11), 34.4 (u, C-1), 34.9 (u, C-3), 50.9 (d, C-6), 55.0 (d, C-13), 63.4 (u, C-2), 72.3 
(d, C-7), 83.0 (d, C-10), 153.3 (u, C-8). 
IR (CHCl3): ν = 2944 (s), 1691 (s), 1453 (m), 1403 (s), 1369 (m), 1308 (m), 1279 (w), 1244 
(w), 1211 (w), 1192 (w), 1161 (w), 1123 (m), 1070 (s), 973 (w), 952 (w), 913 (m), 843 (w), 
759 (m), 698 (w), 617 (w) cm-1.  
MS (EI): m/z (%) = 239 [M+] (8), 225 (14), 224 (100), 209 (16), 208 (35), 197 (35), 182 (25), 
180 (22), 164 (22), 163 (10), 162 (24), 154 (11), 122 (11), 121 (17), 110 (10), 93 (13).  
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HRMS: 
C13H21NO3 (239.3) [M+] 
Calculated 239.15214 
Found 239.15205 
Optical rotation: [α]D = +39.5 ° (c 0.965, EtOAc). 
5.4 (3aS,4R,111S)-4-methyl-2,3,3a,4,10,11-
hexahydrocyclopenta[d]pyrido[1,2-c][1,3]oxazin-6(1H)-one (78) 
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To a mixture of acetal 79 (105 mg, 0.390 mmol) in dry toluene (2 mL) was added p-
toluenesulfonic acid (6.7 mg, 0.039 mmol) and the mixture was stirred at reflux temperature 
for 1 h. Then saturated aqueous NaHCO3 (5 mL) is added and the aqueous layer was extracted 
with EtOAc (3 × 10 mL). The organic layer was dried with MgSO4 and the solvents were 
removed in vacuum. Purification by column chromatography on silica gel 
(EtOAc/cyclohexane, 1:1) gave the desired enamide 78 (60 mg, 74%) as a colorless solid. 
1H NMR (300 MHz, CDCl3): δ = 1.38 (d, 3J7-9 = 6.2 Hz, 3 H, H-9), 1.48–1.90 (m, 7 H, H-6, 
CH2) 1.93–2.09 (m, 2 H, CH2), 2.09–2.14 (m, 2 H, CH2), 4.12–4.24 (dq, 3J6-7 = 9.6 Hz, 3J9-
7 = 6.2 Hz, 1 H, H-7) 5.04–5.13 (m, 1 H, H-11), 6.86–6.93 (dt, 3J11-10 = 8.4 Hz, 4J12-
10 = 2.0 Hz, 1 H, H-10). 
13C NMR (75 MHz, CDCl3): δ = 19.1 (d, C-9), 19.3 (u, CH2), 20.5 (u, CH2), 25.7 (u, CH2), 
30.9 (u, CH2), 33.7 (u, CH2), 48.0 (d, C-6), 63.5 (u, C-2), 74.1 (d, C-7), 108.8 (d, C-11), 125.7 
(d, C-10). 
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IR (KBr): ν = 3061 (w), 2965 (m), 2903 (m), 1673 (s), 1516 (w), 1459 (w), 1406 (s), 1373 
(m), 1315 (s), 1205 (w), 1168 (w), 1124 (m), 1054 (m), 977 (w), 945 (w), 912 (w), 809 (w), 
757 (m), 728 (m), 624 (w) cm-1. 
MS (EI): m/z (%) = 207 [M+] (100), 163 (12), 162 (47), 148 (85), 135 (20), 134 (98), 120 
(26), 108 (21), 95 (43), 94 (28), 91 (12), 82 (16), 80 (15). 
Elemental Analysis: 
C12H17NO2 (207.1) C H N 
Calculated 69.54 8.27 6.76 
Found 69.63 7.88 6.61 
Melting point: 99–102 °C 
Optical rotation:  [α]D = +67.3 ° (c 1.15, CH2Cl2). 
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6. Efforts toward the formal total synthesis of halichlorine 
and pinnaic acid 
6.1 1-((1S,5S)-1-((R)-1-hydroxyethyl)-6-azaspiro[4.5]decan-6-yl)-2-
methylbutan-1-one (93) 
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To a solution of tricycle 75 (100 mg, 0.478 mmol), TMEDA (72 µL, 0.478 mmol) and THF 
(7 mL) at 0 °C was added sec-BuLi (0.51 mL of 1.4 M solution in cyclohexane, 0.717 mmol). 
After the solution was stirred at this temperature for 40 min, allyl bromide (62 µL, 
0.717 mmol) was added and the solution had been stirred for 2 h at 0 °C. Then saturated 
aqueous NH4Cl (10 mL) was added and the mixture was extracted with EtOAc (3 × 10 mL). 
The combined organic phases were dried with MgSO4. The solvents were removed in vacuum 
and the residue was purified by column chromatography (EtOAc/cyclohexane, 1:2) to give 
amides 93 and epi-93 (31 mg, 24%) and starting material 75 (62 mg, 62%) could be isolated 
by washing the column with EtOAc. Small amounts of amides 93 and epi-93 could be 
obtained in a pure form. 
Rf(amide 93) = 0.75, Rf(amide epi-93) = 0.63 and Rf(tricycle 75) = 0.33 in Et2O. 
• Analytical data of 93 
1H NMR (300 MHz, CDCl3): δ = 0.92 (t, 3J12-13 = 7.4 Hz, 3 H, H-13), 1.07 (d, 3J11-
14 = 6.7 Hz, 3 H, H-14), 1.14 (d, 3J7-9 = 6.2 Hz, 3 H, H-9), 1.26–1.48 (m, 3 H, CH2), 1.50–1.76 
(m, 9 H, H-6, CH2), 1.78–1.90 (m, 1 H, CH2), 1.97–2.16 (m, 2 H, CH2), 2.39–2.53 (m, 1 H, 
CH2), 2.50–2.63 (m, 1 H, H-11), 3.54–3.70 (m, 2 H, H-15), 3.72–3.85 (m, 1 H, H-7). 
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13C NMR (75 MHz, CDCl3): δ = 12.1 (d, C-13), 17.1 (u, CH2), 17.2 (d, C-14), 22.8 (u, CH2), 
23.9 (d, C-9), 24.3 (u, CH2), 27.1 (u, CH2), 30.4 (u, CH2), 34.2 (u, CH2), 37.4 (u, CH2), 39.3 
(d, C-11), 41.9 (u, C-15), 60.4 (d, C-6), 68.6 (u, C-2), 69.6 (d, C-7), 176.7 (u, C-10). 
IR (CHCl3): ν = 3423 (m), 2943 (s), 2869 (s), 1723 (w), 1618 (s), 1463 (s), 1427 (s), 1371 
(w), 1321 (w), 1228 (m), 1148 (m), 1116 (m), 1062 (m), 971 (w), 924 (w), 869 (w), 754 (m) 
cm-1.  
MS (EI): m/z (%) = 267 [M+] (15), 249 (31), 210 (30), 184 (14), 182 (34), 181 (33), 180 (44), 
169 (10), 168 (62), 166 (45), 138 (24), 110 (60), 98 (42), 97 (100), 84 (31).  
• Analytical data of epi-93
1H NMR (300 MHz, CDCl3): δ = 0.86 (t, 3J12-13 = 7.7 Hz, 3 H, H-13), 1.09 (d, 3J11-
14 = 6.9 Hz, 3 H, H-14), 1.15 (d, 3J7-9 = 6.2 Hz, 3 H, H-9), 1.28–1.46 (m, 4 H, CH2), 1.48–1.74 
(m, 8 H, H-6, CH2), 1.77–1.90 (m, 1 H, CH2), 1.99–2.17 (m, 2 H, CH2), 2.46–2.63 (m, 2 H, 
H-11, CH2), 3.50–3.82 (m, 3 H, H-7, H-15). 
13C NMR (75 MHz, CDCl3): δ = 12.1 (d, C-13), 17.0 (u, CH2), 17.7 (d, C-14), 22.6 (u, CH2), 
24.1 (d, C-9), 24.4 (u, CH2), 27.3 (u, CH2), 30.7 (u, CH2), 34.2 (u, CH2), 37.6 (u, CH2), 39.4 
(d, C-11), 41.5 (u, C-15), 60.6 (d, C-6), 68.6 (u, C-2), 69.5 (d, C-7), 176.5 (u, C-10). 
IR (CHCl3): ν = 3409 (m), 2943 (s), 2869 (s), 1618 (s), 1463 (s), 1430 (s), 1372 (m), 1320 
(m), 1147 (m), 1117 (m), 1059 (m), 974 (w), 924 (w), 868 (w), 756 (m), 664 (w) cm-1.  
MS (EI): m/z (%) = 267 [M+] (18), 249 (28), 210 (34), 184 (14), 182 (34), 181 (34), 180 (44), 
169 (10), 168 (67), 166 (45), 138 (22), 110 (60), 98 (41), 97 (100), 84 (31).  
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6.2 (3aS,4R,8S,111S)-8-allyl-4-methyloctahydrocyclopenta[d]pyrido[1,2-
c][1,3]oxazin-6(1H)-one (87) 
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To a solution of acetal 76 (31 mg, 0.129 mmol) in CH2Cl2 (4 mL) at –78 °C was added 
BF3.OEt2 (98 µL, 0.774 mmol) and allyltrimethylsilane (123 µL, 0.774 mmol). The mixture 
was allowed to warm to room temperature within 5 h. Then saturated aqueous NaHCO3
(10 mL) was added and the aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The 
combined organic layers were dried with MgSO4 and the solvents were removed in vacuum. 
1H NMR spectroscopy of the crude mixture showed a mixture of alkene 87 (≥ 98% de) and 
enamide 78 in a ratio of 3:1. Column chromatography of the crude mixture (n-pentane/i-
PrOH, 16:1) gave 87 (23 mg, 71%, Rf = 0.5) as a colorless oil and 78 (6 mg, 22%, Rf = 0.4) as 
a colorless solid. 
Analytical data of alkene 87 
1H NMR (500 MHz, C6D6): δ = 0.69-0.78 (ddt, J = 13.1 Hz, J = 4.0 Hz, J = 1.5 Hz, 1 H, H-
1), 0.84-0.94 (m, 1 H, H-5), 0.99 (d, 3J7-9 = 6.1 Hz, 3 H, H-9), 1.00-1.14 (m, 3 H, H-1´, H-4, 
H-12), 1.15-1.48 (m, 7 H, H-3, H-4´, H-5´, H-6, H-11, H-12), 1.67-1.75 (m, 1 H, H-3´), 2.04-
2.13 (m, 1 H, H-13), 2.28-2.36 (m, 1 H, H-13´), 3.47-3.55 (dq, 3J6-7 = 9.8 Hz, 3J9-7 = 6.4 Hz, 
1 H, H-7), 5.00-5.07 (m, 2 H, H-15), 5.07-5.12 (m, 1 H, H-10), 5.80-5.90 (m, 1 H, H-14). 
13C NMR (125 MHz, C6D6): δ = 15.5 (u, C-12), 18.6 (d, C-9), 20.7 (u, C-4), 23.9 (u, C-5), 
26.7 (u, C-11), 35.3 (u, C-3), 35.6 (u, C-1), 38.3 (u, C-13), 50.1 (d, C-6), 51.4 (d, C-10), 63.4 
(u, C-2), 71.5 (d, C-7), 116.3 (u, C-15), 136.7 (d, C-14), 153.1 (u, C-8). 
IR (KBr): ν = 3074 (w), 2938 (s), 1680 (s), 1452 (w), 1405 (s), 1369 (m), 1308 (m), 1276 
(m), 1128 (m), 1089 (m), 997 (w), 916 (m), 759 (m), 658 (w) cm-1. 
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MS (EI): m/z (%) = 250 [M++1] (37), 249 [M+] (1), 209 (13), 208 (100), 165 (12), 164 (93), 
147 (23), 121 (37), 108 (11), 105 (14), 93 (19), 82 (10). 
HRMS: 
C15H23NO2 (249.4) [M+] 
Calculated 249.17288 
Found 249.17276 
Optical rotation:  [α]D = –7.08 ° (c 0.565, CH2Cl2). 
6.2 (4R,4aS,7aR)-4,7a-dimethylhexahydrocyclopenta[d][1,3]oxazin-2(1H)-
one (105) 
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Preparation by reduction of iodide 50 by the undesired formation of copper hydride species 
To a solution of 4-bromobut-1-ene (0.42 mL, 4.07 mmol) in dry THF (5 mL) at –78 °C was 
added t-BuLi (5.40 mL of 1.6 M solution in n-pentane, 8.16 mmol). The mixture was stirred 
at this temperature for 2 h. Then it was added to a solution of CuI (388 mg, 2.04 mmol) in 
THF (5 mL) and Me2S (1 mL) at –30 °C. The mixture was stirred at this temperature for 
30 min. During this time it turned black. Then it was added to a solution of iodide 50
(150 mg, 0.51 mmol) in THF (2 mL) at –30 °C. The mixture was allowed to warm to room 
temperature within 2 h. TLC showed a complete conversion. Saturated aqueous (NH4)2CO3
(10 mL) and concentrated NH3 (10 mL) were added and the mixture was extracted with 
EtOAc. The organic layer was dried with MgSO4 and the solvents were removed in vacuum. 
The residue was purified by column chromatography on silica gel (EtOAc) to give a colorless 
oil (54 mg) which contained oxazinone 105 as the major compound according to NMR. 
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Preparation by reduction of sulfoximine 29a
Nickel aluminium alloy powder (50:50, 3.30 g, 38.4 mmol) was suspended in desalted H2O 
(100 mL) and treated with KOH until the evolution of hydrogen ceased. Subsequenly, the 
suspension was heated at 80 °C for 30 min. After the mixture had cooled to room temperature, 
the aqueous layer was decanted, and the RANEY nickel was washed with desalted H2O 
(10 × 80 mL) and suspended in THF/H2O (4:1, 50 mL). Sulfoximine 29a (310 mg, 0.961 
mmol) was added to the RANEY nickel and the mixture was stirred for 24 h at room 
temperature. The suspension was filtered over celite and saturated aqueous NaCl was added to 
the filtrate. The aqueous layer was extrated with EtOAc (2 × 50 mL) and the combined 
organic phases were dried with MgSO4. Solvent was removed in vacuum and the residue was 
filtered over silica gel (EtOAc) to give the desired tricycle 105 (120 mg, 74%) as a colorless 
oil. 
1H NMR (400 MHz, CDCl3) δ = 1.22 (s, 3 H, H-1), 1.27 (d, 3J7-9 = 6.3 Hz, 3 H, H-9), 1.34-
1.44 (m, 1 H, CH2), 1.50-1.73 (m, 5 H, H-6, CH2), 1.85-1.96 (m, 1 H, CH2), 3.88-3.97 (dq, 
3J6-7 = 10.2 Hz, 3J9-7 = 6.3 Hz, 1 H, H-7), 6.76 (bs, 1 H, H-10). 
13C NMR (100 MHz, CDCl3) δ = 19.2 (d, C-9), 22.5 (u, CH2), 27.3 (u, CH2), 29.5 (d, C-1), 
41.0 (u, CH2), 48.5 (d, C-6), 61.1 (u, C-2), 76.0 (d, C-7), 156.1 (u, C-8). 
IR (KBr): ν =  3247 (m), 3112 (m), 2963 (m), 2878 (m), 1705 (s), 1412 (m), 1324 (m), 1223 
(w), 1174 (w), 1084 (m), 1058 (m), 979 (w), 777 (w), 623 (w) cm-1. 
MS (EI): m/z (%) = 169 [M+] (22), 154 (33), 127 (100), 126 (19), 112 (45), 110 (56), 97 (11), 
96 (63), 83 (16), 82 (30), 81 (13). 
HRMS: 
C9H15NO2 (169.22) [M+] 
Calculated 169.11028 
Found 169.11033 
Melting point:  76–78°C.
Optical rotation:  [α]D = +31.2 ° (c 1.20, CH2Cl2). 
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7. Synthesis of protected β-amino acids  
7.1 (4R,4aS,7aR)-7a-(Chloromethyl)-4-
methylhexahydrocyclopenta[d][1,3]oxazin-2(1H)-one  (115) 
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1-Chlorethyl chloroformate (304 µL, 2.82 mmol) was added at room temperature to a solution 
of oxazinone 29a (700 mg, 2.17 mmol) in CH2Cl2 (10 mL). The mixture was stirred at room 
temperature until TLC indicated almost a complete conversion of the sulfoximine (4 h). 
Concentration in vacuum and purification of the residue by column chromatography 
(EtOAc/cyclohexane, 2:1) afforded the desired chloride 115 (356 mg, 81%) as a colorless 
solid. 
Rf(chloride 115) = 0.55 and Rf(sulfinamide 55) = 0.9 in EtOAc. 
1H NMR (300 MHz, CDCl3): δ = 1.39 (d, 3J7-9 = 6.2 Hz, 3 H, H-9), 1.48–2.12 (m, 7 H, H-3, 
H-4, H-5, H-6), 3.49 (d, 2J1´-1 = 11.4 Hz, 1 H, H-1), 3.56 (d, 3J1-1´ = 11.1 Hz, 1 H, H-1´), 4.02 
(dq, 3J9-7 = 6.2 Hz, 3J6-7 = 9.6 Hz, 1 H, H-7), 6.19 (bs, 1 H, H-10). 
13C NMR (100 MHz, CDCl3): δ = 19.1 (d, C-9), 23.0 (u, CH2), 28.3 (u, CH2), 37.9 (u, CH2), 
46.2 (d, C-6), 52.7 (u, C-1), 65.0 (u, C-2), 75.9 (d, C-7), 156.2 (u, C-8). 
IR (KBr): ν = 3337 (m), 3248 (m), 3132 (m), 2976 (s), 2940 (m), 2889 (m), 1704 (s), 1457 
(m), 1431 (m), 1391 (s), 1321 (s), 1281 (m), 1213 (w), 1162 (w), 1119 (w), 1086 (m), 1054 
(m), 1014 (m), 975 (w), 938 (w), 865 (w), 752 (m), 707 (m), 623 (m) cm–1. 
MS (CI, methane): m/z (%) = 204 [M++1] (100). 
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Elemental Analysis:  
C9H14ClNO2 (203.1) C H N 
Calculated 53.08 6.93 6.88 
Found 53.16 6.95 6.75 
Melting point:  118–120°C.
Optical rotation: [α]D = +1.07 ° (c 1.02, CH2Cl2).
7.2 2-((4R,4aS,7aS)-4-methyl-2-oxooctahydrocyclopenta[d][1,3]oxazin-7a-
yl)acetonitrile (116) 
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KCN (234 mg, 3.56 mmol) was added at room temperature to a solution of chloride 115
(365 mg, 1.80 mmol) in DMF (9 mL). The resulting mixture was heated with stirring at 
100 °C for 2 h. After the mixture had been cooled to room temperature, the solvent was 
removed in vacuum. The remaining solid was purified by column chromatography (EtOAc) to 
afford the desired nitrile 116 (329 mg, 94%) as a colorless solid. 
1H NMR (300 MHz, CDCl3): δ = 1.43 (d, 3J7-9 = 6.4 Hz, 3 H, H-9), 1.52–2.15 (m, 7 H, H-3, 
H-4, H-5, H-6), 2.63 (d, 2J1´-1 = 16.8 Hz, 1 H, H-1), 2.71 (d, 2J1-1´ = 16.6 Hz, 1 H, H-1´), 3.97–
4.09 (m, 1 H, H-7), 7.12 (bs, 1 H, H-10) 
13C NMR (100 MHz, CDCl3): δ = 19.2 (d, C-9), 23.0 (u, CH2), 28.3 (u, CH2), 31.1 (u, C-1), 
40.0 (u, CH2), 47.4 (d, C-6), 62.2 (u, C-2), 76.2 (d, C-7), 116.8 (u, C-11), 156.2 (u, C-8). 
IR (KBr): ν = 3294 (s), 3116 (w), 2961 (m), 2934 (m), 2254 (w), 1671 (s), 1471 (m), 1416 
(s), 1317 (s), 1215 (w), 1168 (m), 1126 (w), 1081 (m), 1052 (m), 1026 (m), 943 (w), 865 (w), 
772 (m), 636 (w) cm–1. 
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MS (EI): m/z (%) = 194 [M+] (0.5), 154 (72), 121 (14), 110 (100), 107 (11), 93 (11), 82 (15). 
Elemental Analysis:  
C10H14N2O2 (194.2) C H N 
Calculated 61.84 7.27 14.42 
Found 61.69 7.22 14.33 
Melting point:  120 °C. 
Optical rotation: [α]D = +27.6 ° (c 1.03, CH2Cl2). 
7.3 Tert-butyl (1R,4aS,7aS)-1-methyl-3-oxooctahydrocyclopenta[c]pyran-
4a-ylcarbamate (118) 
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A mixture of nitrile 116 (150 mg, 0.77 mmol), CsOH (1.74 g, 11.6 mmol), MeOH (3 mL) and 
H2O (3 mL) was stirred at reflux temperature for 3 d. The solution was carrefully acidified to 
pH = 5 with concentrated aqueous HCl (3N). Then MeOH was removed in vacuum and H2O 
was removed by lyophilization to give a mixture of colorless salts. The salts were stirred in a 
solution of CHCl3/MeOH (1:1) to extract the organic compounds. After repeating this process 
(3 × 15 mL), the organic layers were combined and dried with MgSO4. The solvent was 
removed in vacuum to give the crude amino acid 117 which was directly used for the next 
step. To a solution of the crude amino acid 117 in CH2Cl2 (5 mL) was added triethylamine 
(0.54 mL, 3.85 mmol) and Boc-anhydride (840 mg, 3.85 mmol). The mixture was stirred at 
room temperature for 3 d. Then saturated aqueous NH4Cl was added and the aqueous layer 
was extracted with CH2Cl2 (3 × 10 mL). The organic layer was dried with MgSO4 and the 
solvents were removed in vacuum. Purification by column chromatography 
(EtOAc/cyclohexane, 1:2) gave lactone 118 (114 mg, 55%) as a colorless foam. 
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1H NMR (400 MHz, CDCl3): δ = 1.39 (d, 3J7-9 = 6.3 Hz, 3 H, H-9), 1.41–1.51 (m, 3 H, CH2), 
1.44 (s, 9 H, H-13), 1.69–1.80 (m, 1 H, H-6), 1.81–1.96 (m, 2 H, CH2), 2.37 (d, 2J1´-
1 = 17.9 Hz, 1 H, H-1), 2.40–2.47 (m, 1 H, CH2), 3.70 (bd, 2J1-1´ = 17.6 Hz, 1 H, H-1´), 4.37–
4.49 (m, 2 H, H-1, H-7). 
13C NMR (125 MHz, CDCl3): δ = 21.0 (u, CH2), 21.1 (d, C-9), 23.5 (u, CH2), 28.4 (d, C-13), 
36.5 (u, C-10), 41.6 (u, C-12), 51.2 (d, C-6), 60.4 (u, C-2), 76.2 (d, C-7), 169.9 (u, C-8). 
IR (KBr): ν = 3360 (m), 2978 (s), 1708 (s), 1515 (s), 1382 (m), 1248 (m), 1166 (s), 1056 (m), 
1022 (m), 976 (m), 853 (w), 783 (m) cm-1. 
MS (CI, isobutane): m/z (%) = 270 [M++1] (43), 215 (13), 214 (100). 
HRMS:  
C14H23NO4 (269.3) [M+ – C4H8] 
Calculated 213.10011 
Found 213.10035 
Melting point:  40–42 °C 
Optical rotation: [α]D = –31.4 ° (c 1.93, CDCl3). 
Experimental part 
146
8. Synthesis of cycloalkenyl oxiranes starting from vinylic 
sulfoximines 
8.1 Preparation of the cyclic vinyl sulfoximines 
8.1.1 (+)-(R)-(S-Cyclopentylidenmethyl)-N-methyl-S-phenylsulfoximine (31a) 
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Vinyl sulfoximine 31a was prepared according to the literature procedure. The analytical data 
were in agreement with those reported.33  
1H NMR (300 MHz, CDCl3): δ = 1.46–1.76 (m, 4 H, CH2), 2.18–2.48 (m, 3 H, CH2), 2.66 (s, 
3 H, H-7), 2.79–2.93 (m, 1 H, CH2), 6.33 (qui, 4J2-6 = 4J5-6 = 2.3 Hz, 1 H, H-6), 7.46–7.59 (m, 
3 H, H-10, H-11), 7.84–7.93 (m, 2 H, H-9). 
13C NMR (75 MHz, CDCl3): δ = 25.2 (u, CH2), 26.4 (u, CH2), 29.2 (d, C-7), 30.3 (u, CH2), 
36.1 (u, CH2), 121.7 (d, C-6), 128.7 (d, CH), 129.0 (d, CH), 132.2 (C-11), 140.4 (u, C-8), 
164.4 (d, C-1). 
Optical rotation for (S)-31a, literature: [α]D = –53.7 ° (c 1.21, acetone). 
Optical rotation for (R)-31a, found: [α]D = +52.9 ° (c 1.18, acetone). 
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8.1.2 (+)-(R)-(S-Cyclohexylidenmethyl)-N-methyl-S-phenylsulfoximine (31b) 
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Vinyl sulfoximine 31b was prepared according to the literature procedure. The analytical data 
were in agreement with those reported.33
1H NMR (300 MHz, CDCl3): δ = 1.26–1.37 (m, 1 H, CH2), 1.45–1.68 (m, 5 H, CH2), 2.12–
2.19 (m, 2 H, CH2), 2.45–2.54 (m, 1 H, CH2), 2.61–2.72 (m, 1 H, CH2), 2.66 (s, 3 H, H-8), 
6.21–6.23 (m, 1 H, H-7), 7.48–7.56 (m, 3 H, H-11, H-12), 7.87–7.93 (m, 2 H, H-10). 
13C NMR (75 MHz, CDCl3): δ = 25.7 (u, CH2), 27.0 (u, CH2), 28.3 (u, CH2), 29.1 (u, CH2), 
29.2 (d, C-8), 37.4 (u, CH2), 123.7 (d, C-7), 128.5 (d, CH), 129.0 (d, CH), 132.1 (C-12), 141.2 
(u, C-9), 164.4 (d, C-1). 
Optical rotation for (S)-31b, literature: [α]D = –180.8 ° (c 1.21, acetone). 
Optical rotation for (R)-31b, found: [α]D = +176.9 ° (c 1.18, acetone). 
8.2 General procedure for the synthesis of vinyl epoxides (GP2) 
Me3OBF4 reagent (1.3 mmol) was added at 10 °C to a solution of the vinylic sulfoximine 
(1 mmol) in CH2Cl2 (20 mL). The progress of the reaction was monitored by TLC (EtOAc). 
After the mixture had been stirred at 10 °C for 3 h, it was cooled to –78 °C and the aldehyde 
(1.4 mmol) and DBU (1.7 mmol) were added. The mixture was allowed to warm up slowly to 
room temperature over 12 h and was stirred for further 2 h. Saturated aqueous NaHCO3
(10 mL) was added and the aqueous layer was extracted with CH2Cl2. The combined organic 
phases were dried with MgSO4 and carefully concentrated in vacuum using a vacuum 
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controller because of the high volatility of the compounds. Purification by flash 
chromatography (Et2O/n-pentane) gave a mixture of trans- and cis-oxiranes. 
The diastereoselectivities were determined by 1H NMR spectroscopy, the enantioselectivities 
were determined by HPLC. The trans- and cis oxiranes were not separated, so that for the 
minor one (cis) only separated signals are given. 
8.3 Preparation of the cyclic alkenyloxiranes 
8.3.1 2-Cyclopentenyl-3-phenyloxirane (131a) 
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According to GP2, from sulfoximine 31a (450 mg, 1.91 mmol), Me3OBF4 (369 mg, 2.45 
mmol), DBU (486 µL, 3.25 mmol) and benzaldehyde (273 µL, 2.68 mmol), a mixture of 
oxiranes trans-131a and cis-131a (149 mg, 42%) was isolated as a colorless oil. 
de  88% The trans isomer is the major one. 
eetrans  32% Column: Chiralpack-AD, L = 250 mm, ∅ = 4.6 mm 
Solvents: n-heptane (99%), i-PrOH (1%) 
Conditions: 1 mL.min–1, 29 bar 
Detector: UV (230 nm) 
Retention times: t1(major) = 5.2 min, t2(minor) = 9.3 min 
1H NMR (300 MHz, CDCl3) trans-131a: δ = 1.82–2.04 (m, >2 H, CH2), 2.16–2.46 (m, 
>4 H, CH2), 3.56 (bd, 3J1-2 = 2.2 Hz, 1 H, H-2), 3.89 (d, 3J2-1 = 2.2 Hz, 1 H, H-1), 5.92 (m, 
1 H, H-4), 7.24–7.39 (m, >5 H, H-9, H-10, H-11). 
13C NMR (75 MHz, CDCl3) trans-131a: δ =  23.1 (u, CH2), 30.5 (u, CH2), 32.8 (u, CH2), 
58.5 (d, C-1), 61.3 (d, C-2), 125.5 (d, CH), 128.1 (d, CH), 128.5 (d, CH), 131.3 (d, C-4), 
137.6 (u, C), 140.6 (u, C). 
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1H NMR (300 MHz, CDCl3) cis-131a: δ = 3.80 (m, 1 H, H-2), 4.18 (d, 3J2-1 = 4.2 Hz, 1 H, 
H-1), 5.68 (m, 1 H, H-4). 
IR (CHCl3): ν = 3853 (m), 3744 (s), 3675 (m), 3620 (w), 3440 (m), 3036 (m), 2950 (s), 2356 
(s), 1704 (s), 1550 (m), 1456 (m), 1171 (w), 1037 (m), 841 (m), 759 (s), 700 (s) cm–1. 
MS (EI): m/z (%) = 186 [M+] (33), 185 (82), 168 (12), 167 (16), 158 (30), 157 (70), 142 (14), 
141 (14), 130 (17), 129 (100), 115 (31), 108 (11), 105 (25), 91 (39), 90 (17), 89 (21). 
8.3.2 2-Cyclohexenyl-3-phenyloxirane (131b) 
O
2 1 9
H
3
H
12
11
108
7
6
5
4
According to GP2, from sulfoximine 31b (477 mg, 1.91 mmol), Me3OBF4 (369 mg, 2.45 
mmol), DBU (486 µL, 3.25 mmol) and benzaldehyde (273 µL, 2.68 mmol), a mixture of 
oxiranes trans-131b and cis-131b (168 mg, 44%) was isolated as a colorless oil. 
de  82% The trans isomer is the major one. 
eetrans  20% Column: Chiralpack-AD, L = 250 mm, ∅ = 4.6 mm 
Solvents: n-heptane (99%), i-PrOH (1%) 
Conditions: 1 mL.min–1, 32 bar 
Detector: UV (230 nm) 
Retention times: t1(major) = 6.2 min, t2(minor) = 19.0 min 
The spectroscopic data of trans-131b and cis-131b are in accordance with those described in 
the literature.42,92
1H NMR (300 MHz, CDCl3) trans-131b: δ = 1.49–1.76 (m, >4 H, CH2), 1.81–1.93 (m, 
>1 H, CH2), 1.97–2–10 (m, >3 H, CH2), 3.28 (bd, 3J1-2 = 1.9 Hz, 1 H, H-2), 3.84 (d, 3J2-
1 = 1.9 Hz, 1 H, H-1), 5.90 (m, 1 H, H-4), 7.21–7.36 (m, >5 H, H-10, H-11, H-12). 
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13C NMR (75 MHz, CDCl3) trans-131b: δ = 22.2 (u, CH2), 22.4 (u, CH2), 22.8 (u, CH2), 
25.2 (u, CH2), 57.3 (d, C-1), 65.7 (d, C-2), 125.3 (d, CH), 127.3 (d, C-4), 127.7 (d, CH), 128.2 
(d, CH), 133.3 (u, C), 137.6 (u, C). 
1H NMR (300 MHz, CDCl3) cis-131b: δ = 3.60 (m, 1 H, H-2), 4.10 (d, 3J2-1 = 4.4 Hz, 1 H, 
H-1), 5.70 (m, 1 H, H-4). 
IR (CHCl3): ν = 3403 (m), 2930 (s), 1716 (m), 1600 (w), 1495 (m), 1448 (m), 1172 (w), 
1068 (m), 921 (w), 881 (m), 841 (m), 755 (s), 700 (m), 619 (m) cm–1. 
MS (EI): m/z (%) = 200 [M+] (41), 199 (74), 172 (10), 171 (41), 158 (24), 157 (40), 143 (25), 
141 (27), 129 (100), 122 (11), 117 (22), 115 (28), 109 (32), 105 (58), 91 (86), 90 (16), 89 
(35), 81 (23). 
8.3.3 2-(4-Bromophenyl)-3-cyclopentenyloxirane (131c) 
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According to GP2, from sulfoximine 31a (150 mg, 0.64 mmol), Me3OBF4 (123 mg, 0.83 
mmol), DBU (162 µL, 1.08 mmol) and p-bromobenzaldehyde (165 mg, 0.89 mmol), a 
mixture of oxiranes trans-131c and cis-131c (46 mg, 27%) was isolated as a colorless solide. 
de  86% The trans isomer is the major one. 
eetrans  26% Column: Chiralpack-AD, L = 250 mm, ∅ = 4.6 mm 
Solvents: n-heptane (99.5%), i-PrOH (0.5%) 
Conditions: 0.75 mL.min–1, 21 bar 
Detector: UV (230 nm) 
Retention times: t1(major) = 21.8 min, t2(minor) = 39.5 min 
1H NMR (400 MHz, CDCl3) trans-131c: δ = 1.85–2.02 (m, >2 H, CH2), 2.19–2.32 (m, >1 H, 
CH2), 2.33–2.47 (m, >3 H, CH2), 3.51 (bd, 3J1-2 = 1.7 Hz, 1 H, H-2), 3.85 (bd, 3J2-1 = 1.9 Hz, 
1 H, H-1), 5.94 (bs, 1 H, H-4), 7.13–7.19 (bd, 2 H, CH), 7.45–7.50 (bd, 2 H, CH). 
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13C NMR (100 MHz, CDCl3) trans-131c: δ = 23.0 (u, CH2), 30.3 (u, CH2), 32.7 (u, CH2), 
57.8 (d, C-1), 61.2 (d, C-2), 121.7 (u, CH), 126.9 (d, CH), 131.4 (d, CH), 131.6 (d, C-4), 
136.5 (u, C), 140.0 (u, C). 
1H NMR (400 MHz, CDCl3) cis-131c: δ = 3.80 (m, 1 H, H-2), 4.12 (d, 3J2-1 = 4.4 Hz, 1 H, 
H-1), 5.94 (bs, 1 H, H-4). 
IR (KBr): ν = 3728 (w), 3637 (w), 3576 (w), 3227 (w), 2928 (s), 2852 (m), 1912 (w), 1724 
(w), 1659 (w), 1589 (w), 1486 (m), 1392 (w), 1262 (m), 1071 (s), 1018 (s), 953 (w), 872 (m), 
810 (s) cm–1. 
MS (EI): m/z (%) = 266 (18), 265 (8), 264 [M+] (18), 263 (8), 237 (29), 235 (29), 186 (13), 
185 (100), 184 (23), 183 (26), 171 (10), 168 (12), 167 (14), 157 (35), 156 (79), 155 (22), 129 
(13), 128 (19), 108 (12), 89 (14). 
8.3.4 2-(4-Bromophenyl)-3–cyclohexenyloxirane (131d) 
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According to GP2, from sulfoximine 31b (159 mg, 0.64 mmol), Me3OBF4 (123 mg, 0.83 
mmol), DBU (162 µL, 1.08 mmol) and p-bromobenzaldehyde (165 mg, 0.89 mmol), a 
mixture of oxiranes trans-131d and cis-131d (59 mg, 33%) was isolated as a colorless solide. 
de  86% The trans isomer is the major one. 
eetrans  14% Column: Chiralpack-AD, L = 250 mm, ∅ = 4.6 mm 
Solvents: n-heptane (98%), i-PrOH (2%) 
Conditions: 0.75 mL.min–1, 22 bar 
Detector: UV (230 nm) 
Retention times: t1(major) = 8.2 min, t2(minor) = 22.0 min 
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1H NMR (300 MHz, CDCl3) trans-131d: δ = 1.49–2.12 (m, >8 H, H-5, H-6, H-7, H-8), 3.24 
(bd, 3J = 1.7 Hz, 1 H, CH), 3.82 (bd, 3J = 2.0 Hz, 1 H, CH), 5.91 (m, 1 H, H-4), 7.12–7.19 (m, 
2 H, CH), 7.42–7.50 (m, 2 H, CH). 
13C NMR (75 MHz, CDCl3) trans-131d: δ =  22.2 (u, CH2), 22.4 (u, CH2), 22.8 (u, CH2), 
25.2 (u, CH2), 56.8 (d, CH), 65.9 (d, CH), 121.8 (u, C-12), 127.1 (d, CH), 128.4 (d, C-4), 
131.6 (d, CH), 133.2 (u, C), 137.0 (u, C). 
1H NMR (300 MHz, CDCl3) cis-131d: δ = 3.58–3.64 (m, 1 H, CH), 4.05 (d, 3J = 4.5 Hz, 
1 H, CH), 5.70 (m, 1 H, H-4). 
IR (KBr): ν = 3645 (w), 2926 (s), 2857 (s), 2371 (w), 2358 (w), 2343 (w), 1912 (w), 1662 
(w), 1586 (w), 1486 (m), 1440 (m), 1390 (w), 1342 (w), 1262 (w), 1107 (w), 1069 (m), 1008 
(m), 924 (w), 878 (m), 813 (s) cm–1. 
MS (EI): m/z (%) = 280 (36), 279 (18), 278 [M+] (36), 277 (14), 251 (16), 249 (15), 200 (11), 
199 (74), 198 (25), 185 (42), 183 (23), 182 (30), 171 (29), 170 (100), 169 (30), 157 (40), 155 
(14), 142 (19), 141 (17), 129 (14), 128 (11), 122 (15), 109 (27), 91 (10), 89 (16). 
8.3.5 2-Cyclopentenyl-3-(4–nitrophenyl)oxirane (131e) 
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According to GP2, from sulfoximine 31a (150 mg, 0.64 mmol), Me3OBF4 (123 mg, 0.83 
mmol), DBU (162 µL, 1.08 mmol) and p-nitrobenzaldehyde (135 mg, 0.89 mmol), a mixture 
of oxiranes trans-131e and cis-131e (50 mg, 34%) was isolated as a yellow oil. 
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de  88% The trans isomer is the major one. 
eetrans  22% Column: Chiralpack-AD, L = 250 mm, ∅ = 4.6 mm 
Solvents: n-heptane (98%), i-PrOH (2%) 
Conditions: 0.75 mL.min–1, 22 bar 
Detector: UV (230 nm) 
Retention times: t1(major) = 15.8 min, t2(minor) = 24.4 min 
1H NMR (400 MHz, CDCl3) trans-131e: δ =  1.87–2.03 (m, >2 H, CH2), 2.21–2.32 (m, 
>1 H, CH2), 2.34–2.48 (m, >3 H, CH2), 3.55 (bd, 3J = 1.7 Hz, 1H, CH), 4.00 (bd, 3J = 1.9 Hz, 
1 H, CH), 5.98 (m, 1 H, H-4), 7.43–7.48 (m, 2 H, CH), 8.18–8.24 (m, 2 H, CH). 
13C NMR (100 MHz, CDCl3) trans-131e: δ =  23.0 (u, CH2), 30.3 (u, CH2), 32.8 (u, CH2), 
57.3 (d, CH), 61.8 (d, CH), 123.6 (d, CH), 126.0 (d, CH), 132.5 (d, C-4), 139.5 (u, C), 145.0 
(u, C), 147.5 (u, C). 
1H NMR (400 MHz, CDCl3) cis-131e: δ =  3.87 (m, 1 H, CH), 4.25 (bd, 3J = 4.5 Hz, 1 H, 
CH), 5.69 (m, 1 H, H-4). 
IR (CHCl3): ν = 2948 (m), 2851 (m), 1603 (m), 1522 (s), 1439 (w), 1346 (s), 1217 (m), 1107 
(m), 1034 (w), 838 (s), 757 (s), 708 (m), 671 (w) cm–1. 
MS (EI): m/z (%) = 231 [M+] (25), 215 (15), 214 (100), 202 (31), 185 (21), 184 (74), 183 
(15), 157 (13), 156 (65), 155 (15), 150 (11), 141 (12), 129 (10), 128 (24), 108 (14). 
8.3.6 2-Cyclohexenyl-3-(4-nitrophenyl)oxirane (131f) 
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According to GP2, from sulfoximine 31b (159 mg, 0.64 mmol), Me3OBF4 (123 mg, 0.83 
mmol), DBU (162 µL, 1.08 mmol) and p-nitrobenzaldehyde (135 mg, 0.89 mmol), a mixture 
of oxiranes trans-131f and cis-131f (60 mg, 38%) was isolated as a yellow solid. 
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de  88% The trans isomer is the major one. 
eetrans  10% Column: Chiralpack-AD, L = 250 mm, ∅ = 4.6 mm 
Solvents: n-heptane (99%), i-PrOH (1%) 
Conditions: 0.75 mL.min–1, 22 bar 
Detector: UV (230 nm) 
Retention times: t1(major) = 24.1 min, t2(minor) = 52.8 min 
1H NMR (400 MHz, CDCl3) trans-131f: δ = 1.52–1.78 (m, >4 H, CH2), 1.82–1.93 (m, >1 H, 
CH2), 1.97–2.13 (m, >3 H, CH2), 3.28 (bd, 3J = 1.9 Hz, 1 H, CH), 3.97 (bd, 3J = 1.9 Hz, 1 H, 
CH), 5.96 (m, 1 H, H-4), 7.43–7.48 (m, 2 H, CH), 8.17–8.23 (m, 2 H, CH). 
13C NMR (100 MHz, CDCl3) trans-131f: δ =  22.1 (u, CH2), 22.3 (u, CH2), 22.6 (u, CH2),  
25.2 (u, CH2), 56.3 (d, CH), 66.4 (d, CH), 123.6 (d, CH), 126.0 (d, CH), 128.8 (d, C-4), 132.6 
(u, C), 145.3 (u, C), 147.4 (u, C).  
1H NMR (400 MHz, CDCl3) cis-131f: δ =  3.71 (m, 1 H, CH), 4.20 (bd, 3J = 4.4 Hz, 1 H, 
CH), 5.73 (m, 1 H, H-4). 
IR (KBr): ν = 3961 (w), 2993 (m), 2926 (s), 2863 (m), 1931 (w), 1728 (w), 1659 (w), 1600 
(s), 1516 (s), 1447 (m), 1345 (s), 1171 (w), 1104 (m), 1013 (w), 964 (w), 926 (m), 893 (m), 
851 (s), 790 (m), 741 (m), 695 (m) cm–1. 
MS (EI): m/z (%) = 245 [M+] (100), 244 (14), 229 (10), 228 (65), 216 (48), 202 (11), 201 
(38), 199 (27), 198 (63), 171 (14), 170 (98), 151 (20), 150 (42), 142 (24), 141 (23), 129 (12), 
128 (16), 122 (17), 109 (15), 91 (19), 81 (11). 
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9. X-ray crystal structure analyses 
9.1 Structure of sulfoximine 29a
Experimental Details 
Crystal data: 
Chemical formula   : C16H22N2O3S 
Formula weight   : 322.43 
Crystal system   : orthorhombic 
Space group (No.)  :  P212121 (19) 
Z     : 4 
a (Å)    : 10.080(2) 
b (Å)    : 11.737(2) 
c (Å)    : 13.645(3) 
α  (°)    : 90.0 
β  (°)    : 90.0 
γ (°)    : 90.0 
Experimental part 
156
cell volume   : 1614.3(6)Å3
Density calculation  : 1.327g/cm3
Radiation    : CuKα (1.54179Å) 
Range for lattice parameters : Ε<Θ <Ε
Absorption coefficient  : 1.903 mm-1
Temperature   : 150 K 
Crystal source   : recrystallized from  CH2Cl2 and Et2O 
Crystal colour   : colourless 
Crystal shape   : irregular 
Crystal size   : ca.0.3 x 0.3 x 0.3 mm 
Data Collection 
Diffractometer type  : Enraf Nonius CAD4 
collection method   : ω/2Θ scans 
Absorption correction  : none 
No. of reflections measured : 2608 
No. of independent reflections : 1855 
No. of observed reflections : 1794 
Θ max  (Ε)   : 72.79 
hmin 6 hmax   :   -12    6   12 
kmin 6 kmax   :   -  4   6    14 
lmin 6  lmax   :   -14   6    16 
Criterion for observed  : I > 2σ (I ) 
Rint     : 0.097(88) 
Standard reflections  : 2    2    3; -2     2     3;     -2    -2    3 
Variation    : 6126(191) 6383(194)     6410(198)  
Refinement:  
On     : F
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Treatment of hydrogens  : Calculated in idealized positions. Us  
      fixed at 1.5×U of the corresponding  
      heavy atom. No refinement of hydrogen  
      parameters    
R     : 0.075 
Rw     : 0.075 
Weighting scheme  : w=1/σ2(F) 
No. of parameters refined : 199 
No. of reflections in refmnt. : 1784 
Residual electron density  : -1.23/0.44e/Å3  
r*[1]    : not refined 
XABS[2]    : -0.006(97)a)
Goodness of fit   : 2.551 
Solution    : XTAL3.7[3] 
Remarks    : a)From separate calculation 
    
Definitions 
Ueq = 1/3ΣiΣjUijai*aj*ai aj
The anisotropic displacement factor in the structure factor expression is: 
t = exp[-2pi2(ΣiΣjUijhihjai*aj* )] 
Literature 97,98,99,100
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Atomic Positional and Isotropic Displacement Parameters                 
Atom    x/a         y/b         z/c        Ueq/Å2
S1    0.61298(9)  0.19263(6)  0.54748(6) * 0.0300(4) 
O1    0.5312(6)   0.1398(3)   0.1968(3)  * 0.088(3)
O2    0.3903(4)   0.0076(2)   0.2426(2)  * 0.053(2)
O3    0.7043(3)   0.2121(2)   0.4648(2)  * 0.038(1)
N1    0.5602(5)   0.0587(3)   0.3462(3)  * 0.050(2)
N2    0.6602(4)   0.1320(3)   0.6391(3)  * 0.043(2)
C1    0.4975(7)   0.0731(3)   0.2595(4)  * 0.053(3)
C2    0.3707(5)  -0.0897(3)   0.3082(3)  * 0.038(2)
C3    0.3700(4)  -0.0480(3)   0.4130(3)  * 0.034(2)
C4    0.3611(6)  -0.1471(4)   0.4881(4)  * 0.056(3)
C5    0.4894(6)  -0.1457(4)   0.5468(5)  * 0.064(4)
C6    0.5868(5)  -0.0806(3)   0.4819(4)  * 0.048(3)
C7    0.5024(4)   0.0130(3)   0.4358(3)  * 0.033(2)
C8    0.4716(4)   0.1118(3)   0.5076(3)  * 0.031(2)
C9    0.5416(4)   0.3286(3)   0.5733(3)  * 0.031(2)
C10   0.4856(5)   0.3457(3)   0.6648(3)  * 0.038(2)
C11   0.4252(5)   0.4509(3)   0.6854(4)  * 0.046(2)
C12   0.4242(6)   0.5341(3)   0.6127(4)  * 0.051(3)
C13   0.4801(6)   0.5164(3)   0.5230(4)  * 0.049(3)
C14   0.5408(5)   0.4124(3)   0.5006(3)  * 0.039(2)
C15   0.7751(5)   0.1811(4)   0.6895(4)  * 0.055(3)
C16   0.2438(5)  -0.1461(4)   0.2742(4)  * 0.055(3)
H     0.6334(-)   0.1145(-)   0.3471(-)    0.075(-)
H10   0.4881(-)   0.2878(-)   0.7125(-)    0.058(-)
H11   0.3849(-)   0.4649(-)   0.7473(-)    0.068(-)
H12   0.3841(-)   0.6061(-)   0.6272(-)    0.078(-)
H13   0.4755(-)   0.5747(-)   0.4750(-)    0.075(-)
H14   0.5807(-)   0.4005(-)   0.4383(-)    0.057(-)
H8a   0.4116(-)   0.1624(-)   0.4762(-)    0.048(-)
H8b   0.4301(-)   0.0800(-)   0.5641(-)    0.048(-)
H6a   0.6568(-)  -0.0490(-)   0.5198(-)    0.072(-)
H6b   0.6239(-)  -0.1286(-)   0.4324(-)    0.072(-)
H5a   0.4760(-)  -0.1082(-)   0.6067(-)    0.095(-)
H5b   0.5190(-)  -0.2215(-)   0.5575(-)    0.095(-)
H4a   0.2875(-)  -0.1369(-)   0.5301(-)    0.082(-)
H4b   0.3523(-)  -0.2179(-)   0.4541(-)    0.082(-)
H3    0.2980(-)   0.0042(-)   0.4217(-)    0.051(-)
H2    0.4395(-)  -0.1429(-)   0.2991(-)    0.057(-)
H16a  0.1967(-)  -0.0945(-)   0.2305(-)    0.082(-)
H16b  0.1875(-)  -0.1609(-)   0.3285(-)    0.082(-)
H16c  0.2621(-)  -0.2136(-)   0.2400(-)    0.082(-)
H15a  0.7559(-)   0.2547(-)   0.7117(-)    0.081(-)
H15b  0.8482(-)   0.1838(-)   0.6443(-)    0.081(-)
H15c  0.7994(-)   0.1332(-)   0.7429(-)    0.081(-)
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Atomic Displacement Parameters 
  Atom    U11          U22          U33          U12         U13         U23         
   
 S     0.0320(4)   0.0365(4)   0.0280(4)   0.0049(4)  -0.0003(4)  -0.0037(3)     
 O1    0.071(2)    0.093(3)    0.045(2)    0.011(2)    0.025(2)   -0.002(2)      
 O2    0.048(2)    0.054(2)    0.041(1)    0.006(1)    0.003(1)   -0.004(1)      
 O3    0.028(1)    0.055(2)    0.054(2)    0.013(1)   -0.002(1)   -0.005(1)      
 N1    0.048(2)    0.050(2)    0.023(1)    0.001(2)   -0.003(1)   -0.005(1)      
 N2    0.048(2)    0.042(2)    0.026(1)    0.005(1)    0.002(1)   -0.004(1)      
 C1    0.059(3)    0.055(2)    0.031(2)   -0.001(2)    0.005(2)   -0.010(2)      
 C2    0.053(2)    0.038(2)    0.039(2)   -0.007(2)    0.002(2)   -0.009(2)      
 C3    0.049(2)    0.035(2)    0.029(2)   -0.001(2)    0.003(2)   -0.002(1)      
 C5    0.067(3)    0.051(3)    0.061(3)   -0.011(2)    0.022(2)    0.001(2)      
 C6    0.037(2)    0.078(3)    0.062(3)   -0.017(2)    0.008(2)   -0.007(2)      
 C7    0.033(2)    0.073(3)    0.046(2)   -0.006(2)   -0.010(2)   -0.010(2)      
 C8    0.035(2)    0.044(2)    0.026(2)   -0.005(2)   -0.001(2)   -0.004(1)      
 C9    0.036(2)    0.040(2)    0.022(1)   -0.001(2)    0.001(1)    0.000(1)      
 C10   0.073(3)    0.041(2)    0.032(2)    0.005(2)   -0.000(2)    0.007(2)      
 C11   0.090(3)    0.058(2)    0.029(2)   -0.001(3)    0.004(2)    0.010(2)      
 C12   0.074(3)    0.064(3)    0.024(2)    0.006(3)   -0.005(2)    0.003(2)      
 C13   0.041(2)    0.038(2)    0.032(2)   -0.001(2)    0.001(2)   -0.004(2)      
 C14   0.057(3)    0.040(2)    0.068(3)    0.003(2)    0.009(2)   -0.009(2)      
 C15   0.078(4)    0.047(3)    0.102(4)   -0.011(3)    0.026(3)   -0.019(3)      
 C16   0.084(4)    0.084(4)    0.064(3)   -0.039(3)    0.029(3)   -0.030(3)      
 C17   0.050(3)    0.095(4)    0.046(2)   -0.023(3)    0.001(2)   -0.012(3)      
 C18   0.043(2)    0.059(3)    0.045(2)   -0.002(2)   -0.001(2)   -0.002(2)      
 C19   0.067(3)    0.062(2)    0.030(2)    0.004(3)    0.011(2)   -0.004(2)      
 C20   0.078(3)    0.041(2)    0.054(2)    0.006(2)   -0.002(3)   -0.004(2)      
 H6a   0.090(-)                                                                  
 H19a  0.075(-)                                                                  
 H5a   0.090(-)                                                                  
 H10b  0.075(-)                                                                  
 H12a  0.081(-)                                                                  
 H7a   0.076(-)                                                                  
 H7b   0.076(-)                                                                  
 H90   0.050(-)                                                                  
 H11a  0.090(-)                                                                  
 H3    0.057(-)                                                                  
 H19b  0.075(-)                                                                  
 H18   0.075(-)                                                                  
 H10a  0.075(-)                                                                  
 H16   0.116(-)                                                                  
 H6b   0.090(-)                                                                  
 H20a  0.087(-)                                                                  
 H19c  0.075(-)                                                                  
 H14   0.083(-)                                                                  
 H20b  0.087(-)                                                                  
 H5b   0.090(-)                                                                  
 H2    0.065(-)                                                                  
 H15   0.114(-)                                                                  
 H12b  0.081(-)                                                                  
 H11b  0.090(-)                                                                  
 H20c  0.087(-)                                                                  
 H17   0.095(-)                                                                  
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Bond distances, bond angles and dihedral angles 
Bond Distances     (Angstroms) 
S1-O3            1.474(3) 
S1-N2            1.516(4) 
S1-C9            1.786(3) 
S1-C8            1.796(4) 
O2-C1            1.346(7) 
O2-C2            1.465(5) 
O1-C1            1.208(6) 
N1-H              .987(4) 
N1-C1            1.351(7) 
N1-C7            1.457(6) 
N2-C15           1.465(7) 
C7-C6            1.525(6) 
C7-C3            1.546(6) 
C7-C8            1.550(5) 
C14-H14           .951(4) 
C14-C9           1.397(5) 
C14-C13          1.399(6) 
C10-H10           .941(4) 
C10-C9           1.385(6) 
C10-C11          1.405(6) 
C8-H8a            .950(4) 
C8-H8b            .953(4) 
C2-H2             .942(4) 
C2-C3            1.510(6) 
C2-C16           1.514(7) 
C3-H3             .957(4) 
C3-C4            1.552(6) 
C12-H12           .957(4) 
C12-C13          1.364(8) 
C12-C11          1.392(7) 
C6-H6a            .950(5) 
C6-H6b            .957(5) 
C6-C5            1.526(8) 
C15-H15a          .935(5) 
C15-H15c          .953(5) 
C15-H15b          .962(5) 
C4-H4a            .945(6) 
C4-H4b            .956(5) 
C4-C5            1.521(9) 
C13-H13           .948(5) 
C5-H5a            .939(6) 
C5-H5b            .950(4) 
C11-H11           .953(5) 
C16-H16c          .937(5) 
C16-H16b          .950(6) 
C16-H16a          .974(5) 
Bond Angles            (degrees) 
O3-S1-N2               120.6(2) 
O3-S1-C9               105.3(2) 
O3-S1-C8               110.2(2) 
N2-S1-C9               112.6(2) 
N2-S1-C8               104.5(2) 
C9-S1-C8               102.3(2) 
C1-O2-C2               116.6(4) 
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H-N1-C1                106.1(4) 
H-N1-C7                122.2(4) 
C1-N1-C7               126.4(5) 
C15-N2-S1              116.7(3) 
N1-C7-C6               112.9(4) 
N1-C7-C3               110.3(3) 
N1-C7-C8               109.6(3) 
C6-C7-C3               103.4(3) 
C6-C7-C8               112.9(3) 
C3-C7-C8               107.5(3) 
H14-C14-C9             121.9(4) 
H14-C14-C13            120.6(4) 
C9-C14-C13             117.5(4) 
H10-C10-C9             120.6(4) 
H10-C10-C11            120.5(4) 
C9-C10-C11             118.9(4) 
H8a-C8-H8b             109.2(4) 
H8a-C8-C7              108.0(4) 
H8a-C8-S1              108.2(2) 
H8b-C8-C7              107.8(3) 
H8b-C8-S1              108.1(3) 
C7-C8-S1               115.3(3) 
H2-C2-O2               109.7(4) 
H2-C2-C3               110.1(4) 
H2-C2-C16              106.9(3) 
O2-C2-C3               109.1(3) 
O2-C2-C16              105.5(4) 
C3-C2-C16              115.4(4) 
H3-C3-C2               109.2(4) 
H3-C3-C7               109.5(3) 
H3-C3-C4               110.7(4) 
C2-C3-C7               109.6(3) 
C2-C3-C4               112.5(3) 
C7-C3-C4               105.3(4) 
H12-C12-C13            119.7(5) 
H12-C12-C11            118.3(5) 
C13-C12-C11            122.0(4) 
C10-C9-C14             122.5(3) 
C10-C9-S1              118.1(3) 
C14-C9-S1              119.4(3) 
H6a-C6-H6b             108.9(5) 
H6a-C6-C7              110.9(3) 
H6a-C6-C5              111.0(5) 
H6b-C6-C7              110.5(5) 
H6b-C6-C5              111.5(4) 
C7-C6-C5               103.9(4) 
H15a-C15-H15c          110.5(5) 
H15a-C15-H15b          109.7(5) 
H15a-C15-N2            110.6(5) 
H15c-C15-H15b          108.2(5) 
H15c-C15-N2            109.3(4) 
H15b-C15-N2            108.6(5) 
H4a-C4-H4b             109.3(5) 
H4a-C4-C5              110.3(5) 
H4a-C4-C3              110.5(4) 
H4b-C4-C5              110.1(5) 
H4b-C4-C3              109.7(4) 
C5-C4-C3               106.9(4) 
O1-C1-O2               118.3(5) 
O1-C1-N1               124.7(6) 
O2-C1-N1               117.0(4) 
H13-C13-C12            119.3(4) 
H13-C13-C14            120.0(5) 
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C12-C13-C14            120.7(4) 
H5a-C5-H5b             110.4(6) 
H5a-C5-C4              110.0(6) 
H5a-C5-C6              111.3(4) 
H5b-C5-C4              109.7(5) 
H5b-C5-C6              110.9(5) 
C4-C5-C6               104.3(4) 
H11-C11-C12            120.5(4) 
H11-C11-C10            120.9(4) 
C12-C11-C10            118.5(4) 
H16c-C16-H16b          110.6(5) 
H16c-C16-H16a          108.5(6) 
H16c-C16-C2            110.9(5) 
H16b-C16-H16a          107.5(5) 
H16b-C16-C2            110.2(5) 
H16a-C16-C2            109.1(4) 
Dihedral Angles                (degrees) 
O3-S1-N2-C15                    56.5(4) 
C8-S1-N2-C15                  -178.9(3) 
C9-S1-N2-C15                   -68.8(4) 
O3-S1-C8-C7                     40.9(3) 
O3-S1-C8-H8a                   -80.2(3) 
O3-S1-C8-H8b                   161.6(2) 
N2-S1-C8-C7                    -90.0(3) 
N2-S1-C8-H8a                   148.9(3) 
N2-S1-C8-H8b                    30.7(3) 
C9-S1-C8-C7                    152.5(3) 
C9-S1-C8-H8a                    31.4(4) 
C9-S1-C8-H8b                   -86.8(3) 
O3-S1-C9-C14                    22.0(4) 
O3-S1-C9-C10                  -159.7(3) 
N2-S1-C9-C14                   155.2(3) 
N2-S1-C9-C10                   -26.5(4) 
C8-S1-C9-C14                   -93.2(4) 
C8-S1-C9-C10                    85.1(4) 
C1-O2-C2-C3                     54.6(5) 
C1-O2-C2-C16                   179.1(4) 
C1-O2-C2-H2                    -66.1(5) 
C2-O2-C1-O1                    166.0(4) 
C2-O2-C1-N1                    -13.9(6) 
C1-N1-C7-C8                   -102.7(5) 
C1-N1-C7-C3                     15.4(5) 
C1-N1-C7-C6                    130.5(4) 
H-N1-C7-C8                      48.0(6) 
H-N1-C7-C3                     166.2(4) 
H-N1-C7-C6                     -78.8(5) 
C7-N1-C1-O2                    -23.6(7) 
C7-N1-C1-O1                    156.6(5) 
H-N1-C1-O2                    -178.1(4) 
H-N1-C1-O1                       2.0(7) 
S1-N2-C15-H15a                  62.3(6) 
S1-N2-C15-H15b                 -58.1(5) 
S1-N2-C15-H15c                -175.9(4) 
N1-C7-C8-S1                    -61.9(4) 
N1-C7-C8-H8a                    59.3(4) 
N1-C7-C8-H8b                   177.2(4) 
C3-C7-C8-S1                    178.2(3) 
C3-C7-C8-H8a                   -60.6(4) 
C3-C7-C8-H8b                    57.3(4) 
C6-C7-C8-S1                     64.8(4) 
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C6-C7-C8-H8a                  -174.0(3) 
C6-C7-C8-H8b                   -56.1(5) 
N1-C7-C3-C2                     26.1(4) 
N1-C7-C3-C4                    147.3(3) 
N1-C7-C3-H3                    -93.7(4) 
C8-C7-C3-C2                    145.5(3) 
C8-C7-C3-C4                    -93.3(4) 
C8-C7-C3-H3                     25.7(5) 
C6-C7-C3-C2                    -94.8(4) 
C6-C7-C3-C4                     26.4(4) 
C6-C7-C3-H3                    145.4(4) 
N1-C7-C6-C5                   -158.9(4) 
N1-C7-C6-H6a                    81.8(5) 
N1-C7-C6-H6b                   -39.2(5) 
C8-C7-C6-C5                     76.1(4) 
C8-C7-C6-H6a                   -43.2(6) 
C8-C7-C6-H6b                  -164.2(4) 
C3-C7-C6-C5                    -39.8(4) 
C3-C7-C6-H6a                  -159.1(4) 
C3-C7-C6-H6b                    79.9(5) 
C13-C14-C9-S1                  178.0(4) 
C13-C14-C9-C10                   -.2(7) 
H14-C14-C9-S1                   -2.8(6) 
H14-C14-C9-C10                 179.0(4) 
C9-C14-C13-C12                   -.1(7) 
C9-C14-C13-H13                -178.4(5) 
H14-C14-C13-C12               -179.3(5) 
H14-C14-C13-H13                  2.4(8) 
C11-C10-C9-S1                 -178.0(4) 
C11-C10-C9-C14                    .3(7) 
H10-C10-C9-S1                    2.1(6) 
H10-C10-C9-C14                -179.6(4) 
C9-C10-C11-C12                   -.0(7) 
C9-C10-C11-H11                 179.2(5) 
H10-C10-C11-C12                179.8(5) 
H10-C10-C11-H11                  -.9(8) 
O2-C2-C3-C7                    -58.6(4) 
O2-C2-C3-C4                   -175.4(4) 
O2-C2-C3-H3                     61.3(5) 
C16-C2-C3-C7                  -177.1(3) 
C16-C2-C3-C4                    66.2(5) 
C16-C2-C3-H3                   -57.2(4) 
H2-C2-C3-C7                     61.8(4) 
H2-C2-C3-C4                    -54.9(5) 
H2-C2-C3-H3                   -178.2(3) 
O2-C2-C16-H16a                 -14.5(6) 
O2-C2-C16-H16b                -132.3(4) 
O2-C2-C16-H16c                 105.0(5) 
C3-C2-C16-H16a                 106.0(5) 
C3-C2-C16-H16b                 -11.8(6) 
C3-C2-C16-H16c                -134.6(4) 
H2-C2-C16-H16a                -131.2(5) 
H2-C2-C16-H16b                 111.0(5) 
H2-C2-C16-H16c                 -11.7(6) 
C7-C3-C4-C5                     -3.4(5) 
C7-C3-C4-H4a                   116.6(5) 
C7-C3-C4-H4b                  -122.8(5) 
C2-C3-C4-C5                    115.9(4) 
C2-C3-C4-H4a                  -124.0(5) 
C2-C3-C4-H4b                    -3.4(6) 
H3-C3-C4-C5                   -121.6(4) 
H3-C3-C4-H4a                    -1.6(6) 
H3-C3-C4-H4b                   119.1(5) 
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C11-C12-C13-C14                   .3(8) 
C11-C12-C13-H13                178.6(5) 
H12-C12-C13-C14                179.1(5) 
H12-C12-C13-H13                 -2.6(9) 
C13-C12-C11-C10                  -.3(8) 
C13-C12-C11-H11               -179.5(5) 
H12-C12-C11-C10               -179.1(5) 
H12-C12-C11-H11                  1.7(9) 
C7-C6-C5-C4                     37.8(4) 
C7-C6-C5-H5a                   -80.8(6) 
C7-C6-C5-H5b                   155.8(5) 
H6a-C6-C5-C4                   157.1(4) 
H6a-C6-C5-H5a                   38.6(7) 
H6a-C6-C5-H5b                  -84.9(6) 
H6b-C6-C5-C4                   -81.2(5) 
H6b-C6-C5-H5a                  160.2(5) 
H6b-C6-C5-H5b                   36.8(7) 
C3-C4-C5-C6                    -20.9(5) 
C3-C4-C5-H5a                    98.6(5) 
C3-C4-C5-H5b                  -139.8(5) 
H4a-C4-C5-C6                  -141.1(4) 
H4a-C4-C5-H5a                  -21.6(6) 
H4a-C4-C5-H5b                  100.0(6) 
H4b-C4-C5-C6                    98.1(5) 
H4b-C4-C5-H5a                 -142.4(5) 
H4b-C4-C5-H5b                  -20.7(7) 
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9.2 Structure of sulfoximine 71 
Experimental Details 
Structure: 
Chemical formula   : C19H26N2O3S 
formula weight   : 362.49 
Crystal system   : orthorhombic 
Space group (No.)  :  P 212121 (19) 
Z     : 4 
a (Å)    : 6.800(1) 
b (Å)    : 13.202(8) 
c (Å)    : 20.524(8) 
α  (°)    : 90.0 
β  (°)    : 90.0 
γ (°)    : 90.0 
cell volume   : 1842.5(14)Å3
Density calc.   : 1.307g/cm3
Radiation    : CuKα (1.54179Å) 
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Range for lattice parameters : 14.89Ε<Θ <21.18Ε
Absorption coefficient  : 1.727mm-1
Temperature   : 298K 
Crystal source   : recrystallized from  CH2Cl2 and Et2O 
Crystal colour   : colourless 
Crystal shape   : irregular 
Crystal size   : ca. 0.3x0.3.x0.3mm 
Data Collection 
Diffractometer type  : Enraf-Nonius CAD4 
collection method   : ω/2ϑ scans 
Absorption correction  : none 
No. of reflections measured : 3923 
No. of independent reflections : 3339 
No. of observed reflections : 3168 
Θ max  (Ε)    : 67.78 
hmin 6 hmax    :   -  8     6   8 
kmin 6 kmax    :   - 15    6  15 
lmin 6  lmax    :   - 24    6  24 
Criterion for observed  : I > 2σ (I ) 
Rint     : 0.020(31) 
Standard reflections  : 2    2    2, -2   -2    2, 1    -3    4 
Variation    : 1930(48) 2103(69) 11100(238) 
Refinement:  
On     : F
Treatment of hydrogens  : Calculated in idealized positions. Us  
      fixed at 1.5xU of the relevant heavy 
      atom prior to final refinement. No 
      refinement of hydrogen parameters. 
Experimental part 
167
R     : 0.053 
Rw     : 0.076 
Weighting scheme  : w=1/σ2(F) 
No. of parameters refined : 226 
No. of reflections in refmnt. : 3157 
Residual electron density  : -0.63/0.32/Å3  
r*[1]    : not refined 
XABS[2]a)    : -0.007(043) 
Goodness of fit   : 3.357 
Solution    : XTAL3.7[3] 
Remarks    : 
Definitions 
Ueq = 1/3ΣiΣjUijai*aj*ai aj
The anisotropic displacement factor in the structure factor expression is: 
t = exp[-2pi2(ΣiΣjUijhihjai*aj* )] 
Literature 97,98,99,100
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Atomic Positional and Isotropic Displacement Parameters                 
Atom     x/a         y/b         z/c        Ueq/Å2
S     0.3807(1)   0.36648(6)  0.34072(4) * 0.0322(4) 
O1    0.0183(5)   0.5709(3)   0.5612(1)  * 0.070(2)
O2    0.0721(4)   0.6559(2)   0.4703(1)  * 0.048(2)
O3    0.5786(4)   0.3249(2)   0.3499(1)  * 0.046(2)
N1    0.3040(5)   0.5409(2)   0.5052(1)  * 0.040(2)
N2    0.3389(5)   0.4459(2)   0.2895(1)  * 0.039(2)
C1    0.1262(7)   0.5865(3)   0.5150(2)  * 0.048(2)
C2    0.2333(6)   0.6971(3)   0.4306(2)  * 0.043(2)
C3    0.3276(6)   0.6117(3)   0.3926(2)  * 0.038(2)
C5    0.5192(8)   0.6475(3)   0.3596(2)  * 0.060(3)
C7    0.6140(6)   0.5239(4)   0.4405(2)  * 0.051(2)
C8    0.3841(6)   0.5227(3)   0.4391(2)  * 0.035(2)
C9    0.2952(5)   0.4180(3)   0.4177(2)  * 0.033(2)
C10   0.3306(7)   0.3332(3)   0.4679(2)  * 0.049(2)
C11   0.2637(8)   0.3640(4)   0.5367(2)  * 0.059(3)
C12   0.3564(8)   0.4643(3)   0.5544(2)  * 0.054(3)
C13   0.2283(6)   0.2578(3)   0.3268(2)  * 0.037(2)
C14   0.3087(7)   0.1623(3)   0.3284(2)  * 0.055(3)
C15   0.197(1)    0.0814(4)   0.3070(3)  * 0.076(4)
C16   0.007(1)    0.0965(5)   0.2847(3)  * 0.077(4)
C17  -0.0744(7)   0.1919(5)   0.2855(2)  * 0.063(3)
C18   0.0360(7)   0.2741(4)   0.3062(2)  * 0.049(2)
C19   0.3786(8)   0.4149(3)   0.2220(2)  * 0.053(2)
C20   0.1423(8)   0.7779(3)   0.3880(2)  * 0.057(3)
C6    0.6772(7)   0.5678(4)   0.3761(2)  * 0.059(3)
H6a   0.7040(-)   0.5101(-)   0.3335(-)    0.090(-)
H19a  0.3701(-)   0.4827(-)   0.1980(-)    0.075(-)
H5a   0.4913(-)   0.6544(-)   0.2975(-)    0.090(-)
H10b  0.2399(-)   0.2594(-)   0.4496(-)    0.075(-)
H12a  0.3241(-)   0.4845(-)   0.5989(-)    0.081(-)
H7a   0.6583(-)   0.5472(-)   0.4682(-)    0.076(-)
H7b   0.6956(-)   0.4429(-)   0.4478(-)    0.076(-)
H90   0.1619(-)   0.4211(-)   0.4089(-)    0.050(-)
H11a  0.2806(-)   0.3081(-)   0.5703(-)    0.090(-)
H3    0.2311(-)   0.5856(-)   0.3588(-)    0.057(-)
H19b  0.3132(-)   0.3768(-)   0.2025(-)    0.075(-)
H18  -0.0282(-)   0.3485(-)   0.2970(-)    0.075(-)
H10a  0.4792(-)   0.3063(-)   0.4688(-)    0.075(-)
H16  -0.0927(-)   0.0365(-)   0.2668(-)    0.116(-)
H6b   0.8008(-)   0.5948(-)   0.3725(-)    0.090(-)
H20a  0.0627(-)   0.7587(-)   0.3549(-)    0.087(-)
H19c  0.4993(-)   0.3830(-)   0.2171(-)    0.075(-)
H14   0.4696(-)   0.1634(-)   0.3629(-)    0.083(-)
H20b  0.2361(-)   0.8228(-)   0.3419(-)    0.087(-)
H5b   0.5425(-)   0.7058(-)   0.3679(-)    0.090(-)
H2    0.2966(-)   0.7255(-)   0.4606(-)    0.065(-)
H15   0.2676(-)   0.0109(-)   0.3136(-)    0.114(-)
H12b  0.4929(-)   0.4632(-)   0.5601(-)    0.081(-)
H11b  0.1201(-)   0.3681(-)   0.5314(-)    0.090(-)
H20c  0.0434(-)   0.8235(-)   0.4031(-)    0.087(-)
H17  -0.2080(-)   0.2028(-)   0.2711(-)    0.095(-)
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Atomic Displacement Parameters  
  Atom    U11          U22          U33          U12         U13         U23         
   
 S     0.0320(4)   0.0365(4)   0.0280(4)   0.0049(4)  -0.0003(4)  -0.0037(3)     
 O1    0.071(2)    0.093(3)    0.045(2)    0.011(2)    0.025(2)   -0.002(2)      
 O2    0.048(2)    0.054(2)    0.041(1)    0.006(1)    0.003(1)   -0.004(1)      
 O3    0.028(1)    0.055(2)    0.054(2)    0.013(1)   -0.002(1)   -0.005(1)      
 N1    0.048(2)    0.050(2)    0.023(1)    0.001(2)   -0.003(1)   -0.005(1)      
 N2    0.048(2)    0.042(2)    0.026(1)    0.005(1)    0.002(1)   -0.004(1)      
 C1    0.059(3)    0.055(2)    0.031(2)   -0.001(2)    0.005(2)   -0.010(2)      
 C2    0.053(2)    0.038(2)    0.039(2)   -0.007(2)    0.002(2)   -0.009(2)      
 C3    0.049(2)    0.035(2)    0.029(2)   -0.001(2)    0.003(2)   -0.002(1)      
 C5    0.067(3)    0.051(3)    0.061(3)   -0.011(2)    0.022(2)    0.001(2)      
 C6    0.037(2)    0.078(3)    0.062(3)   -0.017(2)    0.008(2)   -0.007(2)      
 C7    0.033(2)    0.073(3)    0.046(2)   -0.006(2)   -0.010(2)   -0.010(2)      
 C8    0.035(2)    0.044(2)    0.026(2)   -0.005(2)   -0.001(2)   -0.004(1)      
 C9    0.036(2)    0.040(2)    0.022(1)   -0.001(2)    0.001(1)    0.000(1)      
 C10   0.073(3)    0.041(2)    0.032(2)    0.005(2)   -0.000(2)    0.007(2)      
 C11   0.090(3)    0.058(2)    0.029(2)   -0.001(3)    0.004(2)    0.010(2)      
 C12   0.074(3)    0.064(3)    0.024(2)    0.006(3)   -0.005(2)    0.003(2)      
 C13   0.041(2)    0.038(2)    0.032(2)   -0.001(2)    0.001(2)   -0.004(2)      
 C14   0.057(3)    0.040(2)    0.068(3)    0.003(2)    0.009(2)   -0.009(2)      
 C15   0.078(4)    0.047(3)    0.102(4)   -0.011(3)    0.026(3)   -0.019(3)      
 C16   0.084(4)    0.084(4)    0.064(3)   -0.039(3)    0.029(3)   -0.030(3)      
 C17   0.050(3)    0.095(4)    0.046(2)   -0.023(3)    0.001(2)   -0.012(3)      
 C18   0.043(2)    0.059(3)    0.045(2)   -0.002(2)   -0.001(2)   -0.002(2)      
 C19   0.067(3)    0.062(2)    0.030(2)    0.004(3)    0.011(2)   -0.004(2)      
 C20   0.078(3)    0.041(2)    0.054(2)    0.006(2)   -0.002(3)   -0.004(2)      
 H6a   0.090(-)                                                                  
 H19a  0.075(-)                                                                  
 H5a   0.090(-)                                                                  
 H10b  0.075(-)                                                                  
 H12a  0.081(-)                                                                  
 H7a   0.076(-)                                                                  
 H7b   0.076(-)                                                                  
 H90   0.050(-)                                                                  
 H11a  0.090(-)                                                                  
 H3    0.057(-)                                                                  
 H19b  0.075(-)                                                                  
 H18   0.075(-)                                                                  
 H10a  0.075(-)                                                                  
 H16   0.116(-)                                                                  
 H6b   0.090(-)                                                                  
 H20a  0.087(-)                                                                  
 H19c  0.075(-)                                                                  
 H14   0.083(-)                                                                  
 H20b  0.087(-)                                                                  
 H5b   0.090(-)                                                                  
 H2    0.065(-)                                                                  
 H15   0.114(-)                                                                  
 H12b  0.081(-)                                                                  
 H11b  0.090(-)                                                                  
 H20c  0.087(-)                                                                  
 H17   0.095(-)                                                                  
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Bond distances, bond angles and dihedral angles 
Bond Distances      (Angstroms) 
S-O3             1.465(3) 
S-N2             1.511(3) 
S-C13            1.793(4) 
S-C9             1.816(3) 
O2-C1            1.347(5) 
O2-C2            1.470(5) 
N1-C1            1.365(6) 
N1-C12           1.472(5) 
N1-C8            1.482(4) 
N2-C19           1.471(5) 
C8-C3            1.562(5) 
C8-C7            1.563(6) 
C8-C9            1.571(5) 
C3-H3            1.014(4) 
C3-C2            1.514(5) 
C3-C5            1.543(6) 
C1-O1            1.217(5) 
C18-H18          1.092(5) 
C18-C17          1.386(7) 
C18-C13          1.391(6) 
C9-H90            .925(4) 
C9-C10           1.540(5) 
C13-C14          1.375(6) 
C7-H7a            .713(4) 
C7-H7b           1.215(5) 
C7-C6            1.506(6) 
C5-H5b            .805(5) 
C5-H5a           1.292(5) 
C5-C6            1.541(7) 
C10-H10a         1.071(5) 
C10-H10b         1.213(4) 
C10-C11          1.539(6) 
C12-H12b          .936(5) 
C12-H12a          .975(4) 
C12-C11          1.511(7) 
C17-H17           .966(5) 
C17-C16          1.376(9) 
C11-H11b          .984(5) 
C11-H11a         1.017(4) 
C19-H19b          .781(5) 
C19-H19c          .928(5) 
C19-H19a         1.024(4) 
C2-H2             .839(4) 
C2-C20           1.513(6) 
C14-H14          1.304(5) 
C14-C15          1.384(7) 
C20-H20a          .906(5) 
C20-H20c          .954(5) 
C20-H20b         1.286(5) 
C16-H16          1.105(6) 
C16-C15          1.383(9) 
C15-H15          1.057(5) 
C6-H6b            .916(5) 
C6-H6a           1.174(5) 
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Bond Angles             (degrees) 
O3-S-N2                121.4(2) 
O3-S-C13               104.6(2) 
O3-S-C9                108.8(2) 
N2-S-C13               109.6(2) 
N2-S-C9                106.6(2) 
C13-S-C9               104.7(2) 
C1-O2-C2               115.1(3) 
C1-N1-C12              114.6(3) 
C1-N1-C8               122.1(3) 
C12-N1-C8              115.4(3) 
C19-N2-S               115.3(3) 
N1-C8-C3               110.3(3) 
N1-C8-C7               110.4(3) 
N1-C8-C9               104.9(3) 
C3-C8-C7               104.4(3) 
C3-C8-C9               113.4(3) 
C7-C8-C9               113.5(3) 
H3-C3-C2               109.4(3) 
H3-C3-C5               110.6(3) 
H3-C3-C8               108.7(3) 
C2-C3-C5               110.9(3) 
C2-C3-C8               110.4(3) 
C5-C3-C8               106.9(3) 
O1-C1-O2               118.7(4) 
O1-C1-N1               125.0(4) 
O2-C1-N1               116.2(3) 
H18-C18-C17            115.8(4) 
H18-C18-C13            124.5(4) 
C17-C18-C13            118.8(4) 
H90-C9-C10             108.5(3) 
H90-C9-C8              113.1(3) 
H90-C9-S                99.2(2) 
C10-C9-C8              113.1(3) 
C10-C9-S               105.0(2) 
C8-C9-S                116.7(2) 
C14-C13-C18            121.5(4) 
C14-C13-S              120.0(3) 
C18-C13-S              118.0(3) 
H7a-C7-H7b              95.0(4) 
H7a-C7-C6              114.4(5) 
H7a-C7-C8              116.2(5) 
H7b-C7-C6              108.5(4) 
H7b-C7-C8              116.7(4) 
C6-C7-C8               105.9(3) 
H5b-C5-H5a              99.8(4) 
H5b-C5-C6              118.0(5) 
H5b-C5-C3              111.4(5) 
H5a-C5-C6              111.6(4) 
H5a-C5-C3              109.3(4) 
C6-C5-C3               106.5(4) 
H10a-C10-H10b          102.7(3) 
H10a-C10-C11           110.5(4) 
H10a-C10-C9            113.5(4) 
H10b-C10-C11           110.3(4) 
H10b-C10-C9            107.3(3) 
C11-C10-C9             112.0(3) 
H12b-C12-H12a           96.4(4) 
H12b-C12-N1            109.7(4) 
H12b-C12-C11           115.4(4) 
H12a-C12-N1            113.6(4) 
H12a-C12-C11           111.7(4) 
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N1-C12-C11             109.6(3) 
H17-C17-C16            120.8(6) 
H17-C17-C18            119.1(5) 
C16-C17-C18            120.2(5) 
H11b-C11-H11a          103.1(4) 
H11b-C11-C12           113.1(4) 
H11b-C11-C10           101.9(4) 
H11a-C11-C12           115.2(4) 
H11a-C11-C10           113.5(4) 
C12-C11-C10            109.3(4) 
H19b-C19-H19c           98.9(5) 
H19b-C19-H19a          106.6(4) 
H19b-C19-N2            123.8(5) 
H19c-C19-H19a          113.3(5) 
H19c-C19-N2            113.0(4) 
H19a-C19-N2            101.5(3) 
H2-C2-O2                98.2(3) 
H2-C2-C20              108.5(4) 
H2-C2-C3               119.6(4) 
O2-C2-C20              106.0(4) 
O2-C2-C3               109.0(3) 
C20-C2-C3              113.6(3) 
H14-C14-C13            109.7(3) 
H14-C14-C15            130.0(4) 
C13-C14-C15            118.8(5) 
H20a-C20-H20c           89.9(5) 
H20a-C20-H20b           82.7(3) 
H20a-C20-C2            118.8(4) 
H20c-C20-H20b          107.3(3) 
H20c-C20-C2            123.1(4) 
H20b-C20-C2            123.2(4) 
H16-C16-C17            114.4(6) 
H16-C16-C15            125.3(6) 
C17-C16-C15            120.2(5) 
H15-C15-C16            126.5(5) 
H15-C15-C14            112.8(6) 
C16-C15-C14            120.5(5) 
H6b-C6-H6a              92.9(4) 
H6b-C6-C7              118.9(4) 
H6b-C6-C5              110.8(5) 
H6a-C6-C7              116.7(4) 
H6a-C6-C5              112.8(4) 
C7-C6-C5               104.9(4) 
Dihedral Angles                 (degrees) 
C2-O2-C1-N1                    -19.3(5) 
O3-S-N2-C19                     60.9(4) 
C9-S-N2-C19                   -173.9(3) 
C13-S-N2-C19                   -61.2(4) 
O3-S-C9-C8                      76.0(3) 
O3-S-C9-C10                    -50.2(3) 
O3-S-C9-H90                   -162.3(2) 
N2-S-C9-C8                     -56.6(3) 
N2-S-C9-C10                    177.3(3) 
N2-S-C9-H90                     65.2(3) 
C13-S-C9-C8                   -172.7(3) 
C13-S-C9-C10                    61.2(3) 
C13-S-C9-H90                   -50.9(3) 
O3-S-C13-C18                  -170.0(3) 
O3-S-C13-C14                     1.7(4) 
N2-S-C13-C18                   -38.4(3) 
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N2-S-C13-C14                   133.3(3) 
C9-S-C13-C18                    75.6(3) 
C9-S-C13-C14                  -112.7(3) 
C2-O2-C1-N1                    -19.3(5) 
C2-O2-C1-O1                    158.8(4) 
C1-O2-C2-C3                     61.4(4) 
C1-O2-C2-C20                  -175.9(3) 
C1-O2-C2-H2                    -63.9(4) 
C1-N1-C8-C3                     35.8(5) 
C1-N1-C8-C9                    -86.6(4) 
C1-N1-C8-C7                    150.7(4) 
C12-N1-C8-C3                  -177.0(3) 
C12-N1-C8-C9                    60.6(4) 
C12-N1-C8-C7                   -62.1(4) 
C8-N1-C1-O2                    -31.6(5) 
C8-N1-C1-O1                    150.4(4) 
C12-N1-C1-O2                  -179.1(3) 
C12-N1-C1-O1                     3.0(6) 
C8-N1-C12-C11                  -65.5(5) 
C8-N1-C12-H12a                 168.7(4) 
C8-N1-C12-H12b                  62.1(5) 
C1-N1-C12-C11                   84.2(4) 
C1-N1-C12-H12a                 -41.5(6) 
C1-N1-C12-H12b                -148.2(4) 
S-N2-C19-H19a                 -168.1(3) 
S-N2-C19-H19b                   72.8(6) 
S-N2-C19-H19c                  -46.5(5) 
N1-C8-C3-C5                    128.8(3) 
N1-C8-C3-C2                      8.1(4) 
N1-C8-C3-H3                   -111.9(3) 
C9-C8-C3-C5                   -114.0(3) 
C9-C8-C3-C2                    125.4(3) 
C9-C8-C3-H3                      5.4(4) 
C7-C8-C3-C5                     10.1(4) 
C7-C8-C3-C2                   -110.6(3) 
C7-C8-C3-H3                    129.4(3) 
N1-C8-C9-S                    -174.8(2) 
N1-C8-C9-C10                   -52.8(4) 
N1-C8-C9-H90                    71.1(4) 
C3-C8-C9-S                      64.8(4) 
C3-C8-C9-C10                  -173.2(3) 
C3-C8-C9-H90                   -49.4(4) 
C7-C8-C9-S                     -54.2(4) 
C7-C8-C9-C10                    67.9(4) 
C7-C8-C9-H90                  -168.3(3) 
N1-C8-C7-C6                   -146.4(3) 
N1-C8-C7-H7a                   -18.2(6) 
N1-C8-C7-H7b                    92.7(4) 
C3-C8-C7-C6                    -27.8(4) 
C3-C8-C7-H7a                   100.4(5) 
C3-C8-C7-H7b                  -148.7(3) 
C9-C8-C7-C6                     96.1(4) 
C9-C8-C7-H7a                  -135.7(5) 
C9-C8-C7-H7b                   -24.7(4) 
C8-C3-C5-C6                     10.7(4) 
C8-C3-C5-H5a                   131.3(3) 
C8-C3-C5-H5b                  -119.3(5) 
C2-C3-C5-C6                    131.1(4) 
C2-C3-C5-H5a                  -108.3(4) 
C2-C3-C5-H5b                     1.1(6) 
H3-C3-C5-C6                   -107.4(4) 
H3-C3-C5-H5a                    13.2(5) 
H3-C3-C5-H5b                   122.6(5) 
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C8-C3-C2-O2                    -51.9(4) 
C8-C3-C2-C20                  -169.9(4) 
C8-C3-C2-H2                     59.8(5) 
C5-C3-C2-O2                   -170.1(3) 
C5-C3-C2-C20                    71.9(5) 
C5-C3-C2-H2                    -58.4(5) 
H3-C3-C2-O2                     67.7(4) 
H3-C3-C2-C20                   -50.3(5) 
H3-C3-C2-H2                    179.4(4) 
C17-C18-C13-S                  170.2(3) 
C17-C18-C13-C14                 -1.4(6) 
H18-C18-C13-S                    1.1(6) 
H18-C18-C13-C14               -170.5(4) 
C13-C18-C17-C16                  -.9(7) 
C13-C18-C17-H17               -180.0(4) 
H18-C18-C17-C16                169.1(4) 
H18-C18-C17-H17                -10.0(7) 
S-C9-C10-C11                  -179.5(3) 
S-C9-C10-H10b                  -58.3(4) 
S-C9-C10-H10a                   54.4(4) 
C8-C9-C10-C11                   52.2(5) 
C8-C9-C10-H10b                 173.4(3) 
C8-C9-C10-H10a                 -73.9(4) 
H90-C9-C10-C11                 -74.1(4) 
H90-C9-C10-H10b                 47.1(4) 
H90-C9-C10-H10a                159.8(3) 
S-C13-C14-C15                 -169.4(4) 
S-C13-C14-H14                   23.3(5) 
C18-C13-C14-C15                  2.0(7) 
C18-C13-C14-H14               -165.3(3) 
C8-C7-C6-C5                     34.8(5) 
C8-C7-C6-H6a                   -90.8(4) 
C8-C7-C6-H6b                   159.3(5) 
H7a-C7-C6-C5                   -94.5(6) 
H7a-C7-C6-H6a                  139.9(5) 
H7a-C7-C6-H6b                   30.0(8) 
H7b-C7-C6-C5                   160.8(3) 
H7b-C7-C6-H6a                   35.2(5) 
H7b-C7-C6-H6b                  -74.7(6) 
C3-C5-C6-C7                    -28.2(5) 
C3-C5-C6-H6a                    99.8(4) 
C3-C5-C6-H6b                  -157.6(4) 
H5a-C5-C6-C7                  -147.4(4) 
H5a-C5-C6-H6a                  -19.4(5) 
H5a-C5-C6-H6b                   83.2(5) 
H5b-C5-C6-C7                    97.9(6) 
H5b-C5-C6-H6a                 -134.2(5) 
H5b-C5-C6-H6b                  -31.6(7) 
C9-C10-C11-C12                 -52.4(5) 
C9-C10-C11-H11a                177.6(4) 
C9-C10-C11-H11b                 67.5(5) 
H10b-C10-C11-C12              -171.8(4) 
H10b-C10-C11-H11a               58.2(6) 
H10b-C10-C11-H11b              -51.9(5) 
H10a-C10-C11-C12                75.4(5) 
H10a-C10-C11-H11a              -54.6(6) 
H10a-C10-C11-H11b             -164.7(4) 
N1-C12-C11-C10                  56.8(5) 
N1-C12-C11-H11a               -174.1(4) 
N1-C12-C11-H11b                -56.0(5) 
H12a-C12-C11-C10              -176.4(4) 
H12a-C12-C11-H11a              -47.4(7) 
H12a-C12-C11-H11b               70.8(5) 
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H12b-C12-C11-C10               -67.6(5) 
H12b-C12-C11-H11a               61.5(6) 
H12b-C12-C11-H11b              179.7(3) 
C18-C17-C16-C15                  2.6(8) 
C18-C17-C16-H16               -179.2(4) 
H17-C17-C16-C15               -178.4(5) 
H17-C17-C16-H16                  -.1(8) 
O2-C2-C20-H20a                 -71.6(6) 
O2-C2-C20-H20b                -172.3(3) 
O2-C2-C20-H20c                  39.3(6) 
C3-C2-C20-H20a                  48.2(7) 
C3-C2-C20-H20b                 -52.5(5) 
C3-C2-C20-H20c                 159.1(4) 
H2-C2-C20-H20a                -176.2(5) 
H2-C2-C20-H20b                  83.1(5) 
H2-C2-C20-H20c                 -65.3(7) 
C13-C14-C15-C16                  -.3(8) 
C13-C14-C15-H15               -175.5(5) 
H14-C14-C15-C16                164.1(5) 
H14-C14-C15-H15                -11.2(9) 
C17-C16-C15-C14                 -2.0(9) 
C17-C16-C15-H15                172.6(6) 
H16-C16-C15-C14                180.0(5) 
H16-C16-C15-H15                   -5(1)
176
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List of Abbreviations 
[α]D specific optical rotation 
Ac acetyl 
AEI route addition-elimination-isomerisation route 
All* chiral allyl rest 
Ar aryl 
Bn benzyl 
Boc tert-butoxycarbonyl 
Bu butyl 
i-Bu i-butyl
n-Bu n-butyl 
sec-Bu sec-butyl 
t-Bu tert-butyl 
Bus tert-butylsulfonyl 
Cbz or Z benzyloxycarbonyl 
CI chemical ionisation 
Cy cyclohexyl 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
DIBAL-H diisobutylaluminium hydride 
DMF N,N-dimethylformamide 
DMSO dimethylsulfoxide 
ee enantiomeric excess 
er enantiomeric ratio 
δ chemical shift 
d day 
de diastereomeric excess 
dppe bis(diphenylphosphino)ethane 
dr diastereomeric ratio 
EI electronic impact 
Et ethyl 
eV electronvolt 
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HPLC high performance liquid chromatography 
HRMS high resolution mass spectroscopy 
IR infrared spectroscopy 
J coupling constant (in NMR spectroscopy) 
LDA lithium diisopropylamine 
LDBB Lithium di-tert-butylbiphenyl 
LG leaving group 
LTA4 leukotriene A4
M molar 
Me methyl 
MEM 2-methoxyethoxymethyl 
Mes 2,4,6-trimethylphenyl (mesityl) 
mol mole 
m.p. melting point 
MS mass spectroscopy 
ν wave number 
NBS N-bromosuccinimide 
NMO N-methylmorpholinoxide 
NMR nuclear magnetic resonance 
NOE nuclear OVERHAUSER effect 
cPLA2 cytosolic phospholipase A2
i-Pr iso-propyl 
PG Protecting group 
RCM ring-closing metathesis 
rt room temperature 
TBDPS tert-butyldiphenylsilyl 
TBS tert-butyldimethylsilyl 
TFA trifluoroacetic acid 
THF tetrahydrofurane 
THP tetrahydropyrane 
TMEDA tetramethylethylendiamine 
TMS trimethylsilyl 
TMS-allyl allyltrimethylsilane 
Tol p-toluyl 
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TOCSY total correlation spectroscopy 
Ts p-toluenesulfonyl (tosyl) 
TS transition state 
VCAM-1 Vascular cell adhesion molecule - 1 
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Classes Préparatoires scientifiques, Lille (F) 
2001-2004 Advanced courses in chemistry, Lille (F) 
09.2003 Erasmus program at the RWTH Aachen University (D) 
-09.2004 including master thesis under the supervision of Prof. Dr. Gais 
10.2004 Degree of Master of Science in Chemistry of the ENSCL: Ecole 
Nationale Supérieure de Chimie de Lille (F) 
11.2004 Degree of Master of Science in the field of organic and macromolecular 
chemistry of the University of Lille (F) 
2005-2007 PhD studies at the RWTH Aachen University (D) 
Under the supervision of Prof. Dr. Gais 
